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 i 
Abstract 
This thesis describes the diastereoselective synthesis of 2,4,5-trisubstituted piperidines using 
carbonyl-ene and Prins cyclisations and their application in natural product synthesis. 
Following on from previous work in the group, we investigated how a preinstalled substituent 
in the 2-position can help to control the sense of induction at the two newly forming 
stereocentres.  
 
We utilised the Prins reaction in the formal synthesis of pseudodistomin F, a marine alkaloid 
that posses a 2,4,5-tribsubstituted piperidine core.  An initial first generation synthesis 
focused on the construction of a cyclisation precursor containing a crotyl-ene component, 
however, cyclisation with anhydrous hydrogen chloride at -78 °C resulted in side product 
formation, presumably resulting from the relative instability of the secondary carbocation. 
Changing the ene component to a prenyl group resulted in successful cyclisation to yield the 
trans, cis-2,4,5-trisubstituted piperidine, with diastereomeric ratios of up to 200:1. An 
improved second generation synthesis completed the formal synthesis of pseudodistomin F on 
a multi-gram scale. Progress towards the total synthesis of pseudodistomin F by a third 
generation synthesis was undertaken.  
  
An investigation into how varying the electronics of the Prins reaction would alter the 
diastereoselectivity was conducted with a range of para-substituted cinnamyl substrates. The 
results indicated that selectivity in favour of the trans diastereomer was favoured as the 
electron withdrawing power of the substituent increased. 
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“Total synthesis has been hailed as a highly demanding and exacting science, but it is also 
recognized in its finest form as an art” 
 
- K. C. Nicolaou 
 1 
1. Introduction 
1.1 Piperidines 
The piperidine structural motif 1 appears frequently in natural products and synthetic 
compounds that possess potent biological activity. For example, the powerful analgesic 
morphine 2 extracted from the poppy, Papaver somniferum, has been used by mankind since 
antiquity.1 The antidepressant Seroxat 3, a synthetic drug, marketed by the pharmaceutical 
company GlaxoSmithKline has been listed in the top 100 best selling drugs with sales of over 
$1 billion.2,3 Quinine 4 extracted from the bark of the cinchona tree, Cinchona officinalis, has 
been used for many centuries in the treatment of malaria.4 Pseudodistomin A 5 isolated from 
the tunicate, Pseudodistoma kanoko, exhibits potent anti-tumour activity and is part of a wider 
family of marine alkaloids5 (Figure 1).  
 
Figure 1: The piperidine structural motif  
 2 
The importance of biologically active molecules such as these drives research towards novel 
routes for the stereocontrolled synthesis of piperidines that display diverse substitution 
patterns. Molecules 4 and 5 both display a 2,4,5-trisubstituted piperidine ring pattern and 
methods in the literature for the synthesis of such systems are considerably underdeveloped.6-9 
 
1.2 Pseudodistomins 
At present there are six members of the pseudodistomin family, pseudodistomins A-F; they 
consist of a core containing a 2,4,5-trisubstituted piperidine ring and differ from one another 
in configuration at their stereogenic centres and nature of the alkyl side chain (Figure 2). 
 
H
N
H
N
H
NR R R
OH
NH2
OH
NH2 NH2
OH
A : R = R1 (5)
B : R = R2 (6)
F : R = R3 (10)
C : R = R1 (7)
E : R = R3 (9)
D : R = R2 (8)
R1 =
R2 =
R3 =
2
4 5
 
 
Figure 2: Pseudodistomins A-F 5-10 
 
Pseudodistomins A 5 and B 6 were isolated from the Okinawan tunicate Pseudodistoma 
kanoko (Image 1) by Kobayashi et al in 1987, making them the first piperidine alkaloids to be 
discovered from a marine source.5 Their proposed side chains were later revised,10,11 and 
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absolute configurations were subsequently determined.12 Pseudodistomin C 7 was later 
isolated from the same tunicate.13 It is considered unusual that pseudodistomins A 5 and B 6 
possess the opposite absolute configurations at (4)-hydroxyl and (5)-amino compared to 
pseudodistomin C 7 isolated from the same tunicate because the proposed biosynthetic 
pathway for pseudoditomins A 5 and B 6 incorporates L-serine while pseudodistomin C 7 
incorporates the much rarer D-serine.14 Three new pseudodistomins D-F 8-10 were isolated 
along with known pseudodistomins B 6 and C 7 from the ascidian Pseudodistoma megalarva 
(Image 1) by Freyer et al in 1997 off the coast of Palau.15  
 
 
 
 
Image 1: From left to right: Pseudodistoma kanoko16 and Pseudodistoma megalarva17 
 
 
Their biological activities were investigated and the pseudodistomin alkaloids were shown to 
exhibit calmodulin antagonistic activity, potent in vitro activity against murine leukemia and 
human epidermoid carcinoma KB cells and were also found to be active in a cell-based assay 
for DNA damage induction.5,13,15 In view of their interesting pharmacological activity and 
unusual structural features, they have become popular synthetic targets. However, a number 
of routes have been limited to the racemic syntheses or the synthesis of simpler analogues 
such as tetrahydropseudodistomin 11 (Figure 3). 
 4 
a Synthesis of incorrectly proposed structure. b Formal synthesis. c Ongoing research. 
H
NR
OH
NH2
R =
11
 
Figure 3: Tetrahydropseudodistomin 11 
 
 
 A summary of the efforts made by the synthetic community towards the construction of the 
pseudodistomin alkaloids is listed below (Table 1). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Table 1: Summary of pseudodistomin syntheses 
 
Year Author Achievement 
1992 Naito, T. (±)-tetrahydropseudodistomin18 
1992 Natsume, M. (±)-tetrahydropseudodistomin19 
1992 Naito, T. and Kobayashi, J. (±)-pseudodistomin B10 
1993 Knapp, S. (+)-tetrahydorpseudodistomin12 
1996 Kobayashi, J. (-)-pseudodistomin C14 
1996 Naito, T. (±)-pseudodistomin Aa, 20 
1996 Naito, T. (±)-tetrahydropseudodistomin21 
1997 Naito, T. (±)-pseudodistomins A and B22 
1998 Naito, T. (+)-tetrahydorpseudodistomin23 
2000 Ma, D. and Sun, H. (-)-pseudodistomins B and F24 
2002 Langlois, N. (-)-pseudodistomin Cb, 25 
2005 Davis, F.A. (-)-pseudodistomin Bb, 26 
2005 Trost, B.M. (+)-pseudodistomin D27 
2005 Haddad, M. studies towards (+)-pseudodistomin D28 
2006 Tanaka, K. (-)-pseudodistomin Cb, 29 
2007 Chandrasekhar, S. (+)-tetrahydorpseudodistomin30 
2009 Woerpel, K.A. studies towards (+)-pseudodistomin B31 
2010 Davies, S.G. (+)-pseudodistomin Dc, 32 
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The literature examples presented below focus on the synthesis of these small but densely 
functionalised natural products in an attempt to show the development from initial attempts 
through to the state of the art in this area. Focus is on the key steps and examples are chosen 
based on diversity and stereocontrol. 
 
The first total synthesis of pseudodistomin C 7 by Kobayashi (Scheme 1),14 utilised D-serine 
derived Garner’s aldehyde33 12 as a starting point. Grignard addition into 12 followed by an 
oxidation-reduction sequence gave the erythro-alcohol 13 with good diastereoselectivity of 
96% de but disappointingly resulted in erosion of enantiopurity with a 60% ee. The erythro-
alcohol 13 was converted to carbamate 14 in seven steps, which set up the key ring forming 
step, a intramolecular amidomercuration, to afford the piperidine products 15 and 16, 
unfortunately with poor diastereocontrol of 1:1.5 in favour of the desired diastereomer 16. A 
further six steps were required to complete the synthesis of pseudodistomin C 7, which 
included a Julia olefination34 to install the side chain. The overall yield was 0.4%, with 
seventeen steps in the longest linear sequence. 
 
O
NOHC
Boc
O
N
BocOH
NHBoc
NBoc
O
Boc
N
O
NBoc
BrHg
Boc
N
O
NBoc
BrHg
H
N
OH
NH2
1) CH2=CHCH2MgBr, quant.
2) DMP, DMF, 68%
3) Zn(BH4)2, benzene:Et2O,
     quant.
7-steps
i) Hg(OAc)2, CHCl3
ii) NaBr, NaHCO3
            84%
6-steps
12 13 14
7
15 16
 
Scheme 1: Kobayashi’s synthesis of pseudodistomin C 7 
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Naito’s synthesis of (+)-tetrahydorpseudodistomin 11 (Scheme 2)23 is notable for its brevity 
rather than its stereocontrol, requiring only eight synthetic steps to complete. The route 
involves two key reactions: first, an intermolecular [3+2] cycloaddition of nitrone 17 with 
vinyl glycinol 18, derived from D-methionine tert-butylester, gave all four possible 
isoxazolidine stereoisomers 19-22 in a 2:3:3:5 mixture, respectively, with the desired isomer 
19 as the minor component; secondly, bicycle formation with mesyl chloride gave the bridged 
piperidine 20. Subsequent reduction by hydrogen in the presence of Pearlman’s catalyst gave 
the corresponding 2,4,5-trisubstituted piperidine 21; removal of the protecting group gave the 
product 11 in an overall yield of 3%. 
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20 21  
Scheme 2: Key transformations in Naito’s synthesis of (+)-tetrahydropseudodistomin 11 
 
 
Ma and Sun have developed a general method for the synthesis of pseudodistomins 
containing the (2R, 4R, 5S)-piperidine core and have showcased the method through the 
synthesis pseudodistomins B & F.24 The shorter synthesis of pseudodistomin F (Scheme 3) 
employed a Dieckmann condensation of diester 22 and silylation of the intermediate enolate 
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to afford a mixture of the two regioisomeric silyl enol ethers 23 and 24 with a poor selectivity 
of 1.6:1 in favour of the desired product. Serendipitously, Raney Nickel hydrogenation of the 
crude reaction mixture selectively reduced 23 over 24, and this was followed by treatment 
with tosic acid in methanol to gave piperidine 25 and piperidinone 26. Four steps were 
required convert the ester into a protected amine 27 and a further eight steps to complete the 
synthesis of the natural product in a total of twenty three steps and an overall yield of 4%. 
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Scheme 3: Key transformations in Ma and Sun’s synthesis of pseudodistomin F 10 
 
 
The Trost synthesis of Pseudodistomin D (Scheme 4)27 employed a regio- and 
diastereoselective reductive intramolecular hydroamination step to construct the core. The 
cyclisation precursor 28 was obtained through a convergent synthesis, in a total of seventeen 
steps, which included: an epoxidation of alkene 29 that proceeded with modest 
diastereoselectivity of 4:1 in favour of the desired epoxide 30; addition into the terminal end 
of the epoxide with alkyne 31 gave 32, treatment with TBSOTf removed the Boc protecting 
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groups and simultaneously protected the hydroxyl. Treatment of diamino alkyne 28 with 
silver tosylate and sodium cyanoborohydride afforded piperidine 33. They report that this step 
afforded a single detectable diastereomer and gave exclusively the piperidine without any 
pyrrolidine by-products, although the yield was a somewhat modest 55%.  
 
i) 10% AgOTs, MeCN, 40 °C, 2 h
ii) NaBH4CN, MeOH, AcOH, H2O, THF
    (55% over 2 steps)
28
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N
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R
NH2
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R =
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NHBoc
BocHN
NHBoc   mCPBA, NaHCO3, 
CH2Cl2, 84%, dr = 4:1 R
+
n-BuLi, Me2AlCl, to
-20 °C - rt, 91%
NHBoc
R
OH
NHBoc
i) TBSOTf, 2,6-lutidine, CH2Cl2, Δ
ii) MeOH, AcOH, H2O, THF
O
30 31
32
33  
Scheme 4: Trost’s synthesis of pseudodistomin D 8 
 
The authors put forward several explanations in order to rationalise the selective formation of 
the piperidine product 33.  One explanation is that the hydroamination of alkyne 28 proceeds 
through a kinetic 5-exo-dig cyclisation to afford imine 34, which is in rapid equilibrium with 
imine 36 (Scheme 5). They reasoned that the reduction of imine 36 was favoured due to a 
faster rate of reduction of an sp2 to an sp3 carbon in a six-membered ring compared to five-
membered ring. An alternative explanation offered relates to the equilibrium strongly 
favouring imine 36, with the observed selectivity simply the result of the reduction of the 
dominant species.  
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Scheme 5: Trost’s proposed mechanism for piperidine formation 
 
 
The total synthesis was achieved in a 13% yield for the longest linear sequence. Installation of 
the side chain early on limits this approach for the synthesis of the whole family of 
pseudodistomin alkaloids. 
 
Tanaka’s formal synthesis of pseudodistomin C (Scheme 6)29 resulted in the formation of an 
advanced intermediate 37 from Kobayashi’s total synthesis.14 Starting from known ,-
epoxylactam35 38, derived from L-pyroglutamic acid, they constructed the azido pyrrolidinone 
derivative 39 in six steps. Intramolecular transamidation of azido γ-lactam 39 was performed 
in the presence of 10% Pd-C under three atmospheres of hydrogen to afford the δ-lactam 40. 
Another six steps were required to complete the formal synthesis, which included a Tebbe 
olefination and hydroboration to install the final stereocenter with complete diastereocontrol. 
Although one synthetic step longer than Kobayashi’s original synthesis, eighteen steps 
compared to seventeen, it is a marked improvement over the original due to the higher levels 
of stereocontrol and overall yield of 10% compared to the original yield of 6% at the same 
stage. However, the real limitation of this synthesis is that relies on Kobayashi’s endgame 
strategy, which gave very poor yields of 13% and 34% for the penultimate and final steps 
respectively.  
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Scheme 6: Tanka’s formal synthesis of pseudodistomin C 7 
 
Recently, Woerpel has developed an annulation/ring expansion strategy that enabled access to 
the core structure of pseudodistomin B (Scheme 7).31 A [3+2] annulation of -silyloxy allylic 
silane 41 with chlorosulfonyl isocyanate (CSI) followed by reduction of the resulting N-
chlorosulfonyl lactam and nitrile substitution of the silyl ether with Et2AlCN provided the γ-
lactam 42. A similar intramolecular transamidation approach to that used by Tanaka afforded 
the ring expanded δ-lactam 43. This was reduced to an N,O-acetal and subsequent 
nucleophilic substitution with 44 gave piperidine 45 as a single diastereomer. Oxidation of the 
silyl group to the corresponding hydroxyl 46 completed the synthesis, which in 15 synthetic 
steps and an overall yield of 16% constructed the core structure and installed a precursor to 
the side chain of pseudodistomin B. Unfortunately the [3+2] annulation step early on in the 
synthesis was not amenable to a multi-gram scale because of the use of toxic and corrosive 
CSI. This may limit further attempts to complete the total synthesis in the future. 
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Scheme 7: Woerpel’s study towards the synthesis of pseudodistomin B 5 
 
 
A number of different approaches have been presented for the synthesis of piperidines 
forming the core of the pseudodistomin alkaloids ranging from: amido mercuration, nitrone 
cycloaddition, Dieckmann condensation, reductive hydroamination and intramolecular 
transamidation. These reactions proceed through either C-C or C-N bond formation with 
concomitant creation of new stereogenic centres. Another class of reactions that have proved 
to be valuable in the synthesis of piperidines are the carbonyl-ene and Prins cyclisations.  
 
1.3 Carbonyl-ene and Prins reactions 
The reaction between an aldehyde or ketone and an alkene allows the formation of two 
contiguous stereocentres and under the correct conditions can proceed with a high degree of 
regio- and stereocontrol.36,37 When the reaction occurs under thermal or Lewis acidic 
conditions it is usually known as the carbonyl-ene reaction,38 whereas the same reaction in the 
presence of a Brønsted acid is usually known as the Prins reaction.39 Mechanistically, both the 
carbonyl-ene and Prins reaction occur through the interaction of an alkene possessing an 
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allylic hydrogen 47, the ene component, and an electron deficient multiple bond, behaving as 
the enophile component, an aldehyde or ketone 48. The process involves a [1,5]-shift of the 
allylic hydrogen from the ene 47 to the enophile 48 and migration of the ene π-bond to form a 
new -bond between the ene 47 and enophile 48, leading to a homoallylic alcohol product 49 
(Scheme 8).40  
O
H O
∗
R2
R3H
∗
49
R1
R2
R3
R1
4748  
Scheme 8: General mechanism for a carbonyl-ene/Prins reaction 
 
The carbonyl-ene reaction is mechanistically related to the Diels-Alder reaction as both 
proceed through a cyclic six electron transition state and it can be considered as a pericyclic 
reaction, although the ene and carbonyl-ene reactions are not necessarily concerted processes.  
In ene and carbonyl-ene reactions the two electrons of the allylic C-H bond replace two π-
electrons in the diene of the Diels-Alder reaction. This has the consequence of raising the 
activation energy compared to an analogous Diels-Alder reaction and so higher reaction 
temperatures are required.41 In the past, this limited its mechanistic study and synthetic use 
causing it to be overlooked in favour of the more renowned Diels-Alder reaction. This was 
until Snider et al. discovered that the carbonyl-ene reaction could be catalysed efficiently 
through the use of Lewis acids.42-44 Complexation of a Lewis acid to the carbonyl has the 
effect of lowering the LUMO of the enophile, allowing facile attack by the ene. Fuki et al. has 
studied the more general case of the ene reaction, where the enophile is also an alkene, using a 
frontier molecular orbital approach.45 They considered that a single orbital for the ene 
component has too small a coefficient at the C-H site for an effective cyclic interaction to 
occur. So a three orbital interaction was proposed with a suprafacial-suprafacial interaction 
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between: the HOMO of the π-bond and the LUMO of the C-H -bond in the ene; and the 
LUMO of the π-bond in the enophile (Scheme 9). 
H H
Eneophile Dienophile
Ene Diene
π−bond LUMO π−bond LUMO
π−bond HOMO
π−bond HOMO
σ−bond LUMO
Ene Reaction Diels-Alder Reaction  
Scheme 9: FMO interactions in ene and Diels-Alder reactions 
 
Such an interaction implies that once the HOMO of the π-bond donates electrons to LUMO of 
the enophile, back donation occurs to the LUMO of the C-H -bond of the ene. This would 
lead to an asynchronous concerted mechanism where C-C bond formation is more advanced 
than C-H bond formation in the transition state (Figure 4).46  
H
Eneophile
Ene
 
Figure 4: Ene reaction envisaged as an asynchronous concerted process 
 
The mechanism of the carbonyl-ene reaction is not so clear-cut and different mechanisms 
have been suggested for different carbonyl-ene reactions. However, Lewis acid promoted ene 
reactions are usually considered in terms of the continuum from a concerted mechanism 51, 
with a polar transition state, through to a stepwise mechanism proceeding through a 
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zwitterionic intermediate 50 (Scheme 10).47,48 The energetics of the two reaction pathways 
have been shown to be very similar and the course of the reaction varies as a function of ene, 
enophile and catalyst.49,50  
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H51
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Scheme 10: Carbonyl-ene reactions proceed through either a concerted or stepwise process 
 
The Prins reaction is considered to proceed through a stepwise process via a cationic 
intermediate 52. This carbocation can react with an external nucleophile, such as water or 
chloride, to give 53, add to a second molecule of aldehyde to give 54 or lose a proton to give a 
homoallylic alcohol 55 (Scheme 11).51 
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55  
Scheme 11: Mechanism of the Prins reaction 
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Recently, the application of organocatalytic chiral Brønsted acids has been reported that can 
deliver high levels of asymmetric induction.52,53 
Intramolecular ene reactions are more facile than their intermolecular counterparts due to a 
lower loss of entropy in the transition state as the intermolecular reaction requires pre-
organisation of two separate moieties. Intramolecular reactions have been shown to be an 
efficient method for ring closure, since they can proceed with high degrees of regio- and 
stereoselectivity through postulated six-membered chair-like transition states. Oppolzer 
classified intramolecular ene reactions into three distinct variants, types I, II and III, 
depending on the attachment position of the connecting ene and enophile.54 Another variant is 
the Conia-ene reaction of unsaturated ketones, where the enol tautomer of the carbonyl serves 
as the ene component (Scheme 12).55  
 
O O
O
H
OH
O
H
OH
H
Type I
Type II
Type III
O OOH
Conia-ene
 
Scheme 12: Carbonyl-ene reaction variants 
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In type I reactions, the enophile is linked to the olefinic terminal, with C-C bond formation 
occurring between the carbonyl and internal carbon of the olefin. This type of reaction is most 
commonly encountered in the formation of five and six-membered rings.56 The type II 
carbonyl-ene reaction, involves C-C bond formation to the terminal carbon of the olefin and 
has been employed in the construction of six and seven-membered rings. The type III reaction 
has the olefin side chain attached to the carbonyl oxygen with the oxocarbenium ion 
generated in situ, usually derived from acetals or hemiacetals, giving rise to cyclic ethers. The 
Conia-ene reaction between an activated carbonyl and an alkene or alkyne usually requires 
very high temperatures. The use of transition metals has been shown to catalyse the reaction 
effectively at ambient temperatures, though the reaction is not thought to proceed through a 
classical ene-type pericyclic mechanism in those cases.57 
1.4 Piperidine synthesis via carbonyl-ene and Prins reactions  
There are relatively few literature examples of piperidine synthesis and nitrogen heterocycles 
in general via carbonyl-ene reactions. Laschat reported the diastereoselective synthesis of 
indolizidine 56 and quinolizidine 57 derivatives.58 Aldehydes 58 and 59 were treated with the 
Lewis acid FeCl3 to afford the cis products 56b and 57b in very high diastereoselectivities 
(Scheme 13).  
NN
2.5 eq FeCl3
CH2Cl2, rt
58 n = 1
59 n = 1
OH OH
HH
(  )n (  )n
CHO
N
(  )n
56a n = 1               1.6:98.4            56b n = 1, 65%
57a n = 2               0.2:99.8            57b n = 2. 59%
 
Scheme 13: Laschat’s carbonyl-ene cyclisations 
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More recently, they have reported the synthesis of a non-peptidic substance P antagonist 60.58 
Aldehyde 61, prepared from phenylglycine, underwent a carbonyl-ene reaction to give two 
diastereomeric piperidines 62 and 63 in a modest diastereoselectivity of ~1:4 (Scheme 14).  
2.2 eq, FeCl3
CH2Cl2, rt
61
Bn
N
O
Ph
Bn
N
OH
Ph
Bn
N Ph
OH
Bn
N Ph
N
H
OMe
6062, 16% 63, 71%  
Scheme 14: Laschat’s synthesis of a substance P antagonist 60 
 
Initial work in our group focused on the synthesis of 3,4-disubstituted piperidines through the  
use of carbonyl-ene and Prins reactions employing aldehyde 64 as the cyclisation precursor 
(Scheme 15).59,60 
Ts
N
O
Ts
N
OH
Ts
N
OH
L.A. or B.A.
Ts
N
OH
Cl
64 65 66 67  
Scheme 15: Initial carbonyl-ene and Prins reactions studied in the Snaith group 
 
Extensive screening of catalysts, catalyst loadings, reaction temperatures and reaction times 
were conducted to assess their effects on altering the diastereoselectivity of the reaction. It 
was shown that the diastereoselectivity could be switched between trans 65 and cis 66 
diastereomers using either Lewis or Brønsted acids (Table 2). The use of the Lewis acid 
MeAlCl2 was found to favour the trans diastereomer 65 with ratios of up to 92:8 (Table 2, 
entry 3). The temperature effect on the carbonyl-ene reaction suggested that under these 
conditions the reaction is reversible and that the cis diastereomer 66 is the kinetic product, 
equilibrating to the thermodynamic trans product 65 upon warming. The use of concentrated 
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hydrochloric acid (Table 2, entry 4) was found be a very effective catalyst in the Prins 
reaction, favouring the cis piperidines of 66 and 67 with ratios up to 97:3 (66+67:65). 
 
 
 
 
 
 
 
 
 
Table 2: Initial carbonyl-ene and Prins reaction results 
 
As mentioned before the carbonyl-ene reaction is highly dependent on the ene, enophile and 
Lewis acid used. Therefore, slight modifications of the ene component were studied. It was 
thought that Z- 68 and E- crotyl 69 substrates would serve as useful probes into the reaction 
mechanism. If, as believed, the reaction proceeded through a chair-like transition state via a 
concerted mechanism then the cyclisation of Z-crotyl aldehyde 68 would only proceed when 
the aldehyde is in a pseudo-axial conformation due to the more sterically demanding ene 
adopting a pseudo-equatorial conformation. This orientation would lead to the formation of 
the cis piperidine 70. Adopting the same idea for the E-crotyl aldehyde 69 would lead to the 
aldehyde component adopting the pseudo-equatorial conformation in the transition state 
leading to the formation of the trans product 71 (Scheme 16).  
 
Entry Catalyst 
Temp / 
°C 
Solvent 
Time / 
h 
Ratio 
65:66:67a 
Yield / %b 
1 MeAlCl2, 1eq -78 CH2Cl2 8 33:67:0 58 (14) 
2 MeAlCl2, 1eq 25 CH2Cl2 16 67:33:0 55 (15) 
3 MeAlCl2, 1eq 61 CHCl3 16 92:8:0 74 
4 HCl(aq),  3eq -78 CH2Cl2 16 5:90:5 86 
a Ratio determined by 1H NMR of crude reaction mixtures. b Isolated yields of major (minor in 
parentheses). 
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Scheme 16: Transition states for a concerted mechanism 
 
 
When both substrates 68 and 69 were subjected to a cyclisation reaction under Lewis acid 
conditions, both led to the cis piperidine 70 with none of trans diastereomer 71 observed. This 
result suggested that a concerted mechanism was unlikely and a reaction mechanism that 
proceeds with significant stepwise character was postulated.  
 
However, under Prins reaction conditions both substrates 68 and 69 failed to cyclise. As the 
Prins reaction is generally thought to proceed through a stepwise mechanism via a 
carbocationic intermediate 72, it would require substrates 68 and 69 to react through a less 
favourable secondary carbocation  (Scheme 17). 
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N
O
N
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68 or 69
OH
HCl
72  
 
 
Scheme 17: Prins reactions through a relatively unstable secondary carbocation 
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In the carbonyl-ene cyclisation it was proposed that aldehydes 68 and 69 would proceed 
through a common low energy pathway leading to the formation of the cis product 70 
(Scheme 18). 
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Scheme 18: Proposed reaction mechanism 
 
 
The pathway leading to the cis piperidines 65 and 70 was thought to be lowest in energy due 
to a stabilising interaction coming from a good overlap between the filled oxygen sp3 orbital 
containing the lone pair and the vacant p-orbital of the carbocation in an intermediate or 
carbocationic character in a transition state. This overlap only exists when the hydroxyl group 
and cation occupy pseudoaxial and pseudoequatorial positions i.e. cis stereochemistry. This 
stereoelectronic stabilisation does not occur in the trans isomer due to poorer overlap of the 
orbitals.  Clark has implied such a stabilizing interaction when he studied the cyclisation of 
citronellal.61 
 
DFT calculations (B3LYP/6-31G(d)) were performed and indicated that the cis carbocation 
resulting from a stepwise cyclisation mechanism was more stable by 0.82 kcal compared to 
the trans carbocation. Calculations for the transition states resulting from a concerted 
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cyclisation mechanism were also performed and indicated that the cis transition state was 
more stable by 0.79 kcal (Figure 5).62 
OH
TsN
R
TsN OH
R
R = H, Me
stabilised carbocation
leading to the cis isomer
non-stabilised carbocation
leading to the trans isomer
 
Figure 5: Stabilising interaction favouring the cis diastereomer  
 
 
Mohan has studied the carbonyl-ene reaction between aldehyde 64 and bismuth triflate as a 
catalyst.63 Impressively, the catalyst could be employed in loadings as low as 0.1 mol%. 
Unfortunately, they could only achieve a modest diastereoselectivity of 70:30 for piperidines 
60 and 59 (Scheme 19). 
Ts
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OH
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N
OH
0.1 mol% Bi(OTf)3.xH2O
CH2Cl2, rt, 10 min
64 66 65  
Scheme 19: Carbonyl-ene reaction of aldehyde 64 with Bi(OTf)3 studied by Mohan 
 
More recent work in the group has made use of an existing stereogenic centre at the 
2-position. The cyclisation of aldehyde precursors 73 could have led to four possible 
diastereoisomers 74-77. It was anticipated that the existing stereogenic centre R would help to 
control the sense of induction at the two newly forming stereogenic centres, working in 
concert with the diastereocontrol model outlined above to afford 2,4,5-trisubstituted 
piperidines (Scheme 20).64 
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a Ratio determined by 1H NMR of crude reaction mixtures. b Isolated yields 
of major (minor in parentheses) isomers following purification. c Reaction 
carried out with a saturated solution of HCl(g). 
d No trans isomer was detected 
due to intramolecular lactone formation .  
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Scheme 20: Synthesis of 2,4,5-trisubstituted piperidines 
The Prins cyclisation of aldehydes 73a-f were studied using the optimised conditions of three 
equivalents of concentrated hydrochloric acid in CH2Cl2 at -78 °C. Only two out of the 
possible four diastereomers were observed, the major isomer was the cis, cis diastereoisomer 
74 while the minor isomer was the trans-trans diastereoisomer 76, summarised in (Table 3).65 
 
 
 
 
 
 
 
Table 3: Prins cyclisation results 
 
The selectivity decreases as the R group increased in size. For smaller R groups (Table 3, 
entries 1-3 and 6) the diastereoselectivity ranged from excellent to moderate. The reaction 
with the Me substituent (Table 3, entry 1) was slow to cyclise and it was believed that some 
Entry Aldehyde R 74 : 76a Yield (%)b 
1 73a Me 78 : 22 70 (22) 
2 73b Bn 94 : 6 70 (3) 
3 73c iPr 80 : 20 75 (19) 
4 73d tBu 47 : 53 42 (37) 
5 73e Ph 54 : 46 53 (40) 
6 73fc CO2Me
 100 : 0d 74 
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equilibration to the thermodynamic isomer occurred during the reaction. Reaction with 
CO2Me substituent (Table 3, entry 6) led only to the cis diastereomer because of 
intramolecular lactone formation between the hydroxyl and ester groups preventing 
equilibration to the trans diastereomer. For the bulkiest substituents, (Table 3, entries 4-5), 
there was almost no selectivity. The selectivity could be rationalised by considering two 
factors. Firstly, there is a preference for the R group to adopt a pseudo-axial conformation in 
the chair-like transition state to avoid pseudo A1,3 strain with the nitrogen protecting 
group.66,67 Secondly, there is a kinetic preference for the ene group and aldehyde to adopt a 
cis relationship in order to benefit from a interaction of an oxygen lone pair stabilising any 
carbocationic character in the transition state (or a carbocationic intermediate, formed during 
a fully stepwise mechanism). The cis relationship is achieved by the aldehyde lying in a 
pseudo-axial orientation and the more sterically demanding ene component occupying the 
pseudo-equatorial orientation (Scheme 21).  As the steric bulk of the 2-substituent increased 
the diastereoselectivity decreased, this was rationalised by an increased pseudo 1,3-diaxial 
interaction between the carbonyl and 2-substituent, which forced the aldehyde into an 
equatorial position.  
N
OH
R
N
R
Ts
Ts N
R OH
Ts
OH
N
R
Ts
OH  
Scheme 21: Rationale for the preferential formation of the cis diastereomer 
 
In the carbonyl ene cyclisations of aldehydes 73, utilising the optimal Lewis acid of MeAlCl2 
under equilibrating conditions, the thermodynamic trans, trans products 76a-e could be 
favoured (Table 4) 
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Table 4: Carbonyl-ene cyclisation results 
 
The diastereoselectivities ranged from good to excellent, with the bulkier substituents giving 
the highest diastereoselectivities of up to 99:1 for tBu (Table 4, entry 4). The rationale for the 
observed diastereoselectivity was a large 1,3-diaxial interaction between the axial 2-
substituent and the Lewis acid-coordinated aldehyde oxygen, compared to the Brønsted acid 
where the steric clash between the protonated oxygen of the carbonyl and the R group is less 
pronounced, leading to the aldehyde adopting the equatorial conformation. Such an 
interaction would account for the increased trans, trans diastereoselectivity as the 2-
substituent increases in size (Scheme 22). 
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Scheme 22: Rationale for the preferential formation of the trans, trans diastereomer 
 
 
 
Entry Aldehyde R Temp / °Ca 74 : 76b Yield (%)c 
1 73a Me 60 4 : 96 71 (4) 
2 73b Bn 40 5 : 95 64 (5) 
3 73c iPr 40 2 : 98 82 (2) 
4 73d tBu 60 1 : 99 88 (1) 
5 73e Ph 60 2 : 98 80 (2) 
a Reactions were carried out in CH2Cl2 (40 °C) or CHCl3 (60 °C)
  b Ratio determined by 
1H NMR of crude reaction mixtures. c Isolated yields of major (minor in parentheses) 
isomers following purification 
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1.5 Project Aims 
The real test of any methodology and its establishment as a valuable chemical tool is its 
application in natural product synthesis. We plan to apply the carbonyl-ene/Prins 
methodology developed in our group to the synthesis of the pseudodistomin alkaloids. We 
believe the methodology is powerful enough to synthesise all the possible diastereomers of 
the 2,4,5-trisubstiuted piperidine core and would furnish cores with sufficient flexibility for 
the attachment of all possible side chains, which would make it very adept to the synthesis of 
new analogues in the hope of testing for improved biological activity.  
 
Following on from previous work in the group we want to further the development of 
2,4,5-trisubstituted piperidine synthesis. It has been shown that access to 2,4,5-trisubstituted 
piperidines possessing the cis, cis stereochemistry 74 is possible, matching the 
stereochemistry of pseudodistomins C 7 and E 9. To access the previously unobtainable trans, 
cis 79 and cis, trans 80 diastereomers, which would lead to pseudodistomins A 5, B 6, F 10 
and D 8 respectively, we envisaged a cyclisation precursor 78 having its 2-substituent 
constrained within a oxazolidinone ring linked to the nitrogen. In doing would confer several 
advantages. Firstly, we believed it would hold the 2-substituent in an equatorial 
disposition,68,69 giving rise to a minimal interaction between the 2-substituent and either the 
axial or equatorial 4-substituent. Working in concert with our previously outlined 
stereochemical model, Prins cyclisation would lead to the trans, cis diastereomer 79, while 
with a carbonyl-ene reaction under equilibrating condition would lead to the cis, trans 
diastereomer 80 (Scheme 23). Furthermore, the cyclic carbamate would be an attractive 
alternative to the tosyl protecting group employed in previous work as it can be cleaved under 
milder conditions but still provide the robustness required in the cyclisation reaction. 
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Scheme 23: Potential synthetic routes to the pseudodistomin alkaloids 
 
 
To assess the viability of the proposal we wish to carry out a formal synthesis of 
pseudodistomin F, by synthesising an advanced intermediate 27 used in Ma and Sun’s total 
synthesis. This intermediate was chosen as it contains the correct functionality and 
stereochemical arrangement of the core and with simple chemical manipulation allows 
appendage of the side chain. Incorporating the desired flexibility of being able to synthesise 
multiple pseudodistomin alkaloids or simpler side chain analogues from a common core.  
 
A retrosynthetic analysis of Ma and Sun’s advanced intermediate 27 was undertaken. The 
cyclic carbamate 27 could be derived from a rearrangement of a carboxylic acid, which in 
turn could be obtained from an oxidative cleavage of an alkene. This would lead to homo 
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allylic alcohol 80 derived from a Prins cyclisation of 78. The cyclisation precursor 78 could 
be obtained from the amino acid L-aspartic acid in four transformations (Scheme 24). 
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Scheme 24: Retrosynthetic analysis of the target molecule 
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2. Results and Discussion 
 
2.1 Model System 
 
Before embarking on the synthesis of the 2,4,5-trisubstituted cyclisation precursor 75, initial 
work focused on the construction of a model system to evaluate Brønsted acids with weakly 
nucleophilic counter ions. The Brønsted acids chosen to study were perchloric acid (HClO4) 
and chlorosulfonic acid (HSO3Cl), which in comparison to the chloride ion of hydrochloric 
acid, were envisaged to reduce HX addition products that have been observed in very electron 
deficient ene components.  
 
The model system chosen was the cyclisation of aldehyde 58 into the corresponding 
2,4-trisubstituted piperidine 60 because the Prins reaction on this substrate has been well 
established allowing thorough evaluation of new reaction conditions and the synthesis is 
relatively simple from the N-tosyl amino alcohol 81 (Scheme 25). 
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Scheme 25: Retrosynthetic analysis of the model system 
 
Starting from the N-tosyl amino alcohol 81 a regioselective N-alkylation with prenyl bromide 
gave the desired product 82 in an excellent yield. Oxidation of the alcohol 82 to the 
corresponding aldehyde 58 was first explored with PCC. Unfortunately, the yields of the 
aldehyde were only modest ~60 % and were accompanied by small amounts ~10% of ester 
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83, presumably formed from the dimerisation of alcohol starting material 82 with the 
aldehyde product 58 giving the hemiacetal 84 that was oxidised with PCC to the 
corresponding ester 83 (Scheme 26).70  
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Scheme 26: Dimerisation occurring during oxidation 
 
 
This by-product had previously been observed in the group and was known to be inseparable 
from the aldehyde product by chromatographic means.60 The oxidation was completed 
successfully through the employment of a Swern oxidation. This gave the desired product 58 
in an excellent yield with no dimerisation occurring (Scheme 27). 
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Scheme 27: Synthesis of the cyclisation precursor 
 
 
With the cyclisation precursor in hand, Prins reactions were carried out using the Brønsted 
acids HClO4 and HSO3Cl, with concentrated HCl used for comparison purposes (Scheme 28). 
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Scheme 28: Prins cyclisation 
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The results from the reaction are summarised below (Table 5). Although no counter ion 
adducts were observed for the Brønsted acids HClO4 and HSO3Cl the diastereoselectivities 
were low c.f. 4:1 and 3:1 respectively and the yields were only poor to modest, with complete 
decomposition of materials when HClO4 was used in excess (entry 1). The use of 
concentrated hydrochloric acid proved to be an effective catalyst giving the cis product 60 in a 
good yield and diastereoselectivity, however a small amount of the HCl adduct 61 was 
detected  (entry 8). As we failed to find a new Brønsted acid to catalyse the reaction, we 
decided to stick with the previously optimised conditions of concentrated hydrochloric acid to 
carry out the Prins reaction. 
 
 
 
 
 
 
 
 
 
 
Table 5: Prins cyclisation results 
 
 
 
 
 
2.2 First Generation Synthesis 
Entry BAa Eq Temp / °C 59 : 60 : 61b Yield (%)c 
1 HClO4 3 rt -
d - 
2 HClO4 1 rt 35 : 65 : 0 19 (7) 
3 HClO4 1 -78 20 : 80 : 0 47 (14) 
4 HClO4 0.1 -78 25 : 75 : 0    39 (13)
e 
5 HSO3Cl 1 rt 40 : 60 : 0 46 (27) 
6 HSO3Cl 1 -78 25 : 75 : 0   67 (22) 
7 HCl 3 rt 10 : 80 : 10 76f (8) 
8 HCl 3 -78 5 : 85 : 10 84f (5) 
a Reactions were carried out in CH2Cl2 for 16 h 
b Ratio determined by 1H NMR of crude 
reaction mixtures. c Isolated yields of major (minor in parentheses) isomers following 
purification. d No product formation, only a complex mixture of unidentified by-products 
determined by 1H NMR of crude reaction mixture. e 16% unreacted starting material 
recovered. f Combined yield of 60 and 61 as they were inseparable by chromatographic 
methods. 
 
 31 
 
2.2.1 Synthesis of Crotyl Substrate 
  
As proposed from our retrosynthetic analysis of Ma and Sun’s advanced intermediate 27, we 
started our synthesis from the naturally occurring amino acid, L-aspartic acid 78. We intended 
to reduce the carboxylic acid functionalities to afford the corresponding diol 85. Although 
there was no literature precedent for this one step reduction of L-aspartic acid we were 
encouraged by the work of Meyers et al who have shown the facile reduction of a variety of -
amino acids to the corresponding amino alcohols using NaBH4 and I2.
71 Unfortunately, this 
protocol failed to give any of the desired product 85. A by-product was isolated in a 40% 
yield, which we believed to be the boron complex 86 based on its 1H NMR, 13C NMR, IR and 
mass spectra (Scheme 29).  
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Scheme 29: Unsuccessful reduction with NaBH4/I2  
 
Instead we employed a two-step procedure to accomplish the reduction: Firstly, esterification 
of aspartic acid 78 with acetyl chloride in MeOH followed by a mild basic work-up gave the 
corresponding methyl ester 87 in good yield of 76%.72 Secondly, treatment of the amino ester 
with LiAlH4 in THF and subsequent Soxhlet extraction of the aluminium salts gave the amino 
diol 85 in a quantitative yield (Scheme 30).73 
 32 
H2N COOH
COOH
OH
OH
H2N
AcCl, MeOH
78 85 quant.87 76%
H2N CO2Me
CO2Me
LiAlH4, THF, Δ
 
Scheme 30: Esterification followed by reduction 
 
Following a modified one-pot literature procedure73 the amino diol 85 was regioselectively 
cyclised to form the 5-membered cyclic carbamate with carbonyldiimidazole (CDI) followed 
by in situ protection of the β-oxygen using TBDPSCl with the imidazole by-product 
generated in the first step functioning both as a base and nucleophilic catalyst. This gave the 
silylated oxazolidinone 88 in a good yield of 82%, an improvement over the 57% yield 
presented in the literature. The cyclisation precursor 78 was then straightforwardly prepared 
in three steps. N-Alkylation of oxazolidinone 88 with crotyl bromide and n-BuLi gave 89, 
which when treated with TBAF removed the silyl ether protecting group to give alcohol 90. 
Finally, oxidation of the alcohol to the corresponding aldehyde using Swern conditions gave 
the cyclisation precursor 78 (Scheme 31).  
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Scheme 31: Synthesis of crotyl cyclisation precursor 
 
The cyclisation precursor 78 was first subjected to the Prins reaction using the previously 
optimised Brønsted acid conditions60 of three equivalents of concentrated HCl in CH2Cl2 at -
76 
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78 °C. Unfortunately this failed to catalyse the reaction and only unreacted starting material 
was recovered, and raising the temperature to room temperature had no effect on the outcome 
of the reaction. We then turned to the Brønsted acid conditions of a saturated solution of HCl 
gas in CH2Cl2 at -78 °C. This caused extensive decomposition of the starting material into 
multiple unidentifiable by-products with no observable product formation. The Prins reaction 
is usually thought of as reacting through a carbocationic intermediate. This requires the 
substrate to react through an unfavourable secondary carbocation, giving a possible 
explanation for its reluctance to form any products (Scheme 32). 
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Scheme 32: Attempted Prins reaction with HCl 
 
 
The previously optimised Lewis acid-catalysed carbonyl-ene reaction conditions of two 
equivalents of MeAlCl2 in CH2Cl2 at -78 °C
60 (Table 6, entry 1) failed to promote the reaction 
and only unreacted starting material was recovered. Raising the temperature to room 
temperature allowed reaction to occur, leading to a mixture of four products: the trans, cis-
piperidine 79 and cis, trans-piperidine 80 as predicted, a new diastereomeric product 
cis,-cis-piperidine 91 and a dimerisation by-product 92 (Scheme 33).   
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Scheme 33: Carbonyl-ene cyclisation of aldehyde 78 
 
The products were obtained in a ratio of 24:30:10:36 for 79, 80, 91 and 92 respectively (Table 
6, entry 2), determined by analytical HPLC. A combination of flash column chromatography 
and semi-preparative HPLC afforded partial separation of the products. The dimer 92 
comprises of four stereocenters allowing for a possibility of sixteen stereoisomers. Analysis 
of the 1H NMR spectrum of 92 revealed a mixture of at least three diastereomers, from the 
presence of three doublets between 1.2-1.6 ppm corresponding to the methyl protons. None of 
the stereochemistries from the diastereomeric mixture of dimers 92 could be determined. The 
stereochemistry of the three piperidines 79, 80 and 91 was tentatively assigned through 
analysis of coupling constants in their 1H NMR spectra. The relative stereochemistry of 
piperidine 79 was determined to be trans, cis. In the 1H NMR spectrum of 79 the axial proton 
of 3”H lies at 1.54 ppm and is split into a doublet of double doublets with coupling of 2.3, 11.7 
and 13.7 Hz corresponding to a axial-equatorial, axial-axial and gem couplings. The axial 
proton of 6”H lies at 3.19 ppm and is split into a triplet with a large coupling constant of 12.5 
Hz indicative of a axial-axial and gem couplings. The corresponding equatorial proton 6’H lies 
at 3.74 ppm and is split into a double doublet with couplings of 5.1 and 12.5 Hz, indicating 
axial-equatorial and gem couplings. The relative stereochemistry of piperidine 80 was 
determined to be cis, trans.  The axial proton 3”H at 1.38 ppm is split into a quartet with a 
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coupling constant of 11.8 Hz coming form two diaxial and a gem coupling. The axial proton 
6”H lying at 2.65 ppm is split into a double doublet with two large couplings of 11.4 and 13.4  
Hz corresponding to a diaxial and a gem coupling. The relative stereochemistry of  91 was 
determined to be cis, cis. The proton assigned to the axial 3”H lies at 1.46 ppm and is split into 
a quartet with a coupling constant of 11.9 Hz corresponding to two diaxial a gem coupling. A 
doublet at 3.13 ppm corresponds to axial 6”H with coupling constants of 3.4 and 13.6 Hz 
equating to an axial-equatorial and gem coupling (Figure 6). 
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Figure 6: Selected coupling constants  
 
Carrying out the reaction with just one equivalent of MeAlCl2 for sixteen hours (Table 6, 
entry 3) led to significant amounts of unreacted starting material and with no noticeable 
decrease in dimerisation. Next, we investigated how the role of reaction concentration would 
affect the ratio of products. Having started with a reaction concentration of 0.1 M in CH2Cl2 
we carried out reactions at 50 mM and 10 mM (Table 6, entries 4 & 5). Pleasingly the higher 
dilutions led to lower amounts of the dimerisation product 92 but also led to lower amounts of 
the desired trans, cis piperidine 79. We then looked into the role that temperature played in 
the reaction. Noting that at very low temperatures no reaction occurred, we hoped that a 
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change in temperature would favour one reaction pathway over another. Carrying out the 
reaction at 0 °C (Table 6, entry 6) gave very similar results to the reaction at room 
temperature (Table 6, entry 2). Performing the reaction at an elevated temperature of 42 °C 
(Table 6, entry 7) resulted in less dimerisation and gave the cis, trans piperidine 80 as the 
major product. We investigated the Lewis acid TMSOTf (Table 6, entry 8) in the hope that 
silylation of the oxygen would occur and so preventing it from attacking another molecule of 
starting material 78. Unfortunately, no reaction occurred under these conditions and only 
unreacted stating material was recovered.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Carbonyl-ene cyclisation conditions 
 
From previous studies,60,64 we believed that the Lewis acid-promoted carbonyl-ene reaction 
proceeds through an asynchronous concerted mechanism with a polar transition state (or a 
fleeting zwitterionic intermediate). The transition state leading to the formation of cis, trans 
piperidine 80 has both the hydroxyl and ene component in equatorial positions; although 
thermodynamically favourable on steric grounds, the configuration does not allow for 
stabilisation of the carbocationic character in the transition state by the lone pair of the 
Entry LAa Eq Temp / °C Conc / mM 78 : 79 : 80 : 91 : 92 
1 MeAlCl2 2 -78 100
 100 : 0 : 0 : 0 : 0b 
2 MeAlCl2 2 rt 100 0 : 24 : 30 :10: 36
c 
3 MeAlCl2 1 rt 100 15 : 19 : 26 : 8 : 32
c 
4 MeAlCl2 2 rt 50 0 : 18 : 32 : 31 : 19
c 
5 MeAlCl2 2 rt 10 0 : 14 : 36 : 34 : 16
c 
6 MeAlCl2 2 0 100 0 : 25 : 27 :10: 38
c 
7 MeAlCl2 2 40 100 0 : 16 : 56 : 22 : 18
c    
8 TMSOTf 1 rt 100 100 : 0 : 0 : 0 : 0b 
a Reactions were carried out in CH2Cl2 for 16 h. 
b Ratio determined by analysis of  the 1H 
NMR of the crude reaction mixture c Ratio determined by HPLC analysis of crude reaction 
mixtures.  
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oxygen. Regarding the piperidines that have the 4- and 5- substituents cis to one another 79 
and 91, we believe them to react through lower energy transition states due to the stabilising 
interaction of any cationic character the transition state (or carbocation in the intermediate)  
by the lone pair on the oxygen. Formation of either 79 or 91 would depend on the preference 
for either the ene component or the Lewis acid-coordinated oxygen to adopt an equatorial 
position. The failure to promote the reaction at cold temperatures highlights the relatively 
high energy transitions (or high energy secondary carbocations) involved in the reaction and 
the need to conduct the reaction at ambient temperatures. This has the consequence of eroding 
the kinetic preference to form cis configuration 79 and 91 in favour of the thermodynamic 
trans product 80. However, the diastereoselectivity cannot be completely turned over 
completely in favour of the thermodynamic product 80 due to the significant contribution 
from the stabilising interactions arising in the cis configuration (Scheme 34).  
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Scheme 34: Postulated transition states leading to products 
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Regarding the mechanism for the formation of the dimerisation product 92, we believe that 
there is a competition between the intramolecular cyclisation of aldehyde 75 and the 
intermolecular reaction between the aldehyde 75 and the piperidine product. After cyclisation 
to the piperidine product, nucleophilic attack of the hydroxyl onto another aldehyde would 
occur. Following breakdown of the Lewis acid-coordinated hemiacetal to reveal an 
oxocarbenium ion, a second cyclisation is proposed to occur, reminiscent of a type III 
carbonyl-ene cyclisation, followed by trapping of the resulting carbocation with a chloride ion 
(Scheme 35). 
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Scheme 35: Proposed mechanism for dimerisation formation 
 
Discouraged by the lack of promising results, we decided to focus our attention on making 
modifications to the ene component in an attempt to improve the cyclisation reaction. The 
most logical modification is replacement of the distal hydrogen in the ene component by a 
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methyl group, which upon successful cyclisation should lead to more stable tertiary 
carbocation. 
 
2.2.2 Synthesis of Prenyl Substrate 
 
The oxazolidinone 88 was alkylated using prenyl bromide and n-BuLi to give the prenyl 
oxazolidinone 93, deprotection of the silyl ether with TBAF gave the free alcohol 94 and 
finally a Swern oxidation gave the modified cyclisation precursor 95, proceeding with 
excellent yields of 98, 94 and 95% respectively (Scheme 36). 
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Scheme 36: Synthesis of prenyl cyclisation precursor 
  
The prenyl cyclisation precursor was first subjected to a Prins reaction using three equivalents 
of concentrated HCl in CH2Cl2 at -78 °C. The cyclisation proved successful, although the 
reaction did not go to completion with 12% of aldehyde starting material still remaining. The 
reaction gave a mixture of three piperidines, 96, 97 and 98 in ratio of 15:7:1 respectively ( 
 
Table 7, entry 1). This gave a combined cis to trans ratio of 96:4. The cis and cis-chloride 
were inseparable by flash column chromatography and gave a combined yield of 78% 
(Scheme 37).  
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Scheme 37: Concentrated HCl cyclisation 
 
 
In an attempt to improve the efficacy of the cyclisation we performed the reaction with a 
saturated solution of anhydrous HCl  in CH2Cl2 at -78 °C for 2 hours (Scheme 38).  
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Scheme 38: Anhydrous HCl cyclisation 
 
This resulted in complete conversion of the aldehyde starting material into products and gave 
an excellent diastereomeric ratio of 99.0 : 0.50 : 0.50 for 97, 96 and 99 respectively (Table 7, 
entry 2) determined by HPLC analysis,  giving a combined cis to trans ratio of 99.5:0.5 and 
isolated in an excellent yield of 98% for cis-chloride.  
 
As the Prins reaction is believed to proceed through a carbocationic intermediate, the prenyl 
substrate would react through a stable tertiary carbocation leading to a facile route into 
product formation, compared to the relatively unstable secondary carbocation of the crotyl 
substrate. The 2-substituent and nitrogen are constrained within an oxazolidinone ring, forcing 
the 2-substituent to adopt an equatorial disposition leading to a minimal steric clash between 
itself and the hydroxyl group lying in the axial position. The isopropyl cation of the prenyl 
substrate is sterically more demanding than the ethyl carbocation of the crotyl substrate 
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Leading to the isopopyl cation having a preference to adopt an equatorial disposition to avoid 
A1,3 diaxial strain. In combination with the stabilising interaction outlined before, the oxygen 
and carbocation to lie cis to one another, this gives rise to the excellent diastereoselectivity if 
favour of the cis product (Scheme 39).  
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Scheme 39: Stabilised intermediate leading to product 
 
Regarding the fate of the carbocationic intermediate, there are two possible pathways leading 
to the cis chloride 97 product; direct trapping of the carbocation intermediate with a chloride 
ion or loss of a hydrogen to form cis alkene 96 followed by HCl addition across the double 
bond (Scheme 40). As the reaction could never be stopped purely at the cis alkene 96 it 
suggests that either both reaction pathways are occurring or HCl addition across the alkene is 
a rapid process.  
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Scheme 40: Postulated reaction intermediates leading to products  
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As the quantity of trans-chloride 99 isolated from HPLC analysis was not sufficient for 
conclusive characterisation (only a mass spectrum) we decided to synthesise a sample of 
trans-chloride 99 from the HCl addition across the alkene of trans piperidine 98.  The trans 
piperidine isolated from the carbonyl-ene reaction (vide infra) was treated with a saturated 
solution of anhydrous HCl in CH2Cl2 at -78 °C for 4 hours before being warmed to room 
temperature and the reaction continued for a further 4 hours. The reaction time to add HCl 
across the trans-alkene of 98 was significantly longer than the analogous addition across the 
cis-alkene 96 and the trans-chloride 99 was only observed when using the forcing conditions 
of a saturated solution of anhydrous HCl in CH2Cl2. The long reaction times required for the 
trans-alkene 98 can be rationalised by the reaction proceeding through a higher energy trans 
carbocation leading to a slower Markovnikov addition of HCl across the alkene. Pleasingly 
HPLC analysis of the trans-chloride 99 obtained from the HCl addition of 98 reaction gave 
identical retention time and mass spectrum to the postulated trans-chloride 99 isolated from 
the Prins reaction of 95.  
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Scheme 41: HCl addition into trans-alkene 98 
 
We turned our attention to the Lewis acid-promoted carbonyl-ene reaction, in the hope of 
favouring the thermodynamic trans product 98. To compare the difference in selectivity 
between the Lewis acid and Brønsted acid reactions, the initial carbonyl-ene reaction was 
carried out with one equivalent of MeAlCl2 in CH2Cl2 at -78 °C (Table 7, entry 3).  
Unsurprisingly, at low temperature, the reaction predominately favoured the kinetic cis 
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diastereomer 96 with cis-chloride 97 and the trans diastereomer 98 formed in lesser amounts 
in a ratio of 6:1:1.5 respectively. Surprisingly for a Lewis acid-promoted reaction there was a 
significant amount of the cis-chloride 97. This result is not without precedent as Snider has 
observed that in carbonyl-ene reactions using one equivalent of an alkylaluminum chloride 
Lewis acid there were significant amounts of the β-hydroxy chloro product. It was proposed 
that the reaction proceeds through a zwitterionic intermediate and a chloride from the alcohol-
Lewis acid complex adds intramolecularly to the carbocation through a [1,5] shift occurring 
across the same face of the molecule, i.e. 95 to 97 in Scheme 42. However, Snider observed 
that performing the reaction with two equivalents of a Lewis acid rendered the chloro-
alkoxide intermediate unstable, even at -78 °C, leading to elimination of HCl to afford the 
homoallylic alcohol product,49 i.e. 95 to 96 in Scheme 42.  We repeated the reaction with two 
equivalents of MeAlCl2 at -78 °C (Table 7, entry 4), which pleasingly gave the cis 96 and 
trans 98 piperidines in a ratio of 6:1, with only a trace amount of the cis-chloride 97 present 
(The observation of chloro alcohol product 97 leads us to believe that the carbonyl-ene 
reaction of aldehyde 95 also proceeds through a transient zwitterionic intermediate.  
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Scheme 42: Mechanism for the formation of chloro alcohol 97 and its breakdown to form alkene 96 
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a Reactions were carried out in CH2Cl2 unless otherwise stated. 
b Ratio determined by 1H NMR analysis of 
crude reaction mixtures unless stated otherwise. c Isolated yields of major (minor in parentheses) isomers 
following purification. d Combined yield of 96 and 97. e Reaction performed with a saturated solution of 
anhydrous HCl. e 16% unreacted starting material recovered. f Ratio determined by HPLC analysis of crude 
reaction mixture. g Reaction carried out in CHCl3 
In an attempt to favour the thermodynamic product we began by raising the temperature of the 
reaction. Performing the reaction at room temperature with two equivalents of MeAlCl2 in 
CH2Cl2 (Table 7, entry 5) gave the cis 96 and trans 98 diastereomers in a ratio of 2:1, with 
none of the cis-chloride 97 observed. Raising the temperature further to 40 °C (Table 7, entry 
6) surprisingly still gave rise to the cis 96 diastereomer as the major component over the trans 
98 diastereomer, in a ratio of 1.5:1. In a final attempt to favour the thermodynamic trans 
product 97 we changed the solvent to CHCl3 and carried out the reaction at 61 °C (Table 7, 
entry 7), unfortunately the ratio was hardly improved with 1.4:1 in favour of the cis 96 over 
the trans 98 (Scheme 43).  
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Scheme 43: Cyclisation under Lewis acid conditions 
 
The results from both the Prins and carbonyl-ene cyclisations are summarised in the table 
below (Table 7). 
 
 
 
Table 7: Prins and carbonyl-ene reaction conditions and outcomes 
Entry Catalysta Eq Temp / °C Time / h 96 : 97 : 98 : 99b Yield (%)c 
1 HCl(aq) 3 -78 16 15 : 7 : 1 : 0 76
d 
2 HCl(g) -
e -78 2 0.5 : 99.0 : 0 : 0.5f 98 
3 MeAlCl2 1 -78 16 6 : 1 : 1.5 : 0 82
d (17) 
4 MeAlCl2 2 -78 16 6 : trace : 1 : 0    85 (14) 
5 MeAlCl2 2 rt 16 2 : 0 : 1 : 0 63 (30) 
6 MeAlCl2 2 40 16 1.5 : 0 : 1 : 0   58 (37) 
7 MeAlCl2 2 61
g 16 1.4 : 0 : 1 : 0 55 (39) 
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Surprisingly for a Lewis acid cyclisation there was a continued preference for the formation 
of the kinetic cis diastereomer 96, even at elevated temperatures. To rationalise this 
observation we believed that the oxazolidinone ring exerted a strong electron-withdrawing 
effect on the system. Resulting in destabilisation of the carbocationic charge in the 
intermediate, making the stabilising interaction from an oxygen lone more significant.  This 
stabilising interaction is only possible when both hydroxyl and ene groups are cis to one 
another and offers an explanation for the preferential formation of the cis diastereomer 96 
under both Prins and carbonyl-ene conditions (Scheme 44). 
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Scheme 44: Carbonyl-ene reaction intermediates leading to products 
 
The structures of cis-alkene 96, cis-chloride 97 and trans-alkene 98 piperidines were 
determined by X-ray crystallography (Figures 7, 8 & 9). 
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Figure 7: Crystal structure of piperidine 96 
 
 
 
 
Figure 8: Crystal structure of piperidine 97 
 
 
 
Figure 9: Crystal structure of piperidine 98 
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The Prins reaction using anhydrous HCl (entry 2) gave the highest cis to trans ratio. 
Unfortunately, the product from this reaction was the HCl adduct 97. In order to make 
progress towards the target 27 we needed to eliminate HCl to access the more synthetically 
useful cis-alkene 96. The initial reaction was carried out with aqueous KOH in MeOH in the 
hope of facilitating two steps in one: first, elimination of HCl to give cis-alkene 97 and 
secondly, hydrolysis of the oxazolidinone ring to give the amino diol 100. Sadly, the reaction 
failed to afford any of the desired product and instead gave a complex mixture of 
unidentifiable products (Scheme 45).   
H
N
OH
OH
100
N
O
O
OH
Cl
KOH, MeOH:H2O, 90 °C
97  
Scheme 45: Failed elimination with KOH 
 
We then turned our attention to the strong non-nucleophilic base KHMDS. Employing one 
equivalent in THF at 0 °C resulted in successful elimination but the results were not 
reproducible, with yields ranging from 50-95% (Scheme 46), and decreasing appreciably 
above the 100 mg scale. Using a crown ether, 18-crown-6, in the hope of increasing the 
basicity of the anion failed to furnish any improvement in yield.  
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96 50-90%
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KHMDS, THF, 0 °C
97  
Scheme 46: Elimination with KHMDS 
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Employing two equivalents of KHMDS still did not afford complete elimination and led to 
significant amounts ~20% of aldehyde 95 resulting from an E1cB elimination (Scheme 47).   
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 2 eq KHMDS
97 95  
Scheme 47: Retro-ene reaction with 2eq KHMDS 
 
 
The elimination was successfully accomplished in a reproducible manner by using 1 
equivalent of NaOAc in refluxing AcOH74,75 for 10 minutes to give the alkene 96 in a good 
yield of 85% after chromatography with none of the cis-chloride 97 starting material 
remaining (Scheme 48).  
N
O
O
OH
96 85%
N
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Cl
NaOAc, AcOH, Δ, 10 min
97  
Scheme 48: Elimination with NaOAc in AcOH 
 
 
Short reaction times were key to the success of this reaction, as extended reaction times led to 
the formation of two by-products increasing in amount as time progressed; acylation of the 
hydroxyl to give 101 and an AcOH adduct 102, both of which were tentatively identified from 
analysis of their 1H NMR and m/z spectra (Figure 10). 
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 Figure 10: By-products from NaOAc/AcOH elimination 
 
 
Although the synthetic route enabled access to the cis piperidine 97 in excellent yields and 
diastereoselectivities, it suffered from a few shortcomings. Firstly, the use of a TBDPS 
protecting group incorporated two redundant steps into the synthesis. A more expedient route 
would utilise functional group reactivity rather than mask it. Secondly, and most importantly, 
it was not amenable to a multigram scale required to complete the formal synthesis, due to the 
poor scalability of the LiAlH4 reduction of ester 87 to diol 85.  
 
2.3 Second Generation Synthesis 
2.3.1 Introduction 
 
Our new retrosynthetic approach to the cyclisation precursor 95 utilised the alcohol 94 which 
could be obtained from a regioselective cyclisation of diol 103, derived from ester 104. The 
tertiary aminoester 104 could be formed from monoalkylation and carbamation of aspartic 
ester 87, which can be obtained from aspartic ester 87 as shown in the previous synthesis 
(Scheme 49). 
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Scheme 49: New retrosynthetic approach to cyclisation precursor 95 
 
 
Two potential routes for the synthesis of 104 were devised. Firstly, monoalkylation of aspartic 
ester 87 to give the secondary amine 105 followed by carbamation giving 104 (Route [A]). 
Alternatively, the tertiary carbamate 104 could be prepared from carbamation of 87 to afford 
the secondary carbamate 106 followed by alkylation (Route [B]), shown in Scheme 50. 
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Scheme 50: Two potential routes for the synthesis of tertiary carbamate 104 
 
2.3.2 Primary Amine Alkylation  
 
Initial research focused on the synthesis of 104 via route [A], as it was reasoned that 
carbamate alkylation would require harsher conditions. The synthesis of secondary amines by 
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direct N-alkylation of primary amines is known as the Hoffmann alkylation;76 it is usually an 
inefficient procedure due to over-alkylation, leading to mixtures of primary, secondary and 
tertiary amines, as well as quaternary ammonium salts.77 The problem arises because upon 
each successive alkylation the products are more reactive than their starting materials. To 
circumvent this problem it is common to employ the amine in large excess relative to the 
alkylating agent.78 This is an expensive and wasteful process, especially when the amine is 
not commercially available. However, owing to the straightforward nature of this 
transformation a number of researchers have studied it in the hope of imparting selectivity to 
the reaction.79 Jung et al. have reported the chemoselective mono-N-alkylation of primary 
amines using cesium bases in DMF in the presence activated 4 Å molecular sieves.80,81 They 
attribute the chemoselectivity to the formation of a strong coordinate bond between the 
alkylated secondary amine and a cesium ion. This has the affect of reducing the 
nucleophilicity of the secondary amine and inhibiting proton abstraction because of the 
increased sterics, which in combination helps to suppress further alkylation (Scheme 53).  
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Scheme 51: Jung’s rationale for the observed chemoselectivity  
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In parallel, Srivstava et al. have reported the selective N-alkylation of primary amines using 
K2CO3 as the base in polar aprotic solvents.
82 The selectivity could be switched between 
mono- and di-N-alkylation by varying the nature of the electrophile used in the reactions. 
More recently, Cho and Kim studying the selective mono-N-alkylation of α-amino esters 
observed poor selectivity when using Jung’s conditions. They observed that the reaction could 
proceed effectively by employing LiOH and DMF in the presence of 4 Å molecular sieves, 
and in one example they alkylated aspartic acid tert-butyl methylester 107 with benzyl 
bromide and achieved a ratio of 15:1 of mono- 108 over dialkylated product 109 (Scheme 
52).83  
CO2Me
CO2tBu
HCl.H2N
107
BnBr, LiOH.H2O
4 Å MS, DMF, rt
CO2Me
CO2tBu
H
N CO2Me
CO2tBu
N
+
Bn Bn
Bn
108 75% 109 5%  
Scheme 52: Alkylation presented by Cho and Kim 
 
In an attempt to afford a similar transformation the aspartic ester hydrochloride salt 110 was 
allowed to react with two equivalents of LiOH, one equivalent of prenyl bromide in DMF in 
the presence of 4 Å molecular sieves. Unfortunately, the reaction favoured the formation of 
the di-alkylated amine 111 over the mono-alkylated amine 105 in a ratio of 2:1 respectively 
(Scheme 53). 
CO2Me
CO2Me
HCl.H2N
110
Prenyl bromide, LiOH.H2O
       4 Å MS, DMF, rt
CO2Me
CO2Me
NCO2Me
CO2Me
H
N
+
111 34%105 16%  
Scheme 53: Alkylation of 1° amine 
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In an attempt to improve the selectivity in favour of the mono-alkylated product 105, we 
screened a variety of bases such as CsOH, Cs2CO3 and K2CO3 but to no avail as they offered 
no improvement over the original attempt with LiOH  (Table 8). 
 
 
 
 
 
 
Table 8: Alkylation of 1° amine with a variety of bases 
 
 
2.3.3 Reductive Amination 
 
 
As the alkylation gave poor yields of the secondary amine, we decided to investigate a 
reductive amination approach. We began by attempting a one-pot procedure of preformation 
of the imine followed by subsequent reduction (shown as a general method in Scheme 54), 
using aspartic ester 87, prenal 112 and NaBH(OAc)3
84 dissolved in DCE at a concentration of 
300 mM (Table 9, entry 1). 
CO2Me
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Scheme 54: General method A for a one-pot reductive amination 
Entry Basea 105 : 111b Yield (%)
c 
 
1 LiOH.H2O 1 : 2 34 (16)
 
2 CsOH.H2O 1 : 3 30 (9) 
3 Cs2CO3 1 : 3 32 (10) 
4 K2CO3
d 1 : 10 48 (3)    
a All reactions were conducted with 1.2 eq of base and 1 eq of prenyl bromide dissolved DMF in the 
presence of 4 Å MS at rt for 16 h. b Ratio of products determined by 1H NMR analysis of the crude 
reaction mixture. c Isolated yields of major (minor in parentheses) isomers following purification. d 
An extra 0.5 eq of prenyl bromide added after 8 h. 
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Surprisingly there was a mixture of mono-alkylated 105 and di-alkylated 111 products in a 
1.2:1 ratio respectively. The significant amount of di-alkylated product can be rationalised by 
a molecule of the mono-alkylated product 105 attacking a molecule of the intermediate imine 
113 to give aminal 114. Breakdown of the aminal to generate a reactive iminium species 115, 
followed by its reduction would yield the di-alkylated product 111 (Scheme 55).  
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Scheme 55: Mechanism for the formation of 111 during reductive amination 
 
To prevent over-alkylation, we employed the more reactive reducing agent NaBH4 (Table 9 , 
entry 2) in the hope of reducing the intermediate imine 113 faster than the rate of attack by the 
secondary amine 105. Although this method gave lower amounts of the over alkylated 
product, the overall yield of 105 was significantly lower due to a complex mixture of 
unidentifiable by-products, most likely formed from the reduction of the ester functionality 
and subsequent side reactions. 
 
In the one-pot reductive amination procedure it was ambiguous whether preformation of the 
imine was complete before addition of the reducing agent, if not side reactions are possible 
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i.e. the reduced product 105 reacting with the aldehyde. A two-step method of imine 
formation followed by reduction was undertaken (shown as a general method in Scheme 56) 
to avoid such a problem. The reaction of aspartic ester 87 and prenal 112 dissolved in MeOH 
gave the crude imine 113 in a 98% yield, which was sufficiently pure to be used in the next 
step without purification. Confident that we had complete imine formation we could 
concentrate our efforts on the reduction, although whether imine formation is reversible in the 
reduction step remained unknown. 
 
CO2Me
CO2MeN
CO2Me
CO2MeH2N
CO2Me
CO2MeN+
87 113, 98% 111
Method B
 112
MeOH
NaBHX
CO2Me
CO2Me
H
N
105  
Scheme 56: General method B for a two step reductive amination 
 
 
The reaction of imine 113 with NaBH(OAc)3 in DCE at a concentration of 300 mM for 16 
hours (Table 9, entry 3) led to significant over alkylation. We believed the over alkylation was 
an issue of concentration. Carrying out the reaction in a higher dilution of 0.1 M (Table 9, 
entry 4) pleasingly led to smaller amounts of over alkylation <10% and the gave secondary 
amine in a good yield of 70% but led to an increased reaction time of 72 hours. Diluting the 
reaction further to 50 mM (Table 9, entry 5) gave <5% over alkylation but the reaction time 
increased dramatically to 120 hours, with trace amounts of starting material still present. It 
was deemed impractical to carry out reactions on a multigram scale at concentrations of 50 
mM because it would require ~100 mL of solvent per gram of reactant. Further efforts 
concentrated on improving the efficiency of the reaction at a concentration of 0.1 M. 
Additives were investigated; 4 Å molecular sieves and 2,6-lutidine had no effect on outcome 
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of the reaction (Table 9, entries 6 & 7); however, AcOH led to large amounts of over 
alkylation (Table 9, entry 8). One explanation to account for the over alkylation is the facile 
reaction between protonated imine 116 and secondary amine 105 leading to the formation of 
111 (Scheme 57). 
CO2Me
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CO2Me
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Scheme 57: Over alkylation resulting from protonation of the imine 
 
Another possible explanation is the acid-catalysed hydrolysis of the imine with trace amounts 
of water leading to amine 87 and aldehyde 112.  Capture of the protonated aldehyde 117 with 
105 would also lead to tertiary amine 111 (Scheme 58). 
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Scheme 58: Over alkylation resulting from acid catalysed hydrolysis of the imine 
 
 
Changing the reducing agent to NaBH4 in solvent mixture of DCE:MeOH (Table 9, entry 9) 
led to no observable over but instead gave significant amounts of diol 118 resulting from 
reduction of the esters (Figure 11).  
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Figure 11: Diol resulting from ester reduction 
 
Changing the reaction solvent to a mixture of DCE:MeOH (Table 9, entry 10) and just MeOH 
(Table 9, entry 11) gave a complex mixtures of unidentifiable by products in both cases. From 
the experiments carried out the optimal conditions to carry out the reaction was via a two step 
procedure of imine formation followed by reduction with NaBH(OAc)3 in DCE at a 
concentration of 0.1 M (Table 9, entry 4). 
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Table 9: Reductive amination results
Entry Method Reducing Agenta Solvent Conc. / mM Time / h Additiveb 105 :111c Yield (%)d 
1 A NaBH(OAc)3 DCE 300 16 none 1.2 : 1 31 (24) 
2 A NaBH4
e MeOH 300 16 none -f 15 
3 B NaBH(OAc)3 DCE 300 16 none 1.5 : 1 39 (13) 
4 B NaBH(OAc)3 DCE 100 72 none 20 : 1  70 
5 B NaBH(OAc)3 DCE 50 120 none >20 : 1 73 
6 B NaBH(OAc)3 DCE 100 72 4 Å MS 20 : 1 68 
7 B NaBH(OAc)3 DCE 100 72 2,6 -lutidine 20 : 1 69 
8 B NaBH(OAc)3 DCE 100 72 AcOH 1 : 1 26 (23) 
9 B NaBH4
g DCE:MeOH 100 16 none >20 :1 22h 
10 B NaBH(OAc)3 DCE:MeOH 100 16 none -
i - 
11 B NaBH(OAc)3 MeOH 100 16 none - - 
a Reactions were carried out at rt with 1.5-2 eq of reducing agent unless stated otherwise. b 1 eq of additive used. c Ratio determined by 1H NMR 
analysis of crude reaction mixtures unless stated otherwise. d Isolated yields of major (minor in parentheses) products following purification. e 
NaBH4 added after 3 h to allow preformation of the imine 
f Many overlapping signals in the 1H NMR of the crude reaction mixture made accurate 
integration impossible. g  Reaction carried out at rt with 1 eq of reducing agent. h Purification gave diol 118 in a 31% yield. i Reaction gave a 
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Reaction of amine 105 with ethyl chloroformate and Cs2CO3 afforded the carbamate 104 in a 
quantitative yield (Scheme 59). 
CO2Me
CO2MeN
CO2Et
CO2Me
CO2MeN
113
NaBH(OAc)3, DCE c 0.1 M
CO2Me
CO2Me
H
N
105, 70%
ClCO2Et, Cs2CO3, 
          MeCN
104, quant.  
Scheme 59: Imine reduction and carbamate formation 
 
 
Reduction of the esters with NaBH4 in THF:EtOH at 0 °C gave the diol 103 and treatment 
with NaH in THF resulted in cyclisation to furnish the oxazolidinone 94 (Scheme 60). 
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Scheme 60: NaBH4 reduction and NaH cyclisation 
 
 
Alternatively, raising the temperature of the NaBH4 reduction reaction to reflux smoothly 
transformed ester 104 into oxazolidinone 94 in an excellent yield of 90%, with none of the 
6-membered oxazinanone regioisomer observed (Scheme 61). 
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Scheme 61: One-pot reduction and cyclisation 
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The characterisation for compound 94 synthesised by this route was consistent with the data 
for the compound synthesised in the first generation synthesis except for the optical rotation. 
The recorded optical rotation from the first generation synthesis was -14.0 while the 
compound obtained from the second generation synthesis recorded a null value. Suspicious of 
the null values obtained for the optical rotations of compounds 103-105 we suspected 
racemisation had occurred. Chiral HPLC analysis of compounds 94, 103, 104 and 105 was 
conducted. Only in compound 104 could the enantiomers be successfully resolved into two 
separate peaks with retention times of 3.8 min and 8.0 min in hexane:isopropanol, 95:5. 
Integration of the peak areas revealed a 50/50 mixture of enantiomers, confirming complete 
racemisation had occurred (Figure 12).  
Figure 12: Chiral HPLC trace of racemic 104 
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To elucidate in which step racemisation occurred compound 105 obtained from the alkylation 
of aspartic ester 87 with prenyl bromide (Scheme 53) was allowed to react with ethyl 
chloroformate and Cs2CO3 to give carbamate 104. Chiral HPLC indicated no observable 
racemisation in this substrate. Subjecting (S)-104 to the reduction and cyclisation reaction 
with NaBH4 to afford oxazolidinone 94, which gave an identical optical rotation to compound 
94 made in the first generation synthesis. These observations pinpointed that racemisation 
occurred during the reductive amination step. Ganesan et al. observed a similar result when 
studying the reductive amination of L-tryptophan methylester 118 with a variety of aldehydes 
and NaBH(OAc)3.
85 They discovered that partial racemisation only occurred when they 
employed prenal 112 as the aldehyde (Scheme 62). They attributed this racemisation to the 
lower reactivity of the α,β-unsaturated imine 119 in the reduction to secondary amine 120; 
although no mechanism is specified, they observed a similar result with D-tryptophan 
methylester. 
N
H
NH2
CO2Me
N
H
N
CO2Me
N
H
NH
CO2Me
S/R = 85/15
prenal, HC(OMe)3,
       CH2Cl2
NaBH(OAc)3,
   
    CH2Cl2
118 119 120, 40% over 2 steps
 
Scheme 62: Racemisation of L-tryptophan methylester observed by Ganesan 
 
 
Ellman et al. have purposely sought to induce racemisation during the reductive amination of 
a variety of amino esters 121 with a resin bound aldehyde 122 in order to access the unnatural 
D-enantiomer.86 They postulate that complete racemisation can be achieved through imine 
tautomerisation, by pre-equilibrating the amino ester hydrochloride salt, 0.3 equivalents of 
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Hünig’s base and the resin bound aldehyde 122 for six hours before addition of the reducing 
agent to afford the secondary amine 123 (Scheme 63).   
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Scheme 63: Racemisation of amino esters studied by Ellman 
 
We believe that a similar process occurs during the imine reduction of 113. Facile 
equilibration between chiral imine 113 and the achiral imine tautomer 124 leads to the 
complete erosion of stereochemistry before the slow reduction of the imine can occur leading 
to (rac)-105 (Scheme 64). Although imine 113 recorded an optical rotation of -8.8 the 
possibility of potential racemization occurring during its formation cannot be ruled out. 
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Scheme 64: Mechanism leading to racemisation   
 
2.3.4 Conjugate Addition 
    
The synthetic route of the second generation synthesis allowed efficient access to the 
cyclisation precursor 95 from the secondary amine 105 (Scheme 65). The major drawback, 
though, is the synthesis of amine 105 as previous attempts have suffered from poor yields 
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(2.3.2, alkylation) or racemisation accompanied with high dilutions and long reaction times 
(2.3.3, reductive amination).  
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Scheme 65: Facile synthesis of 95 from 105 
 
 
We envisaged that the conjugate addition between prenyl amine 125 and dimethylmaleate 126 
would give (rac)-105 (Scheme 66) and hopefully fulfil the premise of the second generation 
synthesis of allowing rapid access to the cyclisation precursor 95 on a multi-gram scale. This 
would provide the required synthetic material to enable the exploration of many possible 
synthetic pathways leading to a successful route to the target molecule 27. Upon discovery of 
a successful racemic pathway we planned to follow up with an enantiomerically synthesis of 
27 using the first generation synthesis, which was conducted on a smaller scale. 
NH2
+
CO2Me
CO2Me
CO2Me
CO2Me
H
N
(rac)-105125 126  
Scheme 66: Potential conjugate addition between amine 125 and α,β-unsaturated ester 126 
 
Surprisingly for a seemingly simple reaction there are only a few literature examples of the 
conjugate addition between a primary allyl amine and a α,β-unsaturated dicarbonyl.87,88 As 
prenyl amine 125 is not commerically available we decided to study a model system using 
allyl amine 127 instead. Using one equivalent of allyamine and dimethylmaleate and heating 
them together neat at 40 °C for ten minutes ( 
 64 
Table 10, entry 1) led to 1:0.7:0.3 mixture of secondary amine 128, dimethylfumarate 129 and 
dimethylmaleate 126 respectively (Scheme 67).  
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Scheme 67: Conjugate addition between allyl amine 127 and dimethylmaleate 126 
 
 
Isomerisation of maleate 126 to the more thermodynamically favourable fumerate 129 
presumably arises from conjugate addition followed by retro-conjugate addition (Scheme 68). 
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Scheme 68: Formation of fumerate 129 
 
In the hope of favouring an intermolecular proton transfer we carried out the reaction with one 
equivalent of dimethylmaleate and two equivalents of allyl amine (Table 10, entry 2), which 
pleasingly gave the product 128 in a quantitative yield. Wishing to employ the allyl amine as 
a limiting reagent, we explored the use of another external base. Reaction with one equivalent 
of dimethylmaleate, allylamine and triethylamine (Table 10, entry3) gave the secondary 
amine 128 in a quantitative yield (Scheme 69). 
NH2 +
CO2Me
CO2Me
CO2Me
CO2Me
H
N
127 126
 Et3N, 40 °C
128, quant.  
Scheme 69: Conjugate addition employing Et3N as an external base 
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The table below summarises the results from the conjugate addition reactions with allyl amine 
and dimethylmaleate.  
 
 
 
 
 
Table 10: Results of conjugate addition with allyl amine 
 
Off the back of the success of the model system, we embarked on the synthesis of prenyl 
amine. A number of different methods have been described in the literature for the preparation 
of primary amines. Direct alkylation of ammonia usually results in poor yields of the primary 
amine due to the competing over alkylation, therefore a number of ammonia synthons have 
been developed that reduce or prevent over alkylation. One such method is the alkylation of 
trityl amine, the steric bulk of the trityl group affords only monoalkylation and it can be 
subsequently removed under mild conditions.89 We first prepared prenyl bromide ourselves, 
due to the variable quality of commercial product, according to a literature procedure from 
prenol and PBr3 to give prenyl bromide in a good yield of 83% (Scheme 70).
90  
 
BrOH
PBr3, Et2O, 0 °C
132 133, 83%  
Scheme 70: Bromination of prenol 132 
 
 
Amination of trityl chloride 134 with aqueous ammonia afforded the trityl amine 135 in a 
good yield of 74%. Alkylation of trityl amine 135 with prenyl bromide and K2CO3 gave the 
Entry Conditionsa 126 : 128 : 129b 
Yield 
(%) 
1 1 eq allyl amine  15 : 50 : 35 -c 
2 2 eq allyl amine 0 : 100 : 0 quant. 
3 1 eq allyl amine, 1 eq Et3N 0 : 100 : 0 quant. 
a Reactions were carried out with 1 eq of dimethylmaleate, neat at 40 °C for 
10 min. b Ratios determined by 1H NMR analysis of the crude reaction 
mixture. c Products not isolated 
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secondary amine 136 in a good yield of 86%. Removal of the trityl group with TFA, trapping 
of the trityl cation with MeOH and displacement of the TFA salt with aqueous HCl gave the 
prenyl amine hydrochloride salt 137 in an excellent yield of 94%. The trityl cleavage step 
could only be preformed successfully on the milligram scale; scaling to the gram scale led to 
poor yields due to HCl addition across the alkene. An alternative was approach was a Gabriel 
synthesis, alkylation of potassium phthalimide 138 with prenyl bromide 133 according to a 
modified literature procedure91 to give the alkylated product 139 in an excellent yield of 98%. 
Hydrolysis of phthalimide 139 with Ba(OH)2 in water afforded the primary amine which was 
extracted via steam distillation and acidified with HCl(aq) to give the prenyl amine 
hydrochloride salt 137 in a excellent yield of 98%.92 This approach could be successfully 
carried out on the multi-gram scale (Scheme 71).   
 
i) Ba(OH)2, H2O, Δ, 16 h 
ii) HCl(aq)
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i) TFA, CH2Cl2
ii) MeOH
iii) HCl(aq)
3 days K2CO3, DMF, 0 °C
133134 135, 74% 136, 86%
137, 98%133 138 139, 98%  
Scheme 71: Synthesis of prenyl amine 
 
 
Conjugate addition between prenyl amine hydrochloride salt 137 and dimethylmaleate 126 
gave the secondary amine (rac)-105 in an excellent yield of 90% (Scheme 72) and could be 
carried out on a 30 g scale. One equivalent of Et3N was required to form the free base and 
because the prenyl amine suffered from greater steric hindrance than allyl amine the reaction 
required extra equivalents of external base as well as higher temperatures and longer reactions 
times to effect the reaction. 
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Scheme 72: Conjugate addition between prenyl amine and dimethylmaleate 
 
From the secondary amine (rac)-105 the synthesis of the cyclisation precursor was carried out 
on a 20 g scale. This gave enough material to test out a variety of synthetic routes that 
eventually led to a successful racemic synthesis of the target molecule 27, outlined vide infra 
as an asymmetric synthesis. 
  
 
2.3.5 Carbamate Alkylation 
 
In order to synthesise the tertiary carbamate 104 in an asymmetric fashion we explored two 
methods via route A, alkylation followed by acylation. In our initial attempt, we attempted the 
chemoselective mono-alkylation of 87 with prenyl bromide and variety of bases to afford the 
secondary amine 105. Unfortunately, attempts to favour mono-alkylation failed, LiOH 
employed as the base gave the highest selectivity but still gave a poor yield of 16% for 105. 
Exploring a reductive amination approach, by performing an imine from amine 87 and prenal 
112 and subsequent reduction with NaBH(OAc)3 afforded the secondary amine in a good 
yield of 70% but unfortunately led to complete racemisation to give (rac)-105 (Scheme 73).  
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Scheme 73: Summary of tertiary carbamate synthesis via route A 
 
In light of these failures, we turned our attention to the synthesis of 104 via route B. This 
entailed the carbamation of amino ester 87 followed by carbamate alkylation (Scheme 74). 
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Scheme 74: Proposed synthesis of tertiary carbamate via route B 
 
Carbamation of the crude amino ester hydrochloride salt 110 was carried out with an excess 
of NaHCO3 and ethyl chloroformate in water to give the carbamate 106 in a good yield of 
75% over two synthetic steps from L-aspartic acid. (Scheme 75). 
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Scheme 75: Carbamation of aspartic ester 
 
 
Alkylation of carbamate 106 with prenyl bromide was attempted with a variety of bases 
(Scheme 76). 
CO2Me
CO2MeN
CO2Et
104
CO2Me
CO2Me
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N
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Scheme 76: General scheme for carbamate alkylation 
 
Initial reactions employing Cs2CO3 (Table 11, entry1) as the base in MeCN, conducting the 
reaction at room temperature and with the addition of TBAI (Table 11, entry 2) failed to 
facilitate the reaction, with only unreacted starting material being recovered. Raising the 
temperature of the reaction to reflux resulted in a complex mixture of unidentified by-
products. Changing the solvent to DMF and carrying out the reaction at room temperature and 
60 °C (Table 11, entries 4 & 5) gave only unreacted starting material. Performing the reaction 
with TBAI and 4 Å molecular sieves as additives and sonicating for extended periods of time 
(Table 11, entry 6) also failed to convert starting material into product. However, carrying out 
the reaction without the inclusion of molecular sieves (Table 11, entry 7) resulted in O-
alkylation. A di-O-alkylated product 140 was isolated in a 33% yield and two regioisomeric 
mono-O-alkylated products, 141a and 141b, were isolated as an inseparable 1:1 mixture in a 
combined yield of 59% (Scheme 77). Presumably an ingress of moisture led to basic 
hydrolysis of the esters followed by carboxylate alkylation. 
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Scheme 77: Alkylation resulting in O-alkylation  
 
 
The use of stronger bases such as LiOH and KHMDS (Table 11, entries 8 & 9) failed to 
promote the reaction. Employing BuLi (Table 11, entry 10) gave extensive decomposition 
resulting in a complex mixture of unidentified by-products. The use of NaH (Table 11, entry 
11) resulted in the formation of the tertiary carbamate 104 product, albeit in a low yield of 
30%, along with the secondary carbamate 142 in a 45% yield, identified by its 1H NMR, 13C 
NMR and infrared spectra, resulting from the elimination of 104 (Scheme 78).  
CO2Me
CO2MeN
CO2Et
H
104
H
N
EtO2C
142
" H+ "
B-  
Scheme 78: NaH promoted elimination 
 
 
In all of the previous reactions deprotonation of the carbamate hydrogen was performed prior 
to the addition of the alkylating agent, making the alkylated product 104 vulnerable to 
elimination. We envisaged that slow addition of NaH to a solution of carbamate 106 and 
prenyl bromide would hinder elimination because generation of the sodium carbamate would 
be followed by rapid trapping by the alkylating agent before elimination can take place. NaH 
was slowly added over two hours via a solid addition funnel to a solution of secondary 
carbamate 106 and prenyl bromide in THF cooled to 0 °C (Table 11, entry 12) to give the 
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tertiary carbamate 104 in a good yield of 81% and was successfully conducted on a 50 g scale 
(Scheme 79). 
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CO2MeN
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i) 1.2 eq prenyl bromide, THF, 0 °C
ii) slow addition of 1 eq NaH
 
Scheme 79: Carbamate alkylation with NaH 
 
 
Table 11: Carbamate alkylation conditions 
 
The tertiary carbamate 104 was prepared with no observable erosion of enantiopurity as 
determined by chiral HPLC (Figure 13). 
 
Entry Conditionsa Solvent Temp. / °C Time / h Additiveb 
Product         
(% Yield)b 
1 Cs2CO3 MeCN rt 16 none no reaction 
2 Cs2CO3
 MeCN rt 16 TBAI no reaction 
3 Cs2CO3 MeCN 85 16 TBAI decomposition 
4 Cs2CO3 DMF rt 8 none no reaction 
5 Cs2CO3 DMF 60 16 none no reaction 
6 Cs2CO3, )))
c DMF rt 72 TBAI, 4 Å MS no reaction 
7 Cs2CO3, )))
c DMF rt 72 TBAI 
 140 (33%) : 
141a+b (59%) 
8 LiOH DMF rt 16 TBAI no reaction 
9 KHMDS THF 0 8 none no reaction 
10 BuLi THF 0 8 none decomposition 
11 NaH THF 0 8 none 
105 (30%) : 142 
(45%) 
12 NaHd THF 0 4 none 104 (81%) 
a Reactions were carried out by the addition of 1-1.5 eq of base followed by the addition of 1-1.2 eq of prenyl 
bromide unless stated otherwise and. b Isolated yields of major products following purification. c Reactions 
were carried out with 3 eq of prenyl bromide. d Reaction was carried out by the addition of 1.2 eq of prenyl 
bromide followed by the slow addition of 1 eq of NaH. 
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Figure 13: Chiral HPLC trace of 104 
 
 
2.3.6 Oxidative Cleavage of  the Methylene Bond 
  
Two routes have been presented that gave access to the cyclisation product 96 on a multigram 
scale: a racemic route from the conjugate addition between prenyl amine 125 and 
dimethylmaleate 126 and an asymmetric route from L-aspartic acid 78 that utilised a NaH 
promoted alkylation of carbamate 106. In the following sections, we will discuss the 
transformation of the cyclisation product 96 into the target molecule 27 (Scheme 80).  
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Scheme 80: Two routes to the cyclisation product 96 
 
Hydrolysis of the oxazolidone ring and Boc protection of the amine was attempted in one-pot 
with a large excess of NaOH in MeOH and water heated to reflux followed by the addition of 
(Boc)2O. Two products were isolated from the reaction (Scheme 81). The piperidine 143 
resulted from successful hydrolysis of the cyclic carbamate followed by Boc protection of the 
nitrogen and Boc protection the primary hydroxyl. The piperidine 144 formed from the Boc 
protection of the secondary hydroxyl in 96; however, as TLC analysis indicated complete 
consumption of the starting material upon hydrolysis, Boc protection of the nitrogen must 
have occurred followed by reformation of the oxazolidone ring by attack from the primary 
hydroxyl under the strong basic conditions. 
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Scheme 81: Hydrolysis and protection in one-pot 
 
 
A two step procedure was employed instead: cleavage of the oxazolidinone ring with NaOH 
in MeOH and water gave the amino diol 145, which was isolated from the reaction mixture, 
and allowed to react with (Boc)2O in THF to give the Boc protected piperidine 146 in a very 
good yield of 86% over the two synthetic steps (Scheme 82). 
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Scheme 82: Hydrolysis and protection in two separate steps 
 
 
An X-ray crystal structure of amino diol 145 was obtained (Figure 14). 
Figure 14: X-ray crystal structure of amino diol 145 
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A chemoselective one-pot procedure was developed that involved basic hydrolysis followed 
by neutralisation with HCl(aq) and then addition of the mild base NaHCO3 and (Boc)2O to give 
the protected piperidine 146 in an excellent yield of 90% (Scheme 83). 
N
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O
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    96
i) NaOH, MeOH:H2O, Δ
ii) HCl(aq)
iii) NaHCO3, (Boc)2O
Boc
N
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146, 90%
HO
 
Scheme 83: Successful hydrolysis and protection in one-pot 
 
 
Protection of the primary hydroxyl as a TBDPS ether gave 147a in a good yield of 77%. 
Oxidative cleavage of alkene 147a with ozone failed to yield any of the desired ketone 148a 
and instead led to complex mixture of uncharacterised by-products (Scheme 84).  
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   -78 °C
ii) DMS, -78 °C - 0°C
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147a R1 = TBDPS, 77%
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148a R1 = TBDPS
148b R1 = TBS  
Scheme 84: Silyl ether protection of primary hydroxyl followed by failed ozonolysis 
 
Unsure whether oxidation of the aromatic ring93 in the TBDPS was the problem, alcohol 146 
was instead protected as its TBS  ether 147b in a very good yield of 81%. Ozonolysis of 147b 
also failed to result in product formation 148b and again led to a complex mixture of 
products. It has been reported that ozonolysis of sterically hindered substrates have led to 
unexpected side product formation,94,95, 96  therefore ozonolysis of the unprotected alkene 146 
was attempted but no unfortunately none of the ketone 149 was detected.  
Uncertain whether there is interference from the β-hydroxyl or how susceptible the α,β-
hydroxy ketone product would be to a retro-aldol reaction, we masked the reactivity of the 
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secondary hydroxyl using an orthogonal protecting group strategy. The secondary hydroxyl of 
the TBDPS 147a and TBS 147b silyl ethers were protected as their acetyl and benzoyl esters 
150a-150d in very good to excellent yields (Scheme 85). 
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150c R1 = TBS, R2 = Ac, 86%
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Scheme 85: Orthogonal protection of the two hydroxyl groups 
 
Ozonolysis of 150a, where R1 = TBDPS and R2 = Ac, gave the desired ketone 151a but in 
quite a poor yield of 42%. Changing R2 from Ac to Bz in the case 150b gave the ketone 151b 
in a very poor yield of 10% and the enone 152b in a yield of 61%, resulting from the 
elimination of benzoate. Presumably the greater steric bulk of the benzoyl group gives greater 
driving force for elimination under the ozonolysis reaction conditions. Changing R1 from 
TBDPS to TBS the expected ketone 151ci in a very poor yield of 5% and ketone 151cii where 
TBS removal has occurred in a good yield of 73%. To our knowledge, this is first example of 
TBS removal under ozonolysis conditions. Finally ozonolysis of 150d, where R1 = TBS and 
R2 = Bz, resulted in both TBS deprotection and benzoate elimination to give enone 152d in a 
poor yield of 29% (Scheme 86). 
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Scheme 86: Oxidative cleavage of isoprenyl group by ozonolysis  
 
Due to the lack of promising results from the oxidative cleavage using ozone we decided to 
try an alternative method using OsO4 and NaIO4. Subjecting 150a to the dihydroxylation and 
oxidative cleavage reaction gave the desired ketone 151a in a moderate yield of 65% as well 
as the intermediate diol 153, where oxidative cleavage has yet to take place, in a 19% yield 
(Scheme 87). 
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Scheme 87: Oxidative cleavage of 150a using OsO4/NaIO4 
 
The structure of diol 153 was determined by X-ray crystallography (Scheme 88).  
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Scheme 88: X-ray crystal structure of diol 153 
 
The oxidative cleavage of the unprotected alkene 146 was preformed with OsO4 and NaIO4 in 
dioxane and water to give the ketone 149 in a poor yield of 33% (Table 12, entry 1). A 
two-step procedure of dihydroxylation with OsO4 and NMO (Table 12, entry 2) followed by 
oxidative cleavage with NaIO4 was attempted in the hope of avoiding side reactions, however 
no product could be isolated from the dihydroxylation step presumably due to the appreciable 
aqueous solubility of the tetraol 154 (Scheme 89). 
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Scheme 89: Attempted two step dihydroxylation/oxidative cleavage 
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A high-yielding one-pot dihydroxylation/oxidative cleavage procedure was performed using 
OsO4 and NaIO4 with 2,6-lutidine as an additive (entry 3),
97 giving the ketone 149 in an 
excellent yield of 97% (Scheme 90).  
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Scheme 90: OsO4/NaIO4 oxidative cleavage with 2,6-luidine as an additive 
 
 
The vast improvement in yield by the addition of 2,6-lutidine is a likely a confirmation of the 
known ligand acceleration of OsO4-mediated dihydroxylations of alkenes by tertiary amines
98 
or more simply a buffering effect of the amine suppressing the acid-induced formation of side 
products. 
 
 
 
Table 12: Dihydroxylation/oxidative cleavage results of ketone 146 
 
 
2.3.7 Methyl Ketone Cleavage  
 
In our initial retrosynthetic analysis, we envisaged a cyclisation product that would have led 
to compound 155 containing a vinyl group. Oxidative cleavage of the alkene would have 
given aldehyde 156 followed by a relatively simple conversion to carboxylic acid 157, which 
could undergo a rearrangement reaction to afford the target molecule 27. Unfortunately, an 
Entry Reagentsa Solvents Yield (%) 
1 OsO4, NaIO4 dioxane:H2O 33 
2 OsO4, NMO t-BuOH:H2O -
b 
3 OsO4, NaIO4, 2,6-lutidine
c dioxane:H2O 97 
a Reactions were carried out with 0.1 mol% of OsO4 and 2-2.5 eq of 
reoxidant. b Product not isolated from aqueous phase. c 2.5 eq or 2,6-lutidine.  
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extra methyl group had to be incorporated to deliver high yields in the Prins cyclisation. 
Subsequent synthetic steps gave the compound 146 containing an isoprenyl group, and 
oxidative cleavage of the isoprenyl group gave the methyl ketone 149. Conversion of the 
methyl ketone 149 to the carboxylic acid 157 and/or amine of 27 is now not such a 
straightforward process (Scheme 91). The following section details how we achieved this 
transformation.  
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Scheme 91: Proposed alkene to amine functional group interconversions  
 
An attractive method for the direct conversion of a ketone to an amine is the Beckmann 
rearrangement. Formation of an oxime followed by suitable activation results in alkyl 
migration anti to the leaving group. Ketone 149 was allowed to react with hydroxylamine 
hydrochloride and Et3N in refluxing EtOH to give oxime 158 in a quantitative yield. Reaction 
of ketone 151a led to a complex mixture of products (Scheme 92). 
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Scheme 92: Oxime formation 
 
 
Beckmann rearrangement of oxime 158 was attempted by tosylation of the oxime using TsCl, 
Et3N and DMAP in refluxing CH2Cl2. The reaction failed to afford the expected product 160 
and instead led to decomposition of starting materials (Scheme 93). 
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Scheme 93: Beckmann rearrangement with TsCl 
 
The failure to effect the Beckmann rearrangement might be due to the unsuccessful 
attachment of a leaving group to the oxime, and so we decided to synthesise a hydroxylamine 
with a preinstalled leaving group. The activated hydroxylamine was prepared in three 
synthetic steps from hydroxylamine hydrochloride 161 according to a literature procedure to 
give O-mesitylenesulfonylhydroxylamine 162 in a moderate yield of 64% over three synthetic 
steps (Scheme 94).99 
SO
H2N
O
O
HCl.NH2OH
i) (Boc)2O, NaHCO3, CH2Cl2:H2O
ii) MesCl, Et3N, MeCN
iii) TFA
162, 64% over 3 steps161  
Scheme 94: Synthesis of activated hydroxylamine 
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The one-pot oxime formation and Beckmann rearrangement of ketone 149 was carried out 
with the activated hydroxylamine 162. Performing the reaction in CH2Cl2 with Et3N and in 
EtOH heated in sealed tubes to 80 °C and 120 °C respectively resulted in the recovery of 
unreacted starting materials with no product formation observed (Scheme 95). 
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Scheme 95: Attempted Beckmann rearrangement with an activated hydroxylamine 
 
One method for the direct conversion of a methyl ketone to its corresponding carboxylic acid 
is the Lieben haloform reaction. The reaction involves exhaustive halogenation of a methyl 
ketone, followed by nucleophilic substitution of hydroxide for the haloform anion. The 
reaction of 149 and 151a with Br2 and NaOH in dioxane and water at 0 °C failed to convert 
the methyl ketones into carboxylic acids and instead, under the strong basic conditions, led to 
elimination to afford enones 152d and 152b in yields of 53% and 52% respectively (Scheme 
96). 
     Br2, NaOH,
dioxane:H2O, 0 °C
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149 R1 = H, R2 =H
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152d R1 = H, 53%
152b R1 = TBDPS, 52%  
Scheme 96: Haloform reaction 
 
Another method to convert the methyl ketone to a carboxylic acid is formation of the kinetic 
silyl enol ether followed by its oxidative cleavage. A rearrangement reaction of the carboxylic 
acid was envisaged to proceed through an isocyanate intermediate; trapping by the secondary 
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hydroxyl would form the corresponding oxazolidinone. To avoid any regioselectivity issues 
during the rearrangement step the primary hydroxyl of ketodiol 149 was protected as its 
TBDPS ether in an excellent yield of 91%. 
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148a, 91%  
Scheme 97: TBDPS protection of ketone 149 
 
Treatment of ketone 148a with two equivalents of TMSOTf and Et3N in CH2Cl2 cooled to -78 
°C did not furnish the expected silyl enol ether but gave silyl ether 163 instead in a good yield 
of 82%. However, utilising the stronger base KHMDS and TMSCl in CH2Cl2 cooled to -78 
°C pleasingly gave the silyl enol ether 164 in a good yield of 79% (Scheme 98). A TMS 
group was employed because of the extremely mild conditions needed for its deprotection and 
low propensity to act as a good leaving group, thereby minimising elimination. 
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Scheme 98: Silyl enol ether formation of 148a 
 
 
Unsurprising in the light of earlier results the reaction between ketone 151a, KHMDS and 
TMSCl failed to yield the silyl enol ether 165 and instead led to the enone 157b in a 83% 
yield. Further reactions utilising compounds with acyl protection of the secondary hydroxyl 
were abandoned due to their susceptibility to undergo elimination. 
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Scheme 99: Attempted silyl enol ether formation of 156a 
 
Attempted oxidative cleavage of silyl enol ether 164 using OsO4, NaIO4 and 2,6-lutidine in 
dioxane and water resulted in the formation of enone 152b, where under the mildly acidic 
reactions conditions hydrolysis and elimination of the silyl enol ether occurred at a faster rate 
than the desired dihydroxylation/oxidative cleavage (Scheme 100). 
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Scheme 100: Silyl enol ether oxidative cleavage using OsO4/NaIO4 
 
Ozonolysis of 164 was then attempted in CH2Cl2 (Table 13, entry 1) and in combination with 
the participating solvent MeOH (Table 13, entry 2) followed by reduction of the intermediate 
peroxides with dimethylsulfide. No carboxylic acid product was detected and instead both 
reactions resulted in conversion of starting materials to ketone 148a. We believed that latent 
acidity associated with the ozonolysis conditions was causing breakdown of the silyl enol 
ether and cleavage of the TMS ether and so we planned to perform the reaction in the 
presence of a variety of bases.  
 
Tertiary amines are often used as additives to improve yields in ozonolysis reactions. The use 
of triethylamine has been reported to directly reduce the secondary ozonide100 or by its N-
65
164 
152b, 83% 151a 
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oxide, generated in situ, to reduce intermediate carbonyl oxide via a Grob fragmentation.101 
The role pyridine in the reduction of the intermediate carbonyl oxides via its N-oxide has been 
reported and later refuted.102,103 Performing the reactions with pyridine and triethylamine 
(Table 13, entries 3 & 4) present resulted in only ketone 148a being isolated from the 
reaction. However, using the inorganic base NaHCO3
104 (Table 13, entry 5) gave the desired 
carboxylic acid 166 in a quantitative yield, following acidification of the carboxylate salt 
(Scheme 101). The synthesis of 166 constituted a formal synthesis of pseudodistomin-F, 
however as Ma and Sun report no characterisation for this compound we needed to synthesise 
the next intermediate with characterisation i.e. 27. 
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i) O2/O3, NaHCO3, CH2Cl2:MeOH, -78 °C
ii) DMS, -78 °C - 0 °C
iii) 1 M HCl(aq), 0 °C
171, quant.  
Scheme 101: Ozonolysis of the silyl enol ether 
 
 
 
 
 
 
 
 
 
Table 13: Conditions tested for the ozonolysis of silyl enol ether 164 
 
A Curtius rearrangement of the carboxylic acid 166 followed by trapping of the intermediate 
isocyanate by the secondary hydroxyl gave the oxazolidinone 167 in a very good yield of 
Entry Solventa Additive Yield of 171 (%) 
1 CH2Cl2 none -
b 
2 CH2Cl2:MeOH none -
b 
3 CH2Cl2:MeOH
 1 eq py -b 
4 CH2Cl2:MeOH 1 eq Et3N -
b 
5 CH2Cl2:MeOH 10 eq NaHCO3 quant. 
a Reactions were carried out by bubbling O2/O3 into the solution cooled to -78 
°C before being  quenched with  DMS 2-10 eq and being allowed to warm to 0 
°C. b Product isolated from reaction was ketone 148a in a 90%-quant. yield. 
164 166, quant. 
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83%. The structure of oxazolidinone 167 was confirmed by X-ray crystallography (Figure 
15).  
 
Figure 15: X-ray crystal structure of 167 
 
 
Removal of the TBDPS protecting group with TBAF gave the unprotected oxazolidinone 27 
in a quantitative yield and completed the formal synthesis of pseudodistomin F (Scheme 102).  
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Scheme 102: Curtius rearrangement followed by deprotection  
 
The structure of oxazolidinone 27 was confirmed by X-ray crystallography, showing that it 
adopted a twist boat conformation in the crystal phase (Figure 16).  
166 167 
166 167, 83
 87 
 
Figure 16: X-ray crystal structure of 27 
 
The IH NMR spectrum of the oxazolidinone 27 synthesised by Ma and Sun is in good 
agreement with IH NMR spectrum of 27 synthesised by ourselves. The IH NMR spectra are 
complicated by the presence of rotamers in a ~2:1 ratio, presumably from restricted rotation 
of the Boc group. This has the effect of causing line broadening and splitting of the peaks into 
separate signals, most obvious in the splitting of the oxazolidinone NH proton into 2 separate 
singlets at ~5.6-6.0 ppm. The peaks in the 1H NMR spectrum can be sharpened by employing 
MeOD as the solvent (Figure 17). Unfortunately, Ma and Sun did not report the 13C NMR, 
melting point, elemental analysis and X-ray crystal structure and so comparisons could not be 
made with our own results. The recorded optical rotation of [α]21D -107.4 (c 1, MeOH) was in 
good agreement with the literature value of [α]21D -111.4 (c 0.92, MeOH),24 and chiral HPLC 
confirmed the existence of only one enantiomer (Figure 18). 
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Figure 17: Comparisons of the 1H NMR spectra of 27 
1H NMR spectrum 27 synthesised by Ma and Sun in CDCl3 
1H NMR spectrum 27 synthesised by ourselves in CDCl3 
1H NMR spectrum of 27 synthesised by ourselves in MeOD  
NH signal 
NH signal 
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• Chiral HPLC trace of racemic target molecule 27  
 
 
 
 
 
 
 
 
 
 
 
• Chiral HPLC trace of enantiopure target molecule 27 
 
 
 
 
 
 
 
 
 
 
 Figure 18: Racemic and enantiopure chiral HPLC traces of 27 
 90 
Having completed the formal synthesis of pseudodistomin F we looked to improve the 
efficiency of the synthetic route. Protection of the primary alcohol as a TBDPS ether 
introduced two additional steps into the synthesis (protection & deprotection). We speculated 
whether it was possible to carry out the Curtius rearrangement without protection of the 
primary hydroxyl, as there is a potential regioselectivity issue of the primary alcohol reacting 
with the isocyanate intermediate in an intermolecular fashion. Therefore, ketone 149 was 
allowed to react with three equivalents of TMSOTf at -78 °C in the hope of forming the 
corresponding silyl ether enol but instead gave the bis-protected TMS silyl ether 168 (Scheme 
103). 
Boc
N
OH O
HO
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   3 eq TMSOTf, Et3N, 
4 Å MS, CH2Cl2, -78 °C
Boc
N
TMSO O
TMSO
 
Scheme 103: Silyl enol formation with TMSOTf at -78 °C 
 
Raising the temperature of the reaction to 0 °C resulted in successful silyl ether formation but 
unfortunately removed the Boc protecting group,105 as confirmed by analysis of the 1H NMR 
of the crude reaction. Unfortunately, attempts to purify 169 led to decomposition (Scheme 
104). 
Boc
N
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HO
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   3 eq TMSOTf, Et3N, 
4 Å MS, CH2Cl2, 0 °C
H
N
TMSO OTMS
TMSO
174  
Scheme 104: Silyl enol formation with TMSOTf at 0 °C 
 
In the hope of preserving the Boc protecting group we employed the bulkier silyl triflate, 
TBSOTf, but regrettably the Boc group was not retained under these conditions which gave 
168, 75% 
69 
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silyl enol ether 170 and ketone 171 that were sufficiently stable to be purified by flash column 
chromatography (Scheme 105). 
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   3 eq TBSOTf, Et3N, 
4 Å MS, CH2Cl2, 0 °C
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TBSO O
TBSO
175, 64% 176, 23%
+
 
Scheme 105: Silyl enol ether formation with TBSOTf 
 
Performing the reaction at an intermediate temperature of -42 °C with 3 equivalents of 
TMSOTf preserved the Boc and gave the silyl enol ether 172 in an excellent yield of 92% . 
Attempts to purify the crude silyl enol ether on neutralised silica by flash column 
chromatography resulted in poor yields ~30% due to breakdown of the silyl enol ether to the 
corresponding ketone. The key to high reaction yields of the pure silyl enol was to flood the 
crude reaction mixture with diethylether, rendering the triethylammonium triflate by-product 
insoluble and allowing for simple separation of the diethylether layer containing the silyl enol 
ether product 173. Ozonolysis of the silyl enol ether gave the carboxylic acid in an 
quantitative yield (Scheme 106). 
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i) O2/O3, NaHCO3, 
   CH2Cl2:MeOH, -78 °C
ii) DMS, -78 °C - 0 °C
iii) 1 M HCl(aq), 0 °C
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Scheme 106: Silyl enol formation and ozonolysis 
 
The structure of carboxylic acid 173 was determined by X-ray crystallography (Figure 19).  
0 171, 23%
172, 92% 173, quant. 
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Figure 19: X-ray crystal structure of carboxylic acid 173 
 
Curtius rearrangement of the carboxylic acid 173 gave the desired oxazolidinone 27 in a good 
yield of 75%, and completed the formal synthesis (Scheme 107).  
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27, 75%178  
Scheme 107: Curtius rearrangement of carboxylic acid 173 
 
High reaction yields were dependent on prior heating of the carboxylic acid and Et3N together 
before the addition of DPPA, due to formation of a phosphate ester by-product 174, 
tentatively assigned from its 1H NMR and mass spectra.  Its formation presumably occurs due 
to the poor solubility of the carboxylic acid in toluene at room temperature compared to the 
corresponding oxazolidinone, which further reacted with reacted with DPPA. 
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Scheme 108: Mechanism for the formation of the phosphate ester by-product 174 
 
2.3.8 Ketone Epimerisation  
 
While investigating the oxidative cleavage of alkene 146 using OsO4/NaIO4 (Table 12, entry 
3) it was observed that after quenching of the reaction with Na2SO3 and heating to remove the 
solvents in vacuo epimerisation occurred at the ketone stereocentre to afford a mixture of cis-
ketone 149 and trans-ketone 175 (Scheme 109). 
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i) OsO4, NaIO4, 2,6-lutidine, dioxane:H2O
ii) Na2SO3, Δ
+
175149146  
Scheme 109: Epimerisation during oxidative cleavage 
 
In an attempt to isolate the species responsible for the epimerisation of 149, we looked at each 
reagent in turn. The reactions between cis-ketone 149 and 2,6-lutidine (Table 14, entry 1), 
NaIO4 (Table 14, entry 2) and a saturated aqueous solution of Na2SO3 (Table 14, entry 3) in 
dioxane and water heated to 40 °C for twenty-four hours resulted in no epimerisation. 
However, treating cis-ketone 149 with NaIO4 and a saturated aqueous solution of Na2SO3 
together in dioxane led to complete epimerisation in one hour (Table 14, entry 4) (Scheme 
110).  
 
174 
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175, 99 %149  
Scheme 110: Epimerisation with a combination of NaIO4 and Na2SO3 
 
We rationalised that the likely products generated from the reaction between NaIO4 and 
Na2SO3 were NaIO3 and Na2SO4. Performing the reaction individually with NaIO3 and 
Na2SO4 (Table 14, entries 5 & 6) and in combination of the two reagents (Table 14, entry 7) 
failed to furnish the epimerisation. 
 
 
 
 
 
 
Table 14: Results from the epimerisation of ketone 149 
 
To gain an insight into the reaction mechanism we performed the reaction using conditions 
normally employed to affect the epimerisation of carbonyls with α-stereogenic centres. The 
strong organic base DBU in CH2Cl2 in 4 hours at room temperature (Table 14, entry 8) 
Entry Reagenta Solventb Temp. / °C Time / h 149 : 175c 
Yield of 175 
(%)d 
1 2,6-lutidine H2O:dioxane 40 24 100 : 0 -
e 
2 NaIO4 H2O:dioxane 40 24 100 : 0 -
e 
3 Na2SO3 (aq)
f dioxane 40 24 100 : 0 -e 
4 NaIO4/Na2SO3 (aq)
f dioxane 40 1 0 :100 99 
5 NaIO3 H2O:dioxane 40 24 100 : 0 -
e 
6 NazSO4 H2O:dioxane 40 24 100 : 0 -
e 
7 NaIO3/Na2SO4 H2O:dioxane 40 24 100 : 0 -
e 
8 DBU CH2Cl2 rt 4 0 : 100 98 
9 Et3N
g CH2Cl2 rt 168 100 : 0 -
e 
10 Et3N
 CH2Cl2 40 8 75 : 25 -
h 
a Two equivalents of reagent used unless stated otherwise. b Reactions carried out at a total c of 0.1 M, in the 
case of mixed solvents a 1:1 ratio was used. c Ratio of products determined by analysis of the 1H NMR of the 
crude reaction mixture. d Isolated yield following purification. e No reaction had taken place. f An equivalent 
volume of a saturated aqueous solution of Na2SO3 to reaction solvent was added. 
g Ten equivalents of reagent 
used. h Products not isolated from crude reaction mixture. 
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afforded complete epimerisation. Using the weaker base triethylamine in CH2Cl2 for 1 week at 
room temperature (Table 14, entry 9) failed to effect epimerisation, however heating the to 40 
°C over eight hours resulted in partial epimerisation (Table 14, entry 10). Unfortunately, we 
were not able to determine the active species responsible for the epimerisation, generated 
from the reaction between NaIO4 and Na2SO3, although it would appear not to occur from a 
simple oxidation/reduction reaction. 
 
The stereochemistry of trans-ketone 175 was determined by a NOESY experiment and was 
compared to the NOESY spectrum of the cis-ketone 149. The important interactions of H5 are 
shown below (Figure 20). In the NOESY spectrum of trans-ketone 175 there are nOes 
between H5 the axial H3’ and a single H6 proton. In addition, the doublet of double doublets 
(ddd) corresponding to H5 has coupling constants of 4.1, 10.1, and 12.2 Hz indicative of two 
diaxial couplings. The nOe interactions supported by the coupling constants are consistent 
with H5 being axial within the chair conformation. In comparison, H5 of cis-ketone 149 
exhibits nOes between the two H6 protons and H4 but crucially there is no nOe between H5 
and any of the H3 protons. The quartet corresponding to H5 has a relatively small coupling 
constant of 3.4 Hz indicating no diaxial couplings. The nOe interactions and coupling 
constants imply that H5 lies equatorial within the chair conformation.  
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Figure 20: Comparison of H5 nOe interactions between trans-ketone 175 and cis-ketone 149  
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We decided to utilise this transformation for the synthesis of an unnatural core structure of the 
pseudodistomin family. Assuming the chemistry to transform 27 into 10 would work for 
(epi)-27 this would allow access to the unnatural diastereomer epi-pseudodistomin F (epi)-10 
(Scheme 111). 
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NH
O
H
N
OH
NH2
(epi)-10 epi-pesudositomin F(epi)-27  
Scheme 111: Potential synthesis of epi-pseudodistomin F 
 
The formation of a strained trans oxazolidinone in the Curtius rearrangement might present a 
greater regioselectivity issue than before. Capture of the isocyanate intermediate by the trans-
secondary hydroxyl was predicted to be slower than the in cis compound, therefore capture by 
the primary hydroxyl was of greater concern. Protection of the primary hydroxyl in 175 was 
accomplished with TBDPSCl to give the protected ketone 176 in an excellent yield of 96%. 
The hydrogens in the methyl group of the trans-ketone are predicted to be more accessible 
than the corresponding hydrogens in the cis-ketone, therefore silyl enol ether formation was 
attempted with two equivalents of TMSOTf at -78 °C but as in the previous case only the 
formation of a silyl ether 177 was observed (Scheme 112). 
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175 176, 96% 177, 78%  
Scheme 112: Primary and secondary hydroxyl protection 
 
Silyl enol ether was successfully accomplished by raising the temperature to -42 °C, giving 
178 in a very good yield of 80%. Ozonolysis of the silyl enol ether gave the carboxylic acid 
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179 in an excellent yield of 92% and a Curtius rearrangement of the carboxylic acid with 
DPPA gave the trans-oxazolidinone 180 in a good yield of 74%. Deprotection of the TBDPS 
silyl ether with TBAF was successful but also resulted in cleavage of the oxazolidinone, 
giving amino diol 181 in a good yield of 74%. The commercial TBAF sold in a solution of 
THF is wet and basic, resulting in hydrolysis of the strained trans-oxazolidinone, which is 
susceptible to ring opening under these mild conditions. Deprotection of the silyl ether and 
retainment of the oxazolidinone ring was accomplished by employing HF in pyridine gave the 
oxazolidinone 182/(epi)-27 in a very good yield of 81% (Scheme 113).  
 
Boc
N
TBDPSO
TMSO OTMS
Boc
N
TBDPSO
OH O
OH
Boc
N
TBDPSO
O
NH
O
Boc
N
HO
O
NH
O
Boc
N
HO
NH2
OH
i) O3/O2, NaHCO3, 
   CH2Cl2:MeOH, -78 °C
ii) DMS, -78 °C - 0 °C
iii) 1 M HCl(aq), 0 °C
2 eq TMSOTf, 
Et3N, 4 Å MS, 
CH2Cl2, -42 °C
DPPA, Et3N
      tol., Δ
TBAF, THF
HF.py, THF:py
Boc
N
TBDPSO
OH O
176 178, 80% 179, 92%
180, 74% 181, 74%
182 / (epi)-27, 81%  
Scheme 113: Silyl enol ether formation, ozonolysis, Curtius rearrangement and deprotection 
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2.4 Third Generation Synthesis 
In parallel with our studies towards the formal synthesis of pseudodistomin F 10 we 
envisaged a more expedient route to the total synthesis of this natural product. Our synthetic 
route to the synthesis of pseudodistomin F via the ‘formal synthesis’ pathway requires the 
construction of two oxazolidinone rings and their cleavage in two separate steps (Scheme 
114).  
N
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Scheme 114: Current synthetic route for the total synthesis of pseudodistomin F 
 
A more logical approach to the total synthesis of pseudodistomin F 10 would be the cleavage 
of both oxazolidinones in one step, therefore an alternative retrosynthetic approach to 10 was 
proposed. Installation of the alkyl side-chain in 10 occur from an olefination reaction of 
diamino diol 183, which in turn can be formed the hydrolysis of bis-oxazolidinone 184 
(Scheme 115).  
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Scheme 115: Alternative retrosynthetic approach 
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Oxidative cleavage of alkene 96, initially performed with ozone in CH2Cl2 at -78 °C with 
PPh3 as the reducing agent (Table 15, entry 1), gave a poor yield of 26% for the ketone 185. 
Changing the solvent to a mixture of CH2Cl2 and MeOH (Table 15, entry 2) resulted in 
smooth conversion into products, but problematic purification of the product and 
triphenylphosphine oxide by-product decreased the yield to 60% yield. Changing the reducing 
agent to DMS (Table 15, entry 3) yielded DMSO as the by-product, which cold be removed in 
vacuo gave the ketone 185 in a quantitative yield. 
 
 
 
 
Table 15: Ozonolysis conditions 
 
The oxidative cleavage was also carried out successfully using OsO4 and NaIO4, giving the 
ketone 189 in a 90% yield (Scheme 116). 
 
N
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N
OH
O
O A. i) O3/O2, MeOH:CH2Cl2, -78 °C
    ii) DMS, -78 °C - rt
B. OsO4, NaIO4, 2,6-lutidine
          H2O:dioxane
96 185, A) quant.
         B) 90%  
Scheme 116: Oxidative cleavage of alkene 96 with either ozone or OsO4/NaIO4  
 
Ketone 185 could be transformed to oxime 186 in a good yield of 78%. The structure of the 
oxime was determined by X-ray crystallography (Figure 21).  
Entry Solvent Reducing agent Time / min Yield of 185 (%) 
1 CH2Cl2 PPh3 30 26
 
2 CH2Cl2 : MeOH PPh3 15 60
 
3 CH2Cl2 : MeOH DMS 15 quant.
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Figure 21: X-ray crystal structure of oxime 186 
 
The Beckmann rearrangement of oxime 186 was attempted with TsCl, but unfortunately the 
oxazoline derivative 187 was not formed and only unreacted starting materials were recovered 
from the reaction (Scheme 117). 
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Scheme 117: Oxime formation and attempted Beckmann rearrangement 
 
The one-pot oxime formation and Beckmann rearrangement between ketone 185 and the 
activated hydroxylamine 162 was attempted. Reaction with Et3N in CH2Cl2 heated to 80 °C in 
sealed tube only gave unreacted starting materials. The same result was obtained when 
heating 185 and 162 together in EtOH at reflux. Performing the reaction in a sealed tube 
heated to 120 °C resulted in elimination to give enone 188 (Scheme 118). 
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Scheme 118: Attempted Beckmann rearrangement with activated hydroxylamine 
 
The TMS enol ethers synthesised previously have been relatively unstable; we believed the 
stability could be increased by the formation of a tethered silyl ether/silyl enol ether 189. 
Ketone 185 was allowed to react with DTBS(OTf)2 and Et3N at -78 °C before warming to 0 
°C. The formation of the tethered silyl enol ether 189 was not observed and only silyl ether 
190 and the elimination product 188 were recovered in yields of 38% and 41% respectively 
(Scheme 119).  
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Scheme 119: Attempted tethered silyl ether/silyl enol ether formation 
 
The reaction between ketone 185 and two equivalents of TMSOTf at -78 °C failed to afford 
the desired silyl enol ether and instead gave silyl ether 191 in a yield of 75% (Scheme 120). 
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Scheme 120: Attempted silyl enol ether formation at -78 °C 
 
 102 
The reaction between ketone 185 and two equivalents of TMSOTf in CH2Cl2 at 0 °C gave the 
silyl enol ether 192 in a very good yield of 84%. Ozonolysis of the silyl enol ether 192 gave 
the carboxylic acid 193 in an excellent yield of 95% followed by a Curtius rearrangement to 
give the bis-oxazolidinone 184 in a good yield of 75%. 
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Scheme 121: Synthesis of bis-oxazolidinone 184 
 
Unfortunately, time constraints prevented further attempts towards the total synthesis of 
pseudodistomin F 10, via this synthetic route. 
 
 
2.5 Modifying the Stereoelectronics of the Prins Reaction 
Due to our ongoing interest in the Prins cyclisation methodology, we wanted to probe the 
mechanistic details of the reaction by studying whether varying the electronics of the ene 
component could alter the diastereoselectivity. The cyclisation precursor 194 bearing various 
substituents on the phenyl ring was chosen for study. This substrate was chosen because 
substituents could be installed relatively easily, enabling the electronics of the system to be  
finely tuned (Figure 22).  
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Figure 22: Substituted phenyl cyclisation precursor 194 
 
We reasoned that as the electron withdrawing ability of the substituent X increases the 
carbocation becomes destabilised, leading to a greater preference for the proposed 
electrostatic interaction of the oxygen lone and carbocation to occur which in turn would lead 
to higher cis diastereoselectivities (Figure 23).  
TsN
OH
X
 
Figure 23: Stabilising interaction of an oxygen lone pair 
 
Previous work in the group has looked at the Prins cyclisation between the Brønsted acid 
HCl(g) and the  cyclisation precursor 194 with substituents  NO2, CF3, Br, H, 
tBu and OMe 
(Scheme 122).64 
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Scheme 122: Previously studied Brønsted acid cyclisations 
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The results from the reaction are summarised below in Table 16. The stereoselectivities for all 
substrates are poor, with cis:trans ratios ranging from 1:2.20 to 1:1.14 for CF3 and OMe 
substrates respectively (entries 2 & 6). Substituting the phenyl ring with a very electron 
withdrawing group (entries 1 & 2) led to significant amounts of the elimination by-product 
199.  
 
Table 16: Previously studied Brønsted acid cyclisations62 
 
The relative stereochemistries of the reaction products were determined by X-ray 
crystallography of the piperidines with phenyl substrate X = H. The stereoselectivities 
countered the proposed stereochemical outcome of the reaction, as the trans diastereomer was 
isolated as the major component. It would appear that the postulated stabilising interaction is 
not as significant in this system compared to previous systems studied. 
 
We wished to study the Lewis acid-promoted Prins cyclisation in the hope of improving the 
diastereoselectivity. We chose to study a similar substrate range of electron-withdrawing to 
electron-donating groups NO2, CF3, Br, H, Me and OMe to allow us to make comparisons 
Entry 194 
Reaction 
time / h 
195(R) 196(S) 197(R) 198(S) 199 cis:trans ratio 
1 NO2 16
a 0 0 traces 42% - 
2 CF3 120
b 24 7 5 64 18% 1:2.20c 
3 Br 16 33 14 24 29 0 1:1.13c 
4 H 16 26 11 29 34 0 1:1.70c 
5 tBu 16 28 15 37 20 0 1:1.33c 
6 OMe 16 - - - - 0 1:1.14d 
a 10% of aldehyde remained. b Traces of aldehyde remained. c Ratio determined by integration of 1H 
NMR of crude reaction mixtures. d Ratio determined by the relative areas from the HPLC of the crude 
reaction mixture. 
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with the previously studied Brønsted acid cyclisations.62 The cyclisation precursors 194 were 
synthesised in five steps from commerically available para-substituted benzaldehydes 200a-e. 
The aldehydes 200a-e were subjected to a Wittig reaction with phosphorous ylide 201 to 
afford the methyl cinnamates 202a-e, with stereoselectivities in favour of the E-isomer with 
ratios ranging from 7:1 to >40:1. Reduction of the esters 202a-e to the corresponding alcohols 
203a-e was achieved with DIBAL-H, before bromination of alcohols, 203a-d with PBr3 gave 
the desired bromides 204a-d (Scheme 123).  
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Scheme 123: Synthesis of allylic bromides 
 
Attempted bromination of the para-methoxy alcohol 203e led to decomposition, so the less 
reactive chloride 205 was synthesised from SOCl2. Alkylation of the amino alcohol 206 with 
the synthesised alkylating agents 204a-d, 205 and the commercially available cinnamyl 
bromide 204f gave the alkylated amino alcohols 207a-f. Oxidation of the alcohols 207a-f with 
PCC, DMP and TPAP led to significant amounts ~20-50% of ester 208 (Figure 24) resulting 
from hemiacetal formation/oxidation.  
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Figure 24: Ester by-product from oxidation reactions 
 
However, oxidation using Swern conditions gave the aldehydes 194a-f in very good to 
excellent yields with no ester by-product occurring (Scheme 124). 
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Scheme 124: Synthesis of the cyclisation precursor 
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With the cyclisation precursors 194a-f in hand we subjected them to a Prins reaction using the 
Lewis acid MeAlCl2 (Scheme 125). The results of the cyclisations are summarised below 
(Table 17). 
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Scheme 125: Prins cyclisation with the Lewis acid MeAlCl2 
Table 17: MeAlCl2 promoted cyclisations of aldehydes 194 
 
The stereochemical assignments were made by comparison 1H NMR spectra of the crude 
reaction mixtures to the known phenyl piperidines determined by X-ray crystallography, in 
particular the shifts of the CH-Cl hydrogen between 4.7-5.5 ppm were diagnostic of the 
Entry 194a 
Temp / 
°C 
195(R) 196(S) 197(R) 198(S) 199 
tans : cis 
ratiob 
Yield / 
%c 
1 NO2 -78
 5 5 69 11 10 8 : 1 45 
2 CF3 -78
 5 5 25 15 50 4 : 1 -d 
3 Br -78 tracee 86 14 0 >25 : 1 77 
4 H -78 5 5 78 12 0 9 : 1 71 
5 Me -78 23e 50 27 0 3.3 : 1 32 
6 OMe -78 - - - - - - -f 
a All reactions carried out with 2 eq of MeAlCl2 in CH2Cl2 unless stated otherwise. 
b Ratios determined by 
integration of the 1H NMR of the crude reaction mixture. c Yield of isolated major component following 
purification. d Purification of the crude reaction mixture was unsuccessful. e Combined ratio of products 
determined by the 1H NMR of the crude reaction mixture. f Reaction led to a complex mixture of 
unidentified by products unidentified by-products. 
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stereochemistry. The Lewis acid-promoted Prins reaction favoured the trans diastereomer as 
seen previously with the Brønsted acid but generally with higher diastereoselectivities ranging 
from to >25:1 to 3.3:1 for trans:cis. Interpretation of the diastereoselectivities for the most 
electron withdrawing substituents, (Table 17, entries 1 & 2), are complicated by significant 
amounts of the elimination product 199. However, for the substrates where no elimination 
occurs the trend is for an increase in trans selectivity as the X substituent becomes more 
electron withdrawing (Table 17, entries 3-5). Cyclisation of the most electron rich substrate, 
OMe, led to complex mixture of unidentified by-products, with none of the desired products 
detected in the 1H NMR of the crude reaction mixture (Table 17, entry 6). Tentatively we can 
account for the observed selectivities favouring the trans products it was envisaged that the 
initial benzyl carbocation 200 becomes delocalised over the phenyl ring. A stabilising 
electrostatic interaction of the delocalised carbocation resulting from the negative charge on 
the oxygen-Lewis acid complex could only occur in intermediates 201 and 204. A 1,3 diaxial 
interaction between the phenyl ring and an axial hydrogen, might favour 202 over 201. The 
coordination of a bulkier Lewis acid to the oxygen, in comparison to a proton for the Brønsted 
acid, would lead to greater 1,3 diaxial interactions helping to reinforce the selectivity for the 
trans diastereomer (Scheme 126).  
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Scheme 126: Postulated intermediates to account for the observed diastereoselectivities 
 
Alternatively, the observed diastereoselectivity can be rationalised by the steric preference for 
the bulky Lewis acid-coordinated oxygen to adopt an equatorial conformation. The reaction 
can be envisaged to proceed through either: an asynchronous concerted process 205, or 
through a zwitterionic intermediate with intramolecular chloride transfer 206 (Figure 25). 
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Figure 25: Alternative explanation for the observed diastereoselectivity 
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3. Conclusions and Future Work 
 
This work describes the successful application of the carbonyl-ene/Prins reaction in total 
synthesis. The aim was to synthesise an advanced intermediate 27 used in Ma and Sun’s total 
synthesis of pseudodistomin F 10. Our initial retrosynthetic approach to the target molecule 
27 was a carbonyl-ene/Prins reaction of the crotyl-ene cyclisation precursor 78 to form 
piperidine 80 (Scheme 127). 
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Scheme 127: Initial retrosynthetic approach to the target molecule  
 
Subjecting the cyclisation precursor 78 to a carbonyl-ene reaction gave the desired piperidine 
80 in a very poor yield of 25% due to the formation of three out of the possible four 
diastereomers and a dimerisation by-product. The poor selectivity in the reaction was thought 
to be a consequence of the reaction proceeding through an unfavourable secondary 
carbocation. Changing the cyclisation precursor to a prenyl-ene substrate 95, resulted in 
successful Prins cyclisation giving excellent diastereoselectivities of up to 200:1 in favour of 
cis over trans.  Two successive generations were developed that gave access to the cyclisation 
precursor 95. Although both generations gave similar yields 53% to 55% for the first and 
second generations respectively, only the second generation synthesis gave access to the 
cyclisation precursor on a multigram scale and required fewer synthetic transformations to 
complete. Using the second generation synthesis we were able to complete the formal 
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synthesis 27 of pseudodistomin F in a total of thirteen synthetic steps and in an overall yield 
of 28% from aspartic acid 76, a noticeable improvement over the original synthesis of 27 
presented by Ma & Sun, which required fifteen steps and with a overall yield of 12% from 
commerically available starting materials.  
N
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1st Genration: 7 steps, 53%
2nd Generation: 5 steps, 55%
97, 98%
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             27
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Scheme 128: 1st and 2nd generation syntheses 
 
We serendipitously discovered a facile method to epimerise the ketone stereocentre of 149 to 
give its epimer 175 using a combination of NaIO4 and Na2SO3, although the active species 
that causes epimerisation remains unresolved. We utilised this reaction and synthesised 
(epi)-27, which possess an unnatural core stereochemistry of the pseudodistomin alkaloids. 
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Scheme 129: Epimerisation and synthesis of (epi)-27 
 
 
Having completed the formal synthesis of pseudodistomin F we turned our attention towards 
its total synthesis. From ketone 185 the bis-oxazolidinone 184 was prepared in three steps, 
this would potentially allow the cleavage of both oxazolidinone groups in one step instead of 
two steps as in the second generation synthesis.  Future work could involve the formation of 
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sulfone 207 from amino diol 183. The sulfone 207 would allow efficient installation of the 
side chain through a Kocienski-modified Julia olefination with aldehyde 208 to give 
pseudodistomin F (Scheme 130). 
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Scheme 130: Towards the total synthesis of pseudodistomin F 10 
 
It would be interesting to conduct an SAR study to test for improved biological activities in 
vitro. In particular olefination reactions with aldehydes of varying chain lengths would 
quickly and easily build up diversity. 
 
We also conducted a study into how changing the electronics of the ene component would 
alter the diastereoselectivity of the reaction. The results indicated that the diastereoselectivity 
favoured the trans products 197 and 198 as the electron withdrawing power of the substituent 
X increased in the cyclisation precursor 194 (Scheme 131).  
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Scheme 131: Prins cyclisation of the substituted cinnamyl substrate 194 
 
Considering the cinnamyl substrates 194 (Figure 26), it would be interesting to expand the 
substituent range and screen a variety of Lewis acids in order to gain a greater understanding 
of the reaction mechanism. 
Ts
N
O
X
194  
Figure 26: Various substituted cyclisation precursors
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4. Experimental 
 
1H and 13C spectra were recorded on either a Bruker AC 300 (300 and 75 MHz), a Bruker AV 
300 (300 and 75 MHz), a Bruker AVIII300 (300 MHz), a Bruker AVIII400 (400 and 101 
MHz), a Bruker AMX 400 (400 and 100 MHz) or a Bruker DRX500 (500 and 125 MHz 
respectively). Chemical shifts () are expressed in parts per million (ppm) Coupling constants 
(J) are reported in Hz. Multiplicity of signals of 1H NMR are expressed as follows: s = 
singlet, d = doublet, t = triplet q = quartet, the term “stack” is used to describe a region where 
resonance arising from non-equivalent nuclei are coincident, and multiplet, m, is used to 
describe a region where resonance arising from a single nucleus (or equivalent nuclei) are 
coincident, but coupling constants cannot be readily assigned. 13C NMR spectra were 
measured using the pendant technique. Multiplicity of signals and coupling constants are 
reported as observed after off-line processing (WinNMR or MestRe Nova). 
 
Mass spectra were recorded on a Micromass ZABspec spectrometer utilizing electrospray 
ionisation (and a methanol mobile phase), and a Micromass Zabspec spectrometer utilising m-
nitrobenzoylalcohol (3-NOBA) as the matrix, EI mass spectra were recorded on either a VG 
ProSpec or VG Zabspec instrument at 70 eV, and are reported as (m/z (%)). 
 
Elemental analyses were recorded on a CARLO ERBA EA110 CHNS elemental analyser. 
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Infrared spectra were recorded as thin films (neat) or with nujol between sodium chloride 
plates on a Perkin Elmer 1600 FTIR spectrometer. The intensity of each band is described as s 
(strong), m (medium) or w (weak). 
 
Optical rotations were measured using an Optical Activity PolAAr 2001 automatic 
polarimeter in 0.25 dm length cells. Concentrations used are expressed in grams of solute per 
100 mL. []D values are reported in units of 10
-1 deg cm2 g-1. 
 
Melting points were determined in open-ended glass capillaries using a Stuart Scientific 
SMP1 apparatus. 
 
X-ray crystallography: Suitable crystals were selected and datasets were measured on a 
Bruker SMART 6000 diffractometer (λCu-Kα = 1.54178 Å) at 120 K.  The data collections 
were driven by SMART and processed by SAINT. Or, suitable crystals were selected and 
datasets were measured by the EPSRC National Crystallography Service on a Bruker 
KappaCCD diffractometer at the window of a Bruker FR591 rotating anode (λMo-Kα = 
0.71073 Å) at 120 K. The data collections were driven by COLLECT and processed by 
DENZO. Absorption corrections for all four datasets were applied using SADABS. The 
structures were solved in SHELXS-97 and were refined by a full-matrix least-squares 
procedure on F in SHELXL-97. All non-hydrogen atoms were refined with anisotropic 
displacement parameters. All hydrogen atoms were added at calculated positions and refined 
by use of a riding model with isotropic displacement parameters based on the equivalent 
isotropic displacement parameter (Ueq) of the parent atom. Figures were produced using 
ORTEP3 for Windows.  
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All reactions were carried out under a nitrogen or argon atmosphere in flame-dried glassware. 
Molecular sieves (3 and 4 Å) were activated by flame-heating under high vacuum during 15 
min and used immediately. Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled 
from sodium and benzophenone ketyl. Dichloromethane (CH2Cl2), acetonitrile (MeCN) and 
dimethylformamide (DMF) were distilled from CaH2. Toluene was distilled from sodium and 
used immediately. Triethylamine was distilled from KOH and stored over 4 Å M.S. Other 
chemicals were used as purchased, unless otherwise stated. Aqueous solutions are saturated 
unless otherwise stated.  
 
Flash column chromatography was carried out using Fluka 60 (40-60 m mesh) silica gel. 
Analytical thin layer chromatography (TLC) was performed on Machery-Nagel SIL G-25 
UV254 pre coated glass-backed plates and visualised by UV (254 nm) and potassium 
manganate(VII) solution. Evaporation and concentration under reduced pressure was done at 
(50-500mBar). Residual solvent was removed under high vacuum (1 mBar). 
 
HPLC was performed on Dionex Summit HPLC systems using helium degassed HPLC grade 
solvents.  Data were collected, recorded and processed using the Dionex Chromeleon 6.11 
software package.  
 
Analytical HPLC: 
Pump: Summit P580 Quaternary Low Pressure Gradient Pump with built in vaccum degasser. 
Detector: Summit UVD 170s UV/Vis Multi-Channel Detector with analytical flow cell. 
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Column: Phenomenex Luna 10μ C18 (250 mm x 4.6 mm). 
Chiral analytical HPLC: 
Pump: Summit P580 Quaternary Low Pressure Gradient Pump with built in vaccum degasser. 
Detector: Summit UVD 170s UV/Vis Multi-Channel Detector with analytical flow cell. 
Column: Daicel Chiral Pak AD (250 mm x 4.6 mm). 
 
Semi-preparative HPLC: 
Pump: Summit P580 Quaternary Low Pressure Gradient Pump with built in vaccum degasser. 
Detector: Summit UVD 170s UV/Vis Multi-Channel Detector with Prep flow cell. 
Column: Phenomenex Luna 10μ C18 (250 mm x 10 mm). 
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N-(3-Hydroxypropyl)-4-methyl-N-(3-methylbut-2-enyl)benzenesulfonamide (82) 
 
Cesium carbonate (1.85 g, 5.67 mmol) was added to a solution of N-(3-
hydroxypropyl)-4-methylbenzenesulfonamide (1.00 g, 4.36 mmol) in MeCN (25 
mL) at 0 °C. The resulting mixture was stirred for 15 min before 1-bromo-3-
methylbut-2-ene (0.50 mL, 4.36 mmol) was added dropwise over 30 s. The resulting solution 
was allowed to warm to room temperature and stirred for a further 2 h. The solvent was 
removed in vacuo and the resulting white solid was dissolved in water (50 mL). The aqueous 
phase was extracted with EtOAc (4 x 50 mL). The combined organic phases were washed 
with brine (100 mL), dried over MgSO4 and evaporated in vacuo to leave a yellow crystalline 
solid, which was purified by flash column chromatography (Rf = 0.28, hexane:EtOAc, 2:1) to 
afford the N-alkylated sulfonamide 82 as a white crystalline solid (1.25 g, 96%).  
mp: 41-42 °C (from hexane:EtOAc) 
max: (film)/cm
-1 3429 (OH), 2936 (CH), 1333 (SO2), 1156 (SO2) 
H: (300 MHz, CDCl3) 1.60 (3H, s, CH3), 1.63 (3H, s, CH3), 1.70-1.78 (2H, m, CH2CH2OH), 
2.41 (3H, s, CH3), 2.47 (1H, br s, OH), 3.20 (2H, t, J 6.5, CH2CH2N), 3.72 (2H, t, J 5.7, 
CH2OH), 3.79 (2H, d, J 7.0, CHCH2N), 4.95 (1H, t, J 7.0,  =CH), 7.29 (2H, d, J 8.0 Ar CH), 
7.67 (2H, d, J 8.0, Ar CH) 
C: (125 MHz), 18.8 (CH3), 22.6 (CH3), 26.8 (CH3), 32.1 (CH2CH2OH), 44.8 (CH2CH2N), 
46.9 (CHCH2N), 59.9 (CH2OH), 119.9 (CH=), 128.2 (Ar CH), 130.7 (Ar CH), 137. 3 (Cq), 
138.1 (Cq), 144.3 (Cq) 
m/z: (ES+) 320.0 (100 %, [M+Na]+)  
HRMS: [Found: (M+Na)+ 320.1289. C15H23NO3S requires M, 320.1296] 
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N
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4-Methyl-N-(3-methyl-but-2-enyl)-N-(3-oxopropyl)benzenesulfonamide (58) 
 
PCC Oxidation 
Celite (1.0 g) was added to a suspension of PCC (0.56 g, 2.56 mmol) in CH2Cl2 
(15 mL). The resultant slurry was stirred vigorously for 5 min before being 
cooled to 0 °C. A solution of N-alkylated sulfonamide 82 (0.52 g, 1.72 mmol) in CH2Cl2 (5 
mL) was then added in one portion. The resulting solution was allowed to warm to room 
temperature and stirred for a further 4 h. NaHSO4 (1.0 g) and Et2O (20 mL) were added and 
the mixture was stirred vigorously for 15 min before being filtered through a silica plug, 
washed with diethyl ether (100 mL) and dried over MgSO4. The solvent was removed in 
vacuo to yield the crude product as a yellow oil, which was purified by flash column 
chromatography (Rf = 0.27, hexane:EtOAc, 3:1) to afford the aldehyde 58 as a colourless oil 
(0.31 g, 61%). 
Swern Oxidation 
Anhydrous DMSO (0.32 mL, 4.56 mmol) was added at a rapid rate to a solution of oxalyl 
chloride (0.24 mL, 2.28 mmol) in CH2Cl2 (25 mL) at -78 °C. The resulting mixture was 
stirred for 5 min before a solution of the alcohol 82 (0.57 g, 1.90 mmol) in CH2Cl2 (20 mL) 
was added dropwise over 10 min. After 30 min Et3N (1.32 mL, 9.50 mmol) was added 
dropwise over 30 s and the resulting solution was stirred for a further 3 h at -78 °C before 
being allowed to warm to room temperature. Water (50 mL) was added and the aqueous phase 
was further extracted with CH2Cl2 (3 x 50 mL). The combined organic phases were washed 
with 1 M HCl (100 mL), water (100 mL) and finally with brine (100 mL) before being dried 
over MgSO4 and concentrated in vacuo to give the crude aldehyde as a pale yellow oil, which 
Ts
N
O
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was purified by flash column chromatography (Rf = 0.27, hexane:EtOAc, 3:1) to give the 
aldehyde 58 as a colourless oil (0.54 g, 97%). 
max: (film)/cm
-1 2973 (CH), 2926 (CH), 1724 (C=O), 1339 (SO2), 1159 (SO2)  
H: (300 MHz, CDCl3) 1.60 (3H, s, CH3), 1.64 (3H, s, CH3), 2.42 (3H, s, CH3), 2.79 (2H, t, J 
6.9  CH2CHO) 3.35 (2H, t, J 6.9, CH2CH2N),  3.75 (2H, d, J 7.0, CHCH2N), 4.96 (1H, t, J 
7.0,  =CH), 7.29 (2H, d, J 8.0 Ar CH), 7.67 (2H, d, J 8.0, Ar CH) 9.74 (1H, s, CHO) 
C: (125 MHz), 16.1 (CH3), 19.8 (CH3), 24.0 (CH3), 39.3 (CH2CHO), 42.2 (CH2CH2N), 44.8 
(CHCH2N), 117.0 (CH=), 125.7 (Ar CH), 128.0 (Ar CH), 134.7 (Cq), 135.9 (Cq), 141.7 (Cq), 
198.8 (CHO) 
m/z: (ES+) 318.1 (100 %, [M+Na]+), 350.2 (20, [M+Na+MeOH]+)  
HRMS: [Found: (M+Na)+ 318.1145. C15H21NO3S requires M, 318.1140] 
 
(3R*, 4S*)-3-Isopropenyl-1-(toluene-4-sulfonyl)piperidin-4-ol (59) and (3S*, 4S*)-3-
isopropenyl-1-(toluene-4-sulfonyl)piperidin-4-ol (59) 
 
Prins Cyclisation 
Concentrated HCl (37 %, 0.10 mL, 1.02 mmol) was added 
to a solution of aldehyde 58 (100 mg, 0.34 mmol) in 
CH2Cl2 (10 mL) at -78 °C. The resulting solution was stirred at -78 °C for 16 h, before being 
quenched by the addition of water (10 mL). The aqueous phase was extracted with CH2Cl2 (3 
x 10 mL). The combined organic phases were washed with brine (10 mL), dried over MgSO4 
and concentrated in vacuo to give a white solid, which was purified by flash column 
chromatography (Rf = 0.23, hexane:EtOAc, 2:1) to give or piperidine 59 as a white crystalline 
solid (79 mg, 79%).  
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mp: 91-92 °C (from hexane:EtOAc) 
max: (film)/cm
-1 3366 (OH), 2925 (CH) 2867 (CH), 1341 (SO2), 1164 (SO2) 
H: (300 MHz, CDCl3) 1.48 (1 H, br s, OH), 1.77 (3 H, s, CH3), 1.83-1.93 (2H, m, CH2CH2N), 
2.36-2.40 (1H, m, CHCH2N), 2.42 (3 H, s, CH3), 2.52-2.63  (2 H, stack, CHCHHN and 
CH2CHHN), 3.54-3.59 (2 H, stack, CHCHHN and CH2CHHN), 3.96 (1H, d, J 2.6, CHOH), 
4.58 (1H, s, C=CHH), 4.97 (1H, s, C=CHH), 7.31 (2H, d, J 8.1 Ar CH), 7.64 (2H, d, J 8.1, Ar 
CH) 
C: (125 MHz), 21.4 (CH3), 22.7 (CH3), 32.1 (CH2CH2NH), 40.5 (CH2CH2N), 43.4 
(CHCH2N), 46.6 (CHCH2NH), 62.9 (CHOH), 112.2 (=CH2), 127.5 (Ar CH),  129.6 (Ar CH), 
133.2 (Cq), 143.4 (Cq), 143.7 (Cq) 
m/z: (ES+) 318.1 (100 %, [M+Na]+) 
HRMS: [Found: (M+Na)+ 318.1128. C15H23NO3S requires M, 318.1140] 
 
Further elution (Rf = 0.15) afforded piperidine 60 as a white crystalline solid (4 mg, 4 %). 
Data vide infra.  
 
Carbonyl-Ene Cyclisation 
MeAlCl2 (1 M soln. in hexanes, 0.34 mL, 0.34 mmol) was added to a solution of aldehyde 58 
(100 mg, 0.34 mmol) in CHCl3 (10 mL). The resulting mixture has heated to reflux for 16 h, 
before being quenched by the addition of water (10 mL). The aqueous phase was extracted 
with CHCl3 (3 x 10 mL). The combined organic phases were washed with brine (10 mL), 
dried over MgSO4 and concentrated in vacuo to give a white solid, which was purified by 
flash column chromatography (Rf = 0.23, hexane:EtOAc, 2:1) to give piperidine 60 as a white 
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crystalline solid (6 mg, 6%), data vide supra. Further elution (Rf = 0.15) afforded piperidine 
59 as a white crystalline solid (74 mg, 74%). 
mp: 149-150 °C (from hexane:EtOAc) 
max: (film)/cm
-1 3364 (OH), 2928 (CH) 2855 (CH), 1341 (SO2), 1165 (SO2) 
H: (300 MHz, CDCl3) 1.58-1.68 (1H, m, CHHCH2N), 1.71 (3 H, s, CH3), 1.85 (1 H, br s, 
OH), 2.01-2.07 (1H, m, CHCH2N), 2.17-2.27 (2 H, stack, CHC2N and CHCHHN), 2.35 (1 H, 
dt, J 12.5 and 2.8, CH2CHHN), 2.44 (3H, s, CH3), 3.44 (1H, dt, J 10.3 and 4.5, CHOH), 3.73-
3.77 (1 H, m, CHCHHN), 3.81-3.86 (1H, m, CH2CHHN), 4.89 (1H, s, C=CHH), 5.01 (1H, s,  
C=CHH), 7.32 (2 H, d, J 8.1 Ar CH), 7.64 (2 H, d, J 8.1, Ar CH) 
C: (125 MHz), 20.5 (CH3), 21.5 (CH3), 32.4 (CH2CH2NH), 45.0 (CH2CH2N), 48.7 
(CHCH2N), 51.5 (CHCH2NH), 69.2 (CHOH), 114.6 (=CH2), 127.5 (Ar CH),  129.7 (Ar CH), 
133.2 (Cq), 143.3 (Cq), 143.6 (Cq)  
m/z: (ES+) 318.1 (100 %, [M+Na]+) 
 
L-Aspartic acid dimethyl ester hydrochloride (110) 
 
Acetyl chloride (85.9 mL, 1.20 mol) was added dropwise over 20 min 
via a dropping funnel to a stirred solution of MeOH (93 mL) cooled to 0 
°C. L-aspartic acid (50.0 g, 0.376 mol) was added to the solution and the resulting mixture 
was warmed to rt and stirred overnight. The solvent was removed in vacuo to afford 76.5 g of 
the crude aspartic ester hydrochloride salt 110 as a colourless viscous oil, which was used 
without further purification.  
[α]D20: +11.4 (c 1.0 in H2O) (lit.106 [α]D20: +10.2 (c 0.65 in H2O)) 
max: (film)/cm
-1 3384 (NH), 3020 (CH), 2955 (CH), 1736 (C=O) 
CO2Me
CO2Me
HCl.H2N
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H: (300 MHz, D2O) 3.14 (2H, t, J 5.9, CH2), 3.71 (3H, s, CH3), 3.81 (3H, s, CH3), 4.47 (1H, 
t, J 5.9 CH) 
C: (75 MHz, D2O) 32.1 (CH2), 47.7 (CH), 51.6 (CH3), 52.5 (CH3), 167.8 (C=O), 170.0 (C=O)  
m/z: (ES+) 162.0 (100%, [M+H-Cl]+) 
 
L-Aspartic acid dimethyl ester (87) 
 
Acetyl chloride (17.1 mL 240 mmol) was added dropwise over 10 min to a 
solution of MeOH (93 mL) cooled to 0 °C. L-aspartic acid (10.0 g, 75.1 mmol) 
was added to the solution and the resulting mixture was slowly warmed to reflux for 3 h. The 
solvent was removed in vacuo to afford the hydrochloride salt as a colourless viscous oil, 
which was dissolved in water (50 mL) and cooled to 0 oC before a saturated aqueous solution 
of NaHCO3 (50 mL) was added slowly to the stirred solution. The aqueous solution was 
extracted with EtOAc (5 x 100 ml) and the combined organic phases were washed with brine 
(100 mL), dried over MgSO4 and concentrated in vacuo to afford the desired product 87 as a 
colourless oil (9.16 g, 76 %).  
[α]D20 : +17.4 (c 1.0 in MeOH) (lit.107 [α]D14: +16.8) 
 max: (film)/cm
-1 3384 (NH), 3020 (CH), 2955 (CH), 1736 (C=O) 
H: (300 MHz, CDCl3) 1.72 (2H, s, NH2), 2.66 (1H, dd J 16.5 and 7.3, CHH), 2.77 (1H, dd J  
16.5 and 4.7, CHH), 3.65 (3H, s, CH3), 3.69 (3H, s, CH3), 3.78 (1H, dd, J 4.7 and 7.3, CH) 
C: (75 MHz, CDCl3) 38.6 (CH2), 51.0 (CH), 51.9 (CH3), 52.2 (CH3), 171.4 (C=O), 174.5 
(C=O); m/z (ES+) 159.0 (5%), 102.0 (100), 88.0 (32), 70.0 (45), 60.0 (28), 43.0 (40.0) 
 
 
H2N CO2Me
CO2Me
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(2S)-Aminobutan-1,4-diol (85) 
 
A solution of L-aspartic acid dimethyl ester 87 (4.77 g, 29.58 mmol) in THF (20 
mL) was added dropwise over 20 min to a stirred slurry of LiAlH4 (3.37 g, 88.75 
mmol) in THF (25 mL) cooled to 0 °C. The solution was heated to reflux for 30 
min before being cooled to room temperature and then to 0 °C. Propan-2-ol (35 mL) was then 
added as fast as effervescence would allow, followed by water (10 mL). The resulting mixture 
was stirred vigorously for 15 min before the solvents were removed in vacuo to give a white 
salt. The salt was added into a cellulose thimble and continuously extracted with a Soxhlet 
extractor using propan-2-ol overnight. The propan-2-ol filtrate was evaporated in vacuo to 
give the product 85 as a pale yellow oil (3.10 g, quant). 
[α]D20: -4.0 (c 1.0 in H2O) (lit.108 [α]D22: -2.0 (c 2.0 in H2O)) 
max: (film)/cm
-1 3341 (OH, NH), 2940 (CH), 1054 (CO) 
 H: (300 MHz, D2O) 1.38-1.49 (1H, m, CHCHHCH2), 1.57-1.68 (1H, m, CHCHHCH2), 2.82-
2.90 (1H, m, CH), 3.36 (1H, dd, J 11.2 and 6.9, CHHOH), 3.53 (1H, dd, J 11.2 and 4.6 and, 
CH2CHH), 3.63 (2H, t, J 6.6, CHCH2OH) 
C: (75 MHz, D2O) 37.5 (CHCH2CH2), 51.6 (CH), 61.5 (CH2OH), 68.8 (CH2OH) m/z: (ES
+) 
128.3 (60%, [M+Na]+), 106.4 (100, [M+H]+)  
m/z: (ES+) 128.2 (60%, [M+Na]+), 106.4 (100, [M+H]+) 
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(4S)-[2-(tert-Butyldiphenylsilanyloxy)ethyl]-oxazolidin-2-one (88) 
CDI (1.64 g, 10.09 mmol) was added to a solution of amino diol 85 (1.06 g, 
10.09 mmol) in DMF (30 mL) at 0 °C. The resulting solution was stirred at 0 
°C for 3 h before warming to room temperature overnight. tert-
butyldiphenylsilyl chloride (3.15 mL, 12.12 mmol) was added dropwise over 5 
min to the solution at 0 °C. The resulting solution was stirred at room temperature 8 h. Water 
(30 mL) was added and the aqueous phase was extracted with Et2O (4 x 30 mL). The 
combined organic fractions were washed with brine (30 mL), dried over MgSO4 and 
concentrated in vacuo to afford the crude product as an orange oil. The oil was purified by 
flash column chromatography (Rf = 0.34, hexane:EtOAc, 1:1) to afford a white crystalline 
solid 88 (3.06 g, 82%). 
mp: 110-111 °C (from hexane:EtOAc) (lit.109 113-114.5 °C) 
[α]D22: -11.2 (c 1 in CHCl3) 
max: (film)/cm
-1 3263 (NH), 3071 (Ar CH), 3050 (Ar CH), 2930 (CH), 2875 (CH), 1754 
(C=O) 
H: (300 MHz, CDCl3) 1.06 (9H, s, C(CH3)3, 1.70-1.89 (2H, m, CHCH2CH2), 3.73-3.77 (2H, 
m, CH2OSi), 4.00-4.12 (2H, stack, CH  and CHHOCO), 4.46-4.53 (1H, m, CHHOCO), 5.51 
(1H, br s, NH), 7.39-7.46 (6H, m, Ar CH), 7.62-.7.65 (4H, m Ar CH) 
C: (75 MHz, CDCl3) 19.0 (SiC(CH3)3, 26.8 (SiC(CH3)3, 37.4 (CHCH2CH2), 51.3 (CH), 61.2 
(OCH2), 70.5, (OCH2), 127.9 (Ar CH), 130.0 (Cq), 132.3 (Ar CH), 135.5 (Ar CH), 159.3 
(C=O) 
m/z: (ES)+ 392.0 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 392.1655. C21H27NNa O3Si requires M 392.1658] 
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(4S)-3-But-2-enyl-4-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-oxazolidin-2-one (89)  
 
(5:1 mixture of E:Z, only E reported) 
 
n-BuLi (2.5 M soln. in hexanes, 4.29 mL, 10.72 mmol) was added dropwise 
over 5 min to a solution of oxazolidinone 88 (3.96 g, 10.72 mmol) in THF (50 
mL) at 0 °C. The resulting solution was stirred for 15 min before crotyl 
bromide (1.12 mL, 10.72 mmol) was added dropwise over 1 min. The 
resulting solution was allowed to warm to room temperature overnight before being quenched 
with water (50 mL). The solvent was removed in vacuo and the aqueous phase was extracted 
with Et2O (4 x 100 mL). The combined organic phases were washed with brine (50 mL), 
dried over MgSO4 and concentrated in vacuo to afford the crude product as a yellow oil, 
which was purified by flash column chromatography (Rf = 0.37, hexane:EtOAc, 4:1) to give 
the product 89 as a colourless oil (4.82 g, 94%).  
[α]D23: -5.6 (c 1 in CHCl3) 
max: (film)/cm
-1 3070 (Ar CH), 3048 (Ar CH), 2930 (CH), 2857 (CH), 1756 (C=O)  
H: (300 MHz, CDCl3) 1.05 (9H, s, C(CH3)3), 1.57-1.72 (4H, stack, =CHCH3 and 
CHCHHCH2) 1.97-2.07 (1H, m, CHCHHCH2), 3.47 (1 H, dd, 1H, J 15.0 and 7.9, NCHH),  
3.70 (2H, t, J 5.8, CH2OSi), 3.87-3.96 (1H, m, CHHOCO), 4.01-4.11 (2H, stack, CH and 
NCHH), 4.32 (1H, t, J 8.5, CHHOCO), 5.34-5.43 (1H, m, =CH), 5.59-5.70 (1H, m, =CH), 
7.38-7.46 (6H, m, Ar CH), 7.62-7.65 (4H, m Ar CH) 
C: (75 MHz, CDCl3) 17.6 (=CCH3), 19.0 SiC(CH3)3, 26.8 (SiC(CH3)3, 34.5 (CHCH2CH2), 
44.0 (NCH2), 53.1 (NCH), 60.1 (OCH2Si), 67.9 (CH2OCO), 124.7  (=CH), 127.8 (Ar CH), 
129.9 (Ar CH), 130.1 (=CH), 132.9 (Cq) 135.4 (Ar CH), 137.0 (Cq), 158.0 (C=O) 
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 m/z: (ES)+ 446.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+446.2124. C25H33NNaO3Si requires M 466.2127] 
 
(4S)-3-But-2-enyl-4-(2-hydroxyethyl)-oxazolidin-2-one (90) 
 
(5:1 mixture of E:Z, only E reported) 
 
TBAF (1 M soln. in THF, 8.47 mL, 8.47 mmol) was added dropwise over 5 min 
to a solution of 89 (3.58 g, 8.47 mmol) in THF (40 mL) cooled to 0 °C. The 
reaction was stirred at room temperature overnight before the solvent was 
removed in vacuo. Water (50 mL) was added and the aqueous phase was extracted with 
EtOAc (4 x 50 mL). The combined organic phases were washed with brine (50 mL), dried 
over MgSO4 and concentrated in vacuo to afford the crude product as a red oil, which was 
purified by flash column chromatography (Rf = 0.24, hexane:EtOAc, 1:4) to give the product 
90 as a colourless oil (1.61 g, 95%). 
[α]D23: -14.0 (c 1 in CHCl3) 
max: (film)/cm
-1 3417 (OH), 2921 (CH), 1732 (C=O) 
H: (300 MHz, CDCl3) 1.62-1.68 (4H, stack, =CHCH3 and CHCHHCH2) 1.92-2.01 (1H, m, 
CHCHHCH2), 2.41 (1H, br s, OH), 3.50 (1H, dd, J 15.3 and 7.8, NCHH),  3.65-3.74 (2H, m, 
CH2OH), 3.83-3.92 (1H, m, CHHOCO), 3.99-4.09 (2H, stack, CH and NCHH), 4.39 (1H, t, J 
8.5, CHHOCO), 5.30-5.38 (1H, m, =CH), 5.59-5.70 (1H, m, =CH)  
C: (75 MHz, CDCl3) 17.6 (=CCH3), 34.2 (CHCH2CH2), 44.0 (NCH2), 53.3 (NCH), 60.1 
(CH2OH), 68.0 (CH2OCO), 127.8 (=CH), 130.1 (=CH), 158.3 (C=O)  
m/z: (ES)+ 208.1 (100%, [M+Na]+)  
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HRMS: [Found: (M+Na)+ 208.0940. C9H15NNaO3 requires M 208.0950] 
 
(4S)-(3-But-2-enyl-2-oxo-oxazolidin-4-yl)-acetaldehyde (78) 
 
(5:1 mixture of E:Z, only E reported) 
 
DMSO (1.54 mL, 21.65 mmol) was added at a rapid rate to a solution of oxalyl 
chloride (0.93 mL, 10.39 mmol) in CH2Cl2 (50 mL) at -78 °C. The resulting 
mixture was stirred for 10 min before a solution of the alcohol 90 (1.60 g, 8.66 
mmol) in CH2Cl2 (40 mL) was added dropwise over 20 min. After 30 min Et3N (6.09 mL, 
43.30 mmol) was added dropwise over 2 min and the resulting solution was stirred for a 
further 3 h at -78 °C before being allowed to warm to room temperature. Water (50 mL) was 
added and the aqueous phase was further extracted with CH2Cl2 (3 x 50 mL). The combined 
organic phases were washed with HCl (1 M, 100 mL), water (100 mL) and finally with brine 
(100 mL) before being dried over MgSO4 and evaporated in vacuo to give the crude aldehyde 
as a pale yellow oil, which was purified by flash column chromatography (Rf = 0.28, 
hexane:EtOAc, 1:3) to give the aldehyde 78 as a colourless oil (1.57 g,  95%). 
[α]D23: +24.8 (c 1 in CHCl3)  
max: (film)/cm
-1  3011 (=CH), 2918 (CH), 2856 (CH), 1748 ( 2 x C=O)  
H: (400 MHz, CDCl3) 1.65 (3H, d, J 6.4, =CHCH3), 2.62 (1H, dd, J 18.6 and 9.1, 
CHCHHCHO) 3.02 (1H, dd, J 18.6 and 3.9, CHCHHCHO), 3.48 (1H, dd, J 15.4 and 7.6, 
NCHH), 3.84 (1H, dd J 8.8 and 6.3, CHHOCO), 3.94-3.99 (1H, m, NCHH), 4.10-4.19 (1H, 
m, NCH), 4.50 (1H, t, J 8.8, CHHOCO), 5.28-5.38 (1H, m, CH2CH=), 5.63-5.72 (1H, m, 
=CHCH3), 9.73 (1H, s, CHO) 
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C: (75 MHz, CDCl3) 17.6 (=CCH3), 44.4 (NCH2), 46.8 (CHCH2CHO), 49.8 (NCH), 67.7 
(CH2OCO), 124.6 (CH2CH=), 130.5 (=CHCH3), 157.6 (NCOO), 198.6 (CHO);  
m/z: (ES)+ 238.0 (100%, [M+MeOH+Na]+)  
HRMS: [Found: (M+MeOH+Na)+ 238.1052. C10H17NNaO4 requires M 238.1055] 
 
(6S,7R,8aS)-7-hydroxy-6-vinyltetrahydro-1H-oxazolo[3,4-a]pyridin-3(5H)-one (79) 
 
 
MeAlCl2 (1 M soln. in hexanes, 1.14 mL, 1.14 mmol) was added to a solution of 
aldehyde 78 (106 mg, 0.57 mmol) in CH2Cl2 (5 mL). The resulting mixture was 
stirred at room temperature for 16 h, before being quenched by the addition of 
water (10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The combined 
organic phases were washed with brine (10 mL), dried over MgSO4 and concentrated in vacuo 
to give the crude product as a yellow oil, which was purified by flash column chromatography 
(Rf = 0.30, EtOAc) to give piperidine 79 as a colourless oil (9 mg, 16%). 
max: (film)/cm
-1 3362 (OH), 2928 (CH) 2855 (CH), 1729 (C=O), 1341 (SO2), 1165 (SO2) 
H: (400 MHz, CDCl3) 1.54 (1H, ddd, J 13.7, 11.7 and 2.3, NCHCHH), 2.05 (1H, dt, J 13.7 
and 3.6, NCHCHH), 2.34-2.38 (1H, m, NCH2CH), 3.19 (1H, t, J, 12.5, NCHH), 3.74 (1H, dd, 
J 5.1 and 2.5, NCHH), 3.88 (1H, dd, J 8.4 and 5.1, CHHO), 4.04-4.14 (2H, stack, CHOH and 
CHNH), 4.41 (1H, t, J 8.4, CHHO) 
m/z: (EI+) 183.1 (50 %, [M]+), 116.0 (100), 86.0 (95) 
HRMS: [Found: (M)+ 183.0893. C9H13NO3 requires M 183.0895] 
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(4S)-[2-(tert-Butyldiphenylsilanyloxy)etyl]-3-(3-methylbut-2-enyl)oxazolidin-2-one (93) 
 
n-BuLi (1.37 M soln. in hexanes, 15.56 mL, 21.32 mmol) was added 
dropwise over 10 min to a solution of oxazolidinone 88 (7.16 g, 19.38 
mmol) in THF (50 mL) at 0 °C. The resulting solution was stirred for 15 
min before 1-bromo-3-methylbut-2-ene (1.32 mL, 11.38 mmol) was added 
dropwise over 1 min. The resulting solution was allowed to warm to room temperature 
overnight before being quenched with water (50 mL). The solvent was removed in vacuo and 
the aqueous phase was extracted with Et2O (4 x 100 mL). The combined organic phases were 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford the crude 
product as a yellow oil, which was purified by flash column chromatography (Rf = 0.33, 4:1, 
hexane:EtOAc) to give the product 93 as a colourless oil (8.46 g, 98%). 
 [α]D22: +3.6 (c 1 in CHCl3)  
max:  (film)/cm
-1 3071 (Ar CH), 3049 (Ar CH), 2931 (CH), 2878 CH) 1756 (C=O); 
H: (300 MHz, CDCl3) 1.05 (9H, s, C(CH3)3, 1.57-1.72 (7H, stack, =C(CH3)2 and 
CHCHHCH2) 1.97-2.07 (1H, m, CHCHHCH2), 3.61 (1H, dd, J 15.4 and 8.3, NCHH), 3.70 
(2H, t, J 5.8 CH2OSi), 3.85-3.93 (1H, m CHHOCO) 4.00-4.08 (2H, stack, CH and NCHH), 
4.31 (1H, t, J 8.5, CHHOCO), 5.51 (1H, m,  =CH), 7.37-7.46 (6H, m, Ar CH), 7.61-7.64 (4H, 
m Ar CH) 
C: (75 MHz, CDCl3) 17.9 (=CCH3), 19.0 (SiC(CH3)3, 25.7 (=CCH3), 26.7 (SiC(CH3)3, 34.6 
(CHCH2CH2), 39.8 (NCH2), 51.2 (NCH), 60.2 (OCH2Si), 67.9 (CH2OCO), 118.3 (=CH), 
127.8 (Ar CH), 129.9 (Ar CH), 132.9 (Cq) 135.4 (Ar CH), 137.0 (Cq), 158.1 (C=O) 
m/z: (ES)+ 460.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 460.2297. C26H35NNaO3Si requires M 460.2284] 
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(4S)-(2-Hydroxy-ethyl)-3-(3-methylbut-2-enyl)oxazolidin-2-one (94) 
 
TBAF Deprotection 
TBAF (1 M soln. in THF, 5.81 mL, 5.81 mmol) was added dropwise over 2 
min to a solution of 93 (2.54 g, 5.81 mmol) in THF (60 mL) cooled to 0 °C. 
The reaction was allowed to warm to room temperature and stirred overnight 
before the solvent was removed in vacuo. Water (50 mL) was added and the aqueous phase 
was extracted with EtOAc (4 x 50 mL). The combined organic phases were washed with brine 
(50 mL), dried over MgSO4 and concentrated in vacuo to afford the crude product as a red oil, 
which was purified by flash column chromatography (Rf = 0.29, hexane:EtOAc, 1:4) to give 
the product 94 as a colourless oil (1.08 g, 94%). 
NaH Cyclisation 
NaH (60 % dispersed in mineral oil, 8 mg, 0.39 mmol) was added to a solution of diol 103 (48 
mg, 0.20 mmol) in THF (4 mL) cooled to 0 °C. The solution was slowly warmed to reflux and 
stirred for a further 2 h. The solution was allowed to cool to room temperature before being 
quenched by the addition of water (4 mL). The solvent was removed in vacuo and the aqueous 
phase extracted with EtOAc (4 x 5 mL). The combined organic phases were washed with 
brine (10 mL), dried over MgSO4 and concentrated in vacuo to afford the crude product as a 
yellow oil, which was purified by flash column chromatography (Rf = 0.29, hexane:EtOAc, 
1:4) to give the product as a colourless oil 94 (28 mg, 70%). 
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NaBH4 Reduction and Cyclisation 
Powdered NaBH4 (9.8 g, 0.318 mol) was added in portions over 30 min to a stirred solution of 
ester 104 (47.9 g, 0.159 mol) in THF:EtOH (3:1, 400 mL) cooled to 0 °C, which resulted in 
gas evolution. The resulting solution was allowed to warm to room temperature and stirred for 
2 h before being warmed to reflux for a further 4 h. The solution was allowed to cool to room 
temperature before being cooled to 0 °C and quenched by the addition of saturated aqueous 
solution of NH4Cl (200 mL), which generated a white precipitate. The reaction mixture was 
filtered and the filter cake washed with EtOH (3 x 50 mL). The combined filtrates were 
concentrated to 1/5 in volume in vacuo and then diluted with EtOAc (300 mL) and water (300 
mL). The organic phase was separated and the aqueous phase was further extracted with 
EtOAc (4 x 300 mL). The combined organic phases were washed with water (400 mL) and 
brine (400 mL) before being dried over MgSO4 and concentrated in vacuo to afford the 
product 94 as a colourless oil (28.4 g, 90%).  
[α]D22: -23.2 (c 1 in CHCl3) 
max: (film)/cm
-1 3415 (OH), 2929 (CH), 1729 (C=O), 1026 (C-O) 
H: (300 MHz, CDCl3) 1.60-1.73 (7H, stack, =C(CH3)2 and CHCHHCH2) 1.91-2.02 (1H, m, 
CHCHHCH2), 2.63 (1H, br s, OH), 3.60-3.76 (3H, stack, CHHOH, NCHH and NCH), 3.82-
3.91 (1H, m, CHCHHOH), 3.97-4.01 (1H, m, NCHH), 4.07 (1H, m, CHHOCO), 4.39 (1H, t, 
J 8.8 CHHOCO) 5.08-5.13 (1H, m, =CH) 
C: (75 MHz, CDCl3) 17.9 (=CCH3), 25.6 =CCH3), 34.4 CHCH2CH2), 39.8 (NCH2), 53.4 
(NCH), 58.6 (CH2OH), 68.0 (CH2OCO), 118.1 (=CH), 137.2 (Cq), 158.5 (C=O) 
m/z: (ES)+ 222.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 222.1102. C10H17NNaO3 requires M 222.1106] 
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(4S)-(2-Oxoethyl)-N-(3-methylbut-2-enyl)-2-oxazolidinone (95) 
 
A solution of DMSO (30.5 mL, 0.429 mol) in CH2Cl2 (43 mL) was added 
dropwise over 20 min via a dropping funnel to a solution of oxalyl chloride 
(18.7 mL, 0.214 mol) in CH2Cl2 (240 mL) cooled to -78 °C resulting in 
considerable gas evolution. The resulting mixture was stirred for a further 5 
min before a solution of alcohol 94 (28.4 g, 0.143 mol) in CH2Cl2 (240 mL) was added 
dropwise over 30 min via a dropping funnel equipped with a cold jacket cooled to -78 °C. The 
dropping funnel was washed with extra portions of CH2Cl2 (3 x 5 mL) to complete the 
transfer. The solution was stirred for a further 15 min before Et3N (100 mL, 0.715 mol) was 
added dropwise over 15 min via a dropping funnel and the resulting solution was stirred for a 
further 20 min at -78 °C before being allowed to warm 0 °C, which resulted in gas evolution. 
The reaction was quenched by the addition of a saturated aqueous solution of NH4Cl (250 
mL). The organic phase was separated and the aqueous phase further extracted with CH2Cl2 
(3 x 250 mL). The combined organic phases were washed with water (250 mL) and brine (250 
mL) before being dried over MgSO4 and in concentrated in vacuo to give the aldehyde 95 as a 
colourless oil (26.8 g, 95%). 
Rf : 0.49 (hexane:EtOAc, 1:3) 
[α]D22 :-25.2 (c 1 in CHCl3) 
max: (film)/cm
-1 3019 (=CH), 2972 (CH), 2927 (CH), 1742 (C=O) 
H: (300 MHz, CDCl3) 1.61 (3H, s, CH3), 1.66 (3H, s, CH3), 2.65 (1H, dd, J 18.6 and 9.1, 
CHHCHO), 2.98 (1H, dd, J 18.6 and 3.8, CHHCHO), 3.58 (1H, dd, J 15.5 and 7.7, NCHH), 
3.82 (1H, dd, J 8.8 and 6.4, CHHO), 3.93 (1H, dd, J 15.5 and 6.3, NCHH), 4.06-4.16 (1H, m, 
NCH), 4.47 (1H, t, J 8.8, CHHO), 5.02-5.08 (1H, m, =CH), 9.71 (1H, s, CHO) 
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C: (75 MHz, CDCl3) 17.7 (CH3), 25.5 (CH3), 40.0 (NCH2), 46.6 (CH2CHO), 49.7 (NCH), 
67.4 (CH2OCO), 117.9 (=CH), 137.2 (Cq), 157.5 (OC=O), 198.7 (HCO); 
m/z: (ES)+ 252.2 (100%, [M+MeOH+Na]+), 220.1 (40, [M+Na]+).  
HRMS: [Found: (M+Na)+ 220.0945. C10H15NNaO3 requires M 220.0950] 
 
(6S, 7R, 8aS)-7-Hydroxy-6-(prop-1-en-2-yl)tetrahydro-1H-oxazolo[3,4-a]pyridin-3(5H)-
one (96) and (6S, 7R, 8aS)-6-(2-Chloropropan-2-yl)-7-hydroxytetrahydro-1H-oxazolo 
[3,4-a] pyridin-3(5H)-one (97) 
 
Concentrated HCl cyclisation 
 
Concentrated HCl (37 %, 0.13 mL, 1.52 mmol) was 
added to a solution of aldehyde 95 (100 mg, 0.51 mmol) 
in CH2Cl2 (10 mL) at -78 
oC. The resulting mixture was 
stirred at -78 oC for 16 h, before being quenched by the addition of water (10 mL). The 
organic layer was separated was the aqueous phase further extracted with CH2Cl2 (3 x 10 
mL). The combined organic phases were washed with brine (10 mL), dried over MgSO4 and 
concentrated in vacuo to afford the crude product as a white crystalline solid, which was 
purified by flash column chromatography (Rf = 0.28, 1:3, hexane:EtOAc) to afford piperidines 
cis-alkene 96 and cis-chloride 97 as an inseparable mixture in a 2:1 ratio as a white crystalline 
solid (70 mg, 76 %). 
max: (film)/cm
-1 3445 (OH), 3028 (=CH), 2972 (CH), 2913 (CH), 1735 (C=O), 760 (C-Cl) 
H: (300 MHz, CDCl3) 1.41-1.51 (1H from cis-Cl, m, CHHCHOH), 1.56 (1H from cis, t, J 
12.5, CHHCHOH), 1.67 (3H from cis-Cl, s, CH3), 1.69 (3H from cis-Cl, s, CH3), 1.72-1.75 
(1H from cis-Cl, m, NCH2CH), 1.78 (3H from cis, s, CH3), 1.92 (1H from cis, s, OH), 2.00-
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2.05 (1H from cis-Cl, m, CHHCHOH), 2.11 (1H from cis, dt, J 12.5 and 3.7, CHHCHOH), 
2.18 (1H from cis, dd, 12.4 and 4.5, NCH2CH), 2.92 (1H from cis-Cl, br s, OH), 3.25 (1H 
from cis, t, J 12.6, NCHH), 3.40-3.42 (1H from cis-Cl, m, NCHH), 3.67 (1H from cis, dd, J 
12.6 and 4.7, NCHH), 3.85-3.95 (1H from cis and 2H from cis-Cl, stack, CHHO from cis, 
CHHO from cis-Cl and NCHH from cis-Cl), 4.03-4.20 (2H from cis and 1H from cis-Cl, 
stack, NCH and CHOH from cis, NCH cis-Cl), 4.37-4.43 (1H from cis and 1H from cis-Cl, 
stack, CHHO from both), 4.42 (1H from cis-Cl, t, J 8.2 CHHO), 4.45 (1H from cis-Cl, br s, 
CHOH), 4.75 (1H from cis, s, =CHH), 5.02 (1H from cis, s, =CHH) 
C: (75 MHz, CDCl3) 22.8 (CH3 from cis), 31.6 (CH3 from cis-Cl), 31.9 (CH3 from cis-Cl), 
36.0 (CH2CHOH from cis), 37.6 (NCHCH2 from cis-Cl), 37.9 (NCH2 from cis-Cl), 38.6 
(NCH2 from cis), 45.8 (NCH2CH from cis), 48.7 (NCH from cis-Cl), 48.8 (NCH from cis), 
50.1 (NCH2CH from cis-Cl), 64.1 (CHOH from cis), 65.0 (CHOH from cis-Cl), 67.4 
(CH2OCO from cis), 67.5 (CH2OCO from cis-Cl), 71.3 (CCl), 112.5 (=CH2), 143.1 (C=CH2), 
157.1 (OCO) 
m/z: (ES)+ 258.1 (12%, [M(37Cl)+Na]+ for cis-Cl), 256.1 (100%, [M(35Cl)+Na]+ for cis-Cl), 
256.1 (50%, [M+Na]+ for cis)  
 
(6S, 7R, 8aS)-6-(2-Chloropropan-2-yl)-7-hydroxytetrahydro-1H-oxazolo[3,4-a] pyridin-
3(5H)-one (97) 
 
Anhydrous HCl cyclisation 
Anhydrous HCl gas was bubbled through a gas dispersion tube and into a 
solution of aldehyde 95 (26.8 g, 0.136 mol) in CH2Cl2 (500 mL) cooled to 
-78 °C, before passing through a gas scrubber containing water, for 10 min. The solution was 
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stirred at -78 °C for 2 h before being allowed to warm slowly to 0 °C. The reaction was 
quenched by the addition of water (500 mL) and the organic layer was separated. The aqueous 
phase was further extracted with EtOAc (3 x 500 mL) and the combined organic phases were 
washed with brine (500 mL), dried over MgSO4 and concentrated in vacuo to afford the crude 
product that was recrystallised from hexane:EtOAc, filtered and the filter cake washed with 
portions of ice cold EtOAc (3 x 20 mL) to give the product  as a white crystalline solid (31.1 
g, 98%). 
Rf : 0.29 (hexane:EtOAc, 1:3) 
[]D
20: -24.4 (c 1.0 in CHCl3) 
mp: 124-125 °C (from hexane:EtOAc)  
µ: (Found: C, 51.71; H, 7.09; N, 5.87. C10H16ClNO3 requires C, 51.40; H, 6.90; N, 5.99%) 
max: (film)/cm
-1 3431 (OH), 2974 (CH), 1748 (C=O), 1088 (C-O), 758 (C-Cl) 
H: (300 MHz, CDCl3) 1.36-1.53 (1 H, m, NCHCHHCH), 1.63-1.74 (7 H, stack, (CH3)2 and 
NCH2CH), 2.03 (1 H, dt, J 13.4 and 3.9, NCHCHHCH), 2.72 (1 H, br s, OH), 3.40 (1 H, t, J 
12.5, NCHH), 3.80-3.99 (2 H, stack, CHHO and NCHH), 4.07-4.22 (1 H, m, NCH),), 4.40 (1 
H, t, J 8.2, CHHO), 4.56 (1H, br s, CHOH) 
C: (75 MHz, CDCl3) 31.8 (CH3), 32.1 (CH3), 37.8 (NCH2), 38.1 (NCHCH2CH), 48.9 (NCH), 
50.3 (NCH2CH), 65.2 (CHOH), 67.72 (CH2O), 71.5 (CCl), 157.4 (C=O) 
m/z: (ES)+ 258.0 (10%, [M(37Cl)+Na]+), 256.0 (100, [M(35Cl)+Na]+), 220.1 (40) 
HRMS: [Found: (M+Na)+ 256.0719 C10H16ClNNaO3 requires M 256.0716] 
X-ray: See Appendix 
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(6S, 7R, 8aS)-7-Hydroxy-6-(prop-1-en-2-yl)tetrahydro-1H-oxazolo[3,4-a]pyridin-3(5H)-
one (96) and (6S, 7S, 8aS)-7-Hydroxy-6-(prop-1-en-2-yl)tetrahydro-1H-oxazolo[3,4-
a]pyridin-3(5H)-one (98) 
 
MeAlCl2 Cyclisation 
MeAlCl2 (1 M in hexanes, 1.12 mL, 1.12 mmol) was 
added dropwise over 30 s to a solution of aldehyde 95 
(110 mg, 0.56 mmol) in CH2Cl2 (20 mL) cooled to -78 °C. The reaction was stirred for a 
further 16 h at -78 °C before being quenched with water (20 mL). After warming to room 
temperature the organic phase was separated and the aqueous phase was further extracted with 
CH2Cl2 (3 x 20 mL). The combined organic phases were washed with brine (10 mL), dried 
over MgSO4 and concentrated in vacuo to afford the crude product as a white crystalline 
solid, which was purified by flash column chromatography (Rf = 0.28, hexane:EtOAc, 1:3) to 
afford cis piperidine 96 as a white crystalline solid (94 mg, 85%), data vide infra. Further 
elution (Rf = 0.14) afforded trans piperidine 98 as a white crystalline solid (15 mg, 14%). 
[]D
22: +4.8 (c 1.0 in CHCl3) 
mp: 112-113 °C (from hexane:EtOAc) 
µ: (Found: C, 60.96; H, 7.77; N, 7.33. C10H15NO3 requires C, 60.90; H, 7.67; N, 7.10%) 
max: (film)/cm
-1 3431 (OH), 3018 (=CH), 2974 (CH), 1748 (C=O), 1095 (C-O) 
H: (300 MHz, CDCl3) 1.38 (1H, q, J 11.7, CHHCHOH), 1.73 (3H, s, CH3), 2.03-2.19 (2H, 
stack, CHHCHOH and NCH2CH), 2.74 (1H, dd, J 13.6 and 11.7, NCHH), 3.67 (1H, td, J 10.7 
and 4.2, CHOH), 3.73-3.80 (1H, m, NCH), 3.84 (1H, dd, J 13.6 and 4.9, NCHH), 3.93 (1H, 
N
OH
O
O
N
OH
O
O
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dd, J 8.6 and 5.1, CHHO), 4.37 (1H, t, J 8.6, CHHO), 4.91 (1H, s, =CHH), 5.01 (1H, s, 
=CHH) 
C: (75 MHz, CDCl3) 20.3 (CH3), 37.8 (CH2COH), 43.4 (NCH2), 51.4 (NCH2CH), 53.0 
(NCH), 67.0 (CH2O), 68.2 (CHOH), 115.0 (=CH2), 141.9 (C=CH2), 156.8 (C=O) 
m/z: (ES)+ 220.1 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 220.0955 C10H15NNaO3 requires M 220.0950] 
X-ray: See Appendix 
 
(6S, 7R, 8aS)-7-Hydroxy-6-(prop-1-en-2-yl)tetrahydro-1H-oxazolo[3,4-a]pyridin-3(5H)-
one (96) 
 
HCl Elimination 
Chloride 97 (15.01 g, 64.3 mmol) was added to a stirred solution of NaOAc 
(5.28 g, 64.3 mmol) in AcOH (215 mL). The resulting solution was heated at 
reflux for 10 min, which resulted in a white precipitate. The reaction mixture 
was poured into water (200 mL) and the aqueous phase extracted with EtOAc (4 x 200 mL). 
The combined organic phases were washed with a saturated aqueous solution of NaHCO3 
(200 mL), water (200 mL) and brine (200 mL) before being dried over MgSO4 and 
concentrated in vacuo to afford the crude product as an orange solid. The crude product was 
purified by flash column chromatography (Rf = 0.28, hexane:EtOAc, 1:3) to afford cis 
piperidine 96 as a white crystalline solid (10.29 g, 85%).  
[]D
22: -85.2 (c 1.0 in CHCl3) 
mp: 121-122 °C (from hexane:EtOAc) 
µ: (Found: C, 60.91; H, 7.64; N, 7.20. C10H15NO3 requires C, 60.90; H, 7.67; N, 7.10%) 
N
OH
O
O
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max: (film)/cm
-1 3445 (OH), 3082 (=CH), 2972 (CH), 1730 (C=O), 1098 (C-O) 
H: (300 MHz, CDCl3) 1.52-1.68 (1H, m, NCHCHH), 1.79 (3H, s, CH3), 1.84 (1H, br s, OH), 
2.12 (1H, dt J 13.2 and 3.7, NCHCHH), 2.20 (1H, dd, J 12.5 and 4.8, NCH2CH), 3.26 (1H, t, 
J 12.5, NCHH), 3.68 (1H, dd, J 12.5 and 4.8, NCHH), 3.90 (1H, dd, J 8.5 and 5.5, CHHO), 
4.03-4.14 (2H, stack, NCH and CHOH), 4.41 (1H, t, J 8.5, CHHO), 4.75 (1H, s, =CHH), 5.02 
(1H, s, =CHH)  
C: (75 MHz, CDCl3) 22.6 (CH3), 35.9 (CH2COH), 48.6 (NCH2), 45.8 (NCH2CH), 58.8 
(NCH), 64.3 (CHOH), 67.6 (CH2O), 112.9 (=CH2), 143.7 (C=CH2), 157.8 (C=O) 
m/z: (ES)+ 252.1 (10%, [M+MeOH+Na]+), 220.1 (100, [M+Na]+) 
HRMS: [Found: (M+Na)+ 220.0947. C10H15NNaO3 requires M 220.0950] 
X-ray: See Appendix 
 
(6S, 7S, 8aS)-6-(2-Chloropropan-2-yl)-7-hydroxytetrahydro-1H-oxazolo[3,4-a] pyridin-
3(5H)-one (99) 
 
Anhydrous HCl gas was bubbled through a solution of piperidine 98 (132 
mg, 0.67 mmol) in CH2Cl2 (7 mL) cooled to -78 °C for 15 min. The 
reaction was stirred at -78 °C for 4 h before being allowed to warm to 
room temperature and stirred for a further 4 h. The reaction was quenched 
by the addition of water (10 mL) and the organic layer was separated. The aqueous phase was 
further extracted with CH2Cl2 (3 x 10 mL) and the combined organic phases were washed 
with brine (10 mL), dried over MgSO4 and concentrated in vacuo to afford the product 99 as a 
white crystalline solid (156 mg, quant.). 
Rf : 0.26 (hexane:EtOAc, 3:1) 
N
OH
O
O
Cl
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[]D
20: +22.4 (c 1.0 in CHCl3) 
mp: 91-92 °C (from hexane:EtOAc) 
H: (300 MHz, CDCl3) 1.52 (1 H, q, J 12.0, NCHCHHCH), 1.70 (3H, s, CH3), 1.82-1.75 (4 H, 
stack, CH3 and NCH2CH), 2.13 (1 H, dt, J 12.0 and 3.8, NCHCHHCH) 2.65 (1 H, br s, OH), 
2.75 (1 H, dd, J 13.6 and 11.5, NCHH), 3.71-3.83 (1 H, m, NCH), 3.90-4.03 (2 H, stack, 
CHHO and CHOH), 4.10 (1 H, dd, J 13.6 and 5.0, NCHH), 4.39 (1 H, t, J 8.3, CHHO) 
C: (75 MHz, CDCl3) 32.2 (CH3), 33.1 (CH3), 39.8 (NCH2), 41.5 (NCHCH2CH), 52.2  (NCH), 
52.8 (NCH2CH), 67.1 (CH2O), 70.2(CHOH), 71.9 (CCl), 157.1 (C=O) 
m/z: (ES)+ 256.1 (100, [M(35Cl)+Na]+), 220.1 (37) 
HRMS: [Found: (M+Na)+ 256.0721. C10H16ClNNaO3 requires M 256.0716] 
 
(S)-N-(3-methylbut-2-enyl)aspartic acid dimethyl ester (105) and (S)-bis(3-methylbut-2-
en-1-yl)aspartic acid dimethyl ester (111) 
LiOH (144 mg, 6.03 mmol) was added 
to a solution of dimethyl L-asparticester 
hydrochloride 110 (567 mg, 2.87 mmol) 
in DMF (15 mL) containing activated 4 
Å MS (1.6 g) at 0 °C. The resulting solution was allowed to warm to room temperature and 
stirred for a further 30 min. Prenyl bromide (0.33 mL, 2.87 mmol) was added and the 
resulting mixture was stirred for a further 5 h before being quenched with water (30 mL). The 
reaction was filtered and washed with Et2O (3 x 5 mL). The organic layer was separated and 
the aqueous phase was further extracted with Et2O (3 x 15 mL). The combined organic phases 
CO2Me
CO2Me
H
N
CO2Me
CO2MeN
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were washed with brine (30 mL) and dried over MgSO4 and concentrated in vacuo to afford 
the crude product as a pale yellow oil, which was purified by flash column chromatography 
(Rf = 0.65, hexane:EtOAc, 4:1) to give the tertiary amine 111 as a colourless oil (295 mg, 
34%). 
[α]D25: -74.4 (c 1 in CHCl3) 
max: (film)/cm
-1 2951 (C-H), 2915 (C-H), 2855 C-H), 1735 (C=O), 1436, 1164 (C-O) 
H: (300 MHz, CDCl3) 1.36 (6H, s, =C(CH3)), 1.52 (6H, s, =C(CH3)), 2.54 (1H, dd, J 12.0 
and 6.8, CHHCO2), 2.83 (1H, dd, J 12.0 and 6.8, CHHCO2), 3.15 (4H, d, J 6.0, CH2N), 3.60 
(3H, s, OCH3), 3.65 (3H, s, OCH3), 3.98 (1H, t, J 6.8, NCH), 5.10-5.20 (2H, m, =CH) 
C: (75 MHz, CDCl3) 20.3 (=C(CH3)), 28.2 (=C(CH3)), 36.7 (CH2CO2), 45.2 (=CCH2), 53.6 
(OCH3), 53.9 (OCH3), 60.6 (NHCH), 124.5 (=CH), 137.5 (=C(CH3)2), 171.4 (C=O), 174.6 
(C=O)  
m/z: (ES)+ 320.1 (100%, [M+Na]+)  
HRMS: [HRMS Found: (M+Na)+ 320.1844. C16H27NNaO4 requires M 320.1838] 
Further elution (Rf = 0.20) gave the secondary amine 105 as a colourless oil (105 mg, 16%). 
[α]D24: +55.6 (c 1 in CHCl3)  
max: (film)/cm
-1 3560 (NH), 2983 (CH), 2956 (CH), 1740 (C=O) 
H: (300 MHz, CDCl3) 1.56 (3H, s, =C(CH3)), 1.64 (3H, s, =C(CH3)),  2.01 (1H, br s, NH), 
2.63 (2H, t, J 6.5 CH2N), 3.07 (1H, dd, J 12.8 and 7.0, CHHCO2), 3.19 (1H, dd, J 12.8 and 
7.0, CHHCO2), 3.57 (1H, t, J 7.0, NHCH), 3.61 (3H, s, OCH3), 3.67 (3H, s, OCH3), 5.10-5.16 
(1H, m, =CH)  
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C: (75 MHz, CDCl3) 17.6 (=C(CH3)), 25.5 (=C(CH3)), 37.6 (CH2COO), 45.2 (=CCH2), 
51.6 (OCH3), 51.9 (OCH3), 56.7 (NHCH), 121.9 (=CH), 135.1 (=C(CH3)2), 171.1 (C=O), 
174.0 (C=O)  
m/z: (ES)+ 252.1 (100%, [M+Na]+)  
HRMS: [HRMS Found: (M+Na)+ 252.1205. C11H19NNaO4 requires M 252.1212] 
 
(S)-N-3-Methyl-but-2-enylidene-aspartic acid dimethyl ester (113) 
 
3-methyl-but-2-enal (13.1 mL, 0.136 mol) was dropwise over 5 min to 
a solution of L-aspartic acid dimethyl ester 87 (20.0 g, 0.124 mol) in 
MeOH (400 mL). The resulting solution was stirred at room 
temperature overnight. The solvent was removed in vacuo to give the imine product 113 as a 
red oil (98% yield).  
[α]D20: -8.8 (c 1 in CHCl3) 
max: (film)/cm
-1 2955 (CH), 1740 (C=O), 1676 (C=N), 1438 
H: (300 MHz, CDCl3) 1.87 (3H, s, CCH3), 1.93 (3H, s, CCH3), 2.76 (1H, dd, J 16.7 and 7.7, 
CHCHH), 3.05 (1H, dd, J 16.7 and 5.9, CHCHH), 3.65 (3H, s, OCH3), 3.72 (3H, s, OCH3), 
4.27 (1H, dd, J  7.7 and 5.9, CHCH2), 6.00 (1H, d, J 9.5, (CH3)2C=CH), 8.25 (1H, d, J 9.5, 
N=CH) 
C: (75 MHz, CDCl3) 18.8 (CCH3), 26.6 (CCH3), 37.5 (CHCH2), 51.7 (OCH3), 52.4 (OCH3), 
68.9 (CHCH2), 125.0 ((CH3)2C=CH), 149.7 ((CH3)2C=CH), 163.5 (N=CH), 171.2 (C=O), 
171.3 (C=O) 
m/z: (ES)+ 250.1 (100%, [M+Na]+), 228.1 (12, [M+H]+)  
HRMS: [Found: (M+Na)+ 250.1045. C11H17NNaO4 requires M 250.1055] 
CO2Me
CO2MeN
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N-(3-methylbut-2-enyl)aspartic acid dimethyl ester (rac-105) 
 
Imine Reduction  
Imine 113 (23.6 g, 0.104 mol) in C2H4Cl2 (500 mL) was added via 
cannula to a solution NaBH(OAc)3 (44.1 g, 0.208 mol) in C2H4Cl2 (500 mL) cooled to 0 °C. 
The resulting solution was stirred for a further 1 h at 0 °C before being allowed to warm to 
room temperature and stirred for 3 days. The reaction was cooled to 0 °C before being 
quenched with a saturated aqueous solution of NaHCO3 (500 mL). The organic layer was 
separated and the aqueous phase was further extracted with CH2Cl2 (3 x 500 mL). The 
combined organic phases were washed with brine (500 mL) and dried over MgSO4 before 
being concentrated in vacuo to afford the crude product as a yellow oil, which was purified by 
flash column chromatography (Rf = 0.20, 4:1, hexane:EtOAc) to afford the product (rac)-105 
as a colourless oil (70%). 
Conjugate Addition 
Et3N (191 mL, 1.37 mol) was added over 10 min to a stirred solution prenyl amine 
hydrochloride 137 (33.2 g, 0.273 mol) cooled to 0 °C. The resulting solution allowed to warm 
to room temperature before dimethyl maleate (34.1 mL, 0.273 mol) was added and the 
reaction mixture was heated to 60 °C for 2 h. The reaction was allowed to cool to room 
temperature and quenched with water (500 mL). The aqueous phase was extracted with 
EtOAc (3 x 500 mL). The combined organic phases were washed with water (500 mL), brine 
(500 mL) and dried over MgSO4 before being concentrated in vacuo to afford the product 
(rac)-105 as a colourless oil (56.3 g, 90%). 
CO2Me
CO2Me
H
N
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max: (film)/cm
-1 3560 (NH), 2983 (CH), 2956 (CH), 1740 (C=O) 
H: (300 MHz, CDCl3) 1.56 (3H, s, =C(CH3)), 1.64 (3H, s, =C(CH3)),  2.01 (1H, br s, NH), 
2.63 (2H, t, J 6.5 CH2N), 3.07 (1H, dd, J 12.8 and 7.0, CHHCO2), 3.19 (1H, dd, J 12.8 and 
7.0, CHHCO2), 3.57 (1H, t, J 7.0, NHCH), 3.61 (3H, s, OCH3), 3.67 (3H, s, OCH3), 5.10-5.16 
(1H, m, =CH)  
C: (75 MHz, CDCl3) 17.6 (=C(CH3)), 25.5 (=C(CH3)), 37.6 (CH2COO), 45.2 (=CCH2), 
51.6 (OCH3), 51.9 (OCH3), 56.7 (NHCH), 121.9 (=CH), 135.1 (=C(CH3)2), 171.1 (C=O), 
174.0 (C=O)  
m/z: (ES)+ 252.1 (100%, [M+Na]+)  
HRMS: [HRMS Found: (M+Na)+ 252.1205. C11H19NNaO4 requires M 252.1212] 
 
(S)-N-Ethoxycarbonylaspartic acid dimethyl ester (106) 
 
 
NaHCO3 (158 g, 1.88 mol) was added in portions over 20 min to a 
stirred solution of the crude aspartic ester 110 (76.5 g) in water (700 
mL) cooled to 0 °C. Ethyl chloroformate (43 mL, 0.45 mol) was added 
over 20 min and the solution was allowed to warm to room temperature and stirred for a 
further 4 h, this produced a colourless oil that pooled at the bottom of the flask. The oil was 
separated and the aqueous phase was further extracted with EtOAc (4 x 500 mL). The 
combined organic phases were washed with brine (500 mL) and dried over MgSO4 before 
being concentrated in vacuo to afford the product 106 as a colourless oil (65.9 g, 75% over 2 
synthetic steps).  
Rf : 0.61 (hexane:EtOAc, 1:1) 
CO2Me
CO2Me
H
N
EtO2C
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[α]D23:  +38.4 (c 1.0 in CHCl3) (Lit.72  [α]D24 +41.5 (c 4.65 in CHCl3)) 
max: (film)/cm
-1 3358 (NH), 2983 (CH), 2956 (CH), 1736 (C=O) 
H: (300 MHz, CDCl3) 1.20 (3H, t, J 7.1, CH2CH3), 2.80 (1H, dd, J 17.1 and 4.6, CHCHH), 
2.98 (1H, dd, J 17.1 and 4.6, CHCHH), 3.65 (3H, s, OCH3), 3.72 (3H, s, OCH3), 4.08 (2H, q, 
J 7.1, CH3CH2), 4.58 (1H, m, CH) 5.65 (1H, d, J 8.2, NH)  
C: (75 MHz, CDCl3) 14.4 (CH3CH2), 36.7 (CHCH2), 50.1 (NCH), 51.9 (OCH3), 52.7 
(OCH3), 61.2 (OCH2), 156.0 (NCO2Et), 172.0 (CO2Me)  
m/z: (ES)+ 256.1 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 256.0799. C9H15NNaO6 requires M 256.0797]  
 
(S)-N-Ethoxycarbonyl-aspartic acid bis(3-methylbut-2-enyl) ester (140) and (S)-N-
Ethoxycarbonyl-aspartic  acid 1-methyl 4-(3-methylbut-2-enyl) ester (141a) and (S)-N-
Ethoxycarbonyl-aspartic  acid 1-(3-methylbut-2-enyl) 4-methyl ester (141b) 
 
H
N
EtO2C
O
O
O
O
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N
EtO2C
O
O
 
 
Cs2CO3 (425 mg, 1.30 mmol) was added in one portion to a stirred solution of carbamate 106 
(101 mg, 0.43 mmol) and TBAI (483 mg, 1.30 mmol) in DMF (4 mL). The resulting mixture 
was stirred for 15 min before prenyl bromide (0.15 mL, 1.30 mmol) was added to the 
solution. The reaction mixture was sonicated for 2 h before being stirred at rt for 48 h. The 
reaction was quenched by the addition of water (20 mL) and diluted with Et2O (10 mL) the 
CO2Me
H
N
EtO2C
O
O
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organic phase was separated and the aqueous phase further extracted with Et2O (3 x 10 mL). 
The combined organic fractions were washed with water (20 mL), brine (20 mL) and dried 
over MgSO4 before the solvent was removed in vacuo. The crude residue was purified by 
flash column chromatography (Rf = 0.40, hexane:EtOAc, 4:1) to give the bis-O-alkylated 
product 140 as a colourless oil (48 mg, 33%). 
max: (film)/cm
-1 3366 (NH), 2980 (CH), 1734 (C=O), 1517, 1212 
H: (300 MHz, CDCl3) 1.21 (3H, t, J 7.0, CH2CH3), 1.68 (6H, s, CH=CCH3) 1.79 (6H, s 
=CCH3) 2.74 (1H, dd, J 17.0 and 4.4, CHCHH), 2.90 (1H, dd, J 17.0 and 4.4, CHCHH), 4.18 
(2H, q, J 7.0, CH2CH3), 4.52-4.63 (5H, stack, OCH2 and NCH), 5.35 (2H, t, J 7.4, 
CH=CCH3), 5.60 (1H, m, NH)  
C: (75 MHz, CDCl3) 13.8 (CH2CH3), 17.3 (CH=CCH3), 26.0 (CH=CCH3), 36.2 (CHCH2), 
59.7 (NCH), 60.5 (CH2CH3), 61.2 (OCH2), 61.9 (OCH2), 117.3 (CH=CCH3), 117.4 
(CH=CCH3), 139.2 (CH=CCH3), 139.3 (CH=CCH3), 156.2 (NCO2Et), 170.1 (CO2Me)  
m/z: (ES)+ 364.2 (100%, [M+Na]+) 
Further elution (Rf = 0.31) gave the mono-O-alkylated products 141a and 141b as a colourless 
oil (73 mg, 59%) in a 1:1 mixture. (NMR data reported on the mixture). 
max: (film)/cm
-1 3364 (NH), 2977 (CH), 2934 (CH) 1734 (C=O), 1511, 1209 
H: (300 MHz, CDCl3) 1.20 (6H, stack, CH2CH3), 1.67 (6H, stack, CH=CCH3) 1.78 (6H, 
stack, CH=CCH3) 2.75-2.92 (4H, stack, CHCHH), 3.62 (3H, s, OCH3), 3.74 (3H, s, OCH3), 
4.20 (4H, stack, CH2CH3), 4.85-4.72 (6H, stack OCH2 and NCH), 5.35 (2H, stack, 
CH=CCH3), 5.60 (2H, stack, NH)  
m/z: (ES)+ 310.1 (100%, [M+Na]+), 242.1(48, [M+Na-C5H8]
+ 
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(S)-N-Ethoxycarbonyl-3-methylbut-2-enyl aspartic acid dimethyl ester (104) 
Carbamation of 2o amino-ester 
Cs2CO3 (523 mg, 1.60 mmol) was added to a solution of secondary 
amine 105 (184 mg, 0.80 mmol) in MeCN (8 mL) cooled to 0 °C. The 
solution was stirred for 30 min before ethyl chloroformate (750 L, 0.80 mmol) was added to 
the solution at 0 °C. The resulting solution was allowed to warm to room temperature and 
stirred for a further 4 h. The solvent was removed in vacuo and the resulting white solid was 
dissolved in water (10 mL). The aqueous phase was extracted with EtOAc (4 x 10 mL). The 
combined organic phases were washed with brine (10 mL), dried over MgSO4 and 
concentrated in vacuo to leave the product 104 as a colourless oil  (242 mg, quant.). 
Carbamate Alkylation 
Prenyl bromide 133 (36.0 mL, 0.310 mol) was added to a solution of carbamate 106 (60.1 g, 
0.258 mol) in DMF (650 mL) cooled to 0 °C. NaH (60% dispersion in mineral oil, 8.67 g, 
0.258 mol) was added in small portions over 2 h via a solid addition funnel to the stirred 
solution, gas evolution followed and a white precipitate fell out of solution as the reaction 
progressed. The reaction was stirred at 0 °C for a further 2 h before being quenched by the 
addition of water (600 mL). The solution was diluted with Et2O (300 mL) and the organic 
phase separated. The aqueous phase was further extracted with Et2O (3 x 300 mL) and the 
combined organic phases were washed with water (2 x 500 mL), brine (500 mL) and dried 
over MgSO4 before being concentrated in vacuo to give the crude product as a yellow oil. The 
crude product was split in half and purified in two portions by flash column chromatography 
(Rf = 0.35, hexane:EtOAc, 4:1) to give  as a colourless oil (62.9 g, 81%).  
CO2Me
CO2MeN
CO2Et
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 [α]D21 : -76.8  (c 1 in CHCl3) 
max: (film)/cm
-1 2980 (CH), 2953 (CH), 1740 (C=O), 1704 (C=O) 
H: (400 MHz, C2H2Cl4 at 100 °C) 1.20 (3H, t, J 7.1, CH3CH2), 1.65 (3H, s, =C(CH3)), 1.70 
(3H, s, =C(CH3)), 2.69 (1H, dd, J 16.4 and 6.8, CHCHHCO), 3.11 (1H, dd, J 16.4 and 6.8, 
CHCHHCO), 3.66 (3H, s, OCH3), 3.67 (3H, s, OCH3), 3.86 (1H, dd, J 15.4 and 6.7, NCHH), 
3.95 (1H, dd, J 15.4 and 6.7, NCHH), 4.10 (2H, q,  J 7.1, CH3CH2), 4.52 (1H, t, J 6.8, NCH), 
5.17 (1H, t,  J 6.7, =CH)  
C: (100 MHz, C2H2Cl4 at 100 °C); 14.2 (CH3CH2), 17.4 (=CCH3), 25.2 (=CCH3), 35.4 
(NCH2), 45.6 (CHCH2CO), 51.3 (OCH3), 51.9 (OCH3), 56.3 (NCH), 61.3 (CH3CH2), 120.2 
(=CH), 135.3 (=C(CH3)2), 155.5 (OCON), 170.6 (CO2CH3), 170.9 (CO2CH3) 
m/z: (ES)+ 324.2 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 324.1430. C14H23NNaO6 requires M 324.1423] 
 
(S)-2-(Ethoxycarbonyl-3-methylbut-2-enylamino)-butan-1,4-diol (103) 
 
NaBH4 (59 mg, 1.56 mmol) was added in small portions over 5 min to a 
solution of carbamate ester 104 (100 mg, 0.31 mmol) in EtOH:THF 
(3:1, 4 mL)  cooled to 0 °C. The reaction was allowed to warm to room 
temperature and stirred for a further 5 h, before being quenched with water (5 mL). The 
solvent was removed in vacuo and the aqueous phase was extracted with EtOAc (4 x 5 mL). 
The combined organic phases were washed with brine (5 mL), dried over MgSO4 and 
evaporated in vacuo to afford a yellow oil, which was purified by flash column 
chromatography (Rf = 0.29, hexane:EtOAc, 1:4), to give the product 103 as a colourless oil 
(32 mg, 88%).  
N
CO2Et
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[α]D23:  +8.0 (c 1 in CHCl3) 
max: (film)/cm
-1 3418 (OH), 2965 (CH), 2927 (CH), 1742 (C=O), 1736 (C=O) 
H: (300 MHz, CHCl3) 1.23 (3H, t, J 7.0, CH3CH2), 1.64 (3H, s, =CCH3), 1.71 (3H, s, 
=CCH3), 1.71-1.86 (1H, m, CHCHHCO), 2.84-2.91 (1H, m, CHCHHCO), 3.45-3.75 (6H, 
stack, CHCH2OH, CH2CH2OH and NCH2), 4.01-4.07  (1H, m, NCH), 4.12 (2H, q, J 7.0, 
CH3CH2), 5.17 (1H, br s, =CH) 
C: (75 MHz, CHCl3); 14.6 (CH3CH2), 17.8 (=CCH3), 25.7 (=CCH3), 29.7 (NCH2), 31.5 
(NCH2), 42.4 (CHCH2CH2), 55.9 (NCH), 58.9 (CH2OH), 61.8 (CH2OH), 64.0 (CH3CH2), 
121.2 (=CH), 134.9 (=C(CH3)2), 158.1 (C=O) 
m/z: (ES)+ 268.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 268.1522. C12H23NNaO4 requires M 268.1525] 
 
N-(Allyl)aspartic acid dimethyl ester (128) 
Allyl amine (40 µL, 1.00 mmol) was added to a solution of dimethyl 
maleate (125 µL, 1.00 mmol) in Et3N (139 µL, 1.00 mmol). The 
resulting mixture was heated to 40 °C for 10 min before being 
concentrated in vacuo to give the product 128 as a colourless oil (201 mg, quant.). 
max: (film)/cm
-1 3340 (N-H), 3079 (=C-H)), 2954 (C-H), 1738 (C=O), 1438, 1169 (C-O) 
H: (300 MHz, CDCl3) 1.84 (1H, br s, NH), 2.64 (2H, t, J 6.3, CH2NH), 3.12 (1H, dd, J 13.9 
and 6.0 , CH2CO), 3.26 (1H, dd, J 13.9 and 6.0, CH2CO), 3.55-3.66 (4H, stack, CH3 and 
CHCH2), 3.68 (3H, s, CH3), 5.04 (1H, d, J 10.2, HHC=), 5.12 (1H, d, J 15.2, HHC=), 5.58-
6.06 (1H, m, =CH) 
CO2Me
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C: (75 MHz, CDCl3) 37.9 (CH2CH), 50.6 (CH2NH), 51.8 (CH3), 52.1 (CH3), 56.7 (CHNH), 
116.5 (=CH2), 136.1 (=CH), 171.2 (C=O), 174.1 (C=O) 
m/z: (ES)+ 224.1 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+224.0891. C9H15NNaO4 requires M 224.0899] 
 
Prenyl bromide (133) 
 
PBr3 (43 mL, 0.24 mol) was added to a stirred solution of prenol (60 mL, 0.59 
mol) in Et2O (200 mL) cooled to 0 °C. The resulting solution was stirred for a 
further 30 min before being quenched with a saturated aqueous solution containing NaHCO3 
(200 mL) and diluted with Et2O (100 mL). The organic layer was separated and the aqueous 
layer extracted with Et2O (3 x 100 mL). The combined organic layers were washed with brine 
and dried over MgSO4 before the solvent was removed in vacuo at 20 °C to give prenyl 
bromide 133 as a colourless oil (72 g, 83%). This was used straight away or stored in the dark 
over silver wire under Ar at -25 °C for up to week before being used in the next step. 
max: (film)/cm
-1 2970, 2910, 2855, 1664, 1443, 1150, 980, 845, 760 
H: (300 MHz, CDCl3) 1.73 (3H, s, CH3), 1.78 (3H, s, CH3), 4.02 (2H, d, J 8.2, CH2), 5.58 
(1H, t, J 8.2, CH) 
C: (75 MHz, CDCl3) 17.0 (CH3), 25.2 (CH3), 29.1 (CH2), 120.2 (=CH), 139.4 (=Cq) 
 
 
 
 
Trityl amine (135) 
 
 
Br
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Aqueous ammonia (35% soln., 350 mL, 5.25 mol) was added in 4 portions 
over 10 min to a mechanically stirred solution of trityl chloride (97.5 g, 
0.35 mol) in CH2Cl2 (350 mL) cooled to 0 °C. The solution was allowed to 
warm to room temperature and stirred for a further 3 days. The organic 
layer was separated and the aqueous phase further extracted with CH2Cl2 (2x 200 mL). The 
combined organic layers were washed with water (300 mL) and brine (300 mL) before being 
dried over MgSO4. The solvent was removed in vacuo to give the crude product as a pale 
yellow solid. The crude product was recrystallised from EtOH to give the pure product 135 as 
a white crystalline solid (67.2 g, 74%). 
mp: 98-100 °C (from ethanol) (Lit.110 100-102 °C (from H2O)) 
max: (film)/cm
-1 2970, 2910, 2855, 1664, 1443, 1150, 980, 845, 760 
H: (300 MHz, CDCl3) 2.48 (2H, br s, NH2), 7.25- 7.43 (15H, m, ArCH) 
C: (75 MHz, CDCl3) 62.8 (CNH2), 125.5 (ArCH), 126.9 (ArCH), 127.1 (ArCH), 147.5 
(ArCq) 
m/z: (EI)+ 259 (20%, [M]+), 243 (40, [M-NH2]
+), 182 (100, [M-C6H5]
+)  
 
 
 
3-methyl-N-tritylbut-2-en-1-amine (136) 
 
 
K2CO3 (110 g, 0.798 mol) was added in 4 portions over 10 min to a stirred 
solution of trityl amine 136 (69 g, 0.266 mol) in DMF (670 mL) cooled to 
0 °C. Prenyl bromide (46 mL, 0.399 mol) was added over 10 min to the stirred suspension. 
The resulting solution was stirred at 0 °C for 1 h before being allowed to warm to room 
temperature and stirred for a further 6 h. The reaction was quenched with H2O (1 L) and the 
H2N
NHTr
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aqueous layer was extracted with Et2O (3 x 600 mL). The combined organic layers were 
washed with H2O (2 x 500 mL) and brine (500 mL) before being dried over MgSO4. The 
solvent was removed in vacuo to give the crude product 136 as a pale yellow oil (87 g), which 
was used in the next step without further purification. 
max: (film)/cm
-1 3365 (NH), 3047, 3018, 2855, 1596, 1575, 1448, 1444, 1212, 844, 766, 696 
H: (300 MHz, CDCl3) 1.53 (3H, s, CH3), 1.75 (3H, s, CH3), 2.78 (2H, d, J 8.0, CH2), 5.42 
(1H, t, J 8.0, CH), 7.15-7.23 (3H, ArCH), 7.24-7.31 (6H, m, ArCH), 7.48-7.55 (6H, m, 
ArCH) 
C: (75 MHz, CDCl3) 22.4 (CH3), 30.2 (CH3), 48.1 (CH2), 119.4 (CH=), 135.2 (ArCH), 135.3 
(ArCH), 144.3 (Cq), 148.5 (Cq) 
m/z: (ES)+ 350.2 (81%, [M+Na]+), 243.1 (100) 
HRMS: [Found: (M+Na)+ 350.1879. C24H25NNa requires M 350.1885] 
 
2-(3-methylbut-2-enyl)isoindoline-1,3-dione (138) 
 
Prenyl bromide 133 (50.0 g, 0.335 mol) was added over 2 min to a 
stirred solution of potassium phthalimide (68.4 g, 0.369 mol) in DMF 
(250 mL) cooled to 0 °C, this resulted in the generation of a white 
precipitate. The solution was allowed to warm to room temperature and stirred for a further 30 
min. The reaction was diluted with water (500 mL) and the aqueous phase extracted with 
Et2O (4 x 250 mL). The combined organic phases were washed with 1 M NaOH (250 mL), 
water (250 mL) and brine (250 mL) before being dried over MgSO4 and the solvent removed 
in vacuo to give the product 138 as a white crystalline solid (70.7 g, 98%). 
Rf : 0.44 (hexane:EtOAc, 3:1) 
N
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mp: 96-98 °C (from CHCl3) (Lit.
111 100 °C (from MeOH)) 
max: (film)/cm
-1 2978 (CH), 2941 (CH), 2923 (CH), 1767 (C=O), 1699, 1425, 1096, 943, 718 
H: (300 MHz, CDCl3) 1.61 (3H, s, CH3), 1.73 (3H, s, CH3), 4.25 (2H, d, J 7.9, CH2), 5.22 
(1H, t, J 7.9, CH), 7.58-7.67 (2H, ArCH), 7.71-7.79 (2H, m, ArCH) 
C: (75 MHz, CDCl3) 18.2 (CH3), 25.9 (CH3), 36.1 (CH2), 118.6 (CH=), 123.4 (ArCH), 132.8 
(Cq), 134.1 (ArCH), 137.5 (Cq), 166.9 (C=O) 
m/z: (ES)+ 238.0 (100%, [M+Na]+), 182.2 (27) 
 
 
Prenyl amine hydrochloride (137) 
 
 
Phthalimide Cleavage 
Ba(OH)2.8H2O (234 g, 0.743 mol) was added in portions over 15 min to a 
stirred suspension of alkylated phthalimide 139 (64.0 g, 0.297 mol) in water (600 mL). The 
resulting solution was heated to reflux and the free amine extracted via steam distillation for 
16 h until the pH of the distillate was no longer alkaline, while the still pot is topped up with 
water equal to the volume of distillate removed. The alkaline distillate is then neutralised to 
pH 7 with 1M HCl and the distillate is then concentrated in vacuo to 1/10 th volume before 
MeOH (100 mL) is added and the solvent removed in vacuo to give the product 137 as a 
white amorphous solid upon standing (35.4 g, 98%). 
Trityl Cleavage 
Trifluoroacetic acid (3 mL) was added over 2 min to a stirred solution of alkylated trityl 
amine 136 (240 mg, 0.73 mmol) in CH2Cl2 (2 mL) cooled to 0 °C, resulting in a colour 
change from colourless to bright yellow. The solution was stirred for 10 min at 0 °C before 
NH2.HCl
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MeOH (10 mL) was added to the resulting solution over 10 min, resulting in a colour change 
from bright yellow to colourless. The solvent was removed in vacuo to give a yellow solid 
that was treated with concentrated HCl (2 mL, 2.19 mmol) in MeOH (8 mL) before the 
solvent removed in vacuo. The resulting residue was washed Et2O to precipitate a white solid, 
which was filtered from the mother liquid and washed with further portions of Et2O to give 
the product as a white amorphous solid 137 (83 mg, 94%). 
mp: 196-197 °C (from MeOH) (lit.112 200 °C (from EtOH))  
max: (film)/cm
-1 3424 (NH), 2977 (CH), 1671, 1596, 1449, 756, 706 
H: (300 MHz, CD3OD) 1.71 (3H, s, CH3), 1.78 (3H, s, CH3), 3.53 (2H, d, J 8.2, CH2), 5.31 
(1H, t, J 8.2, CH) 
C: (75 MHz, CD3OD) 17.4 (CH3), 25.2 (CH3), 37.5 (CH2), 116.1 (CH=), 141.4 (=Cq) 
 
(6S, 7S, 9S)-4-tert-Butoxycarbonyloxy-2-hydroxymethyl-5-isopropenylpiperidine-1-
carboxylic acid tert-butyl ester (143) and (6S, 7S, 9S)-7-Carbonic acid tert-butyl ester-6-
isopropenyl-hexahydro-oxazolo[3,4-a]pyridine-3-one (144)  
A solution of aqueous NaOH (6 M, 3 mL) was 
added to a solution of piperidine 96 (58 mg, 0.29 
mmol) in MeOH (6 mL). The reaction was heated 
to 95 °C for 16 h before the solvent was removed 
in vacuo. The resulting solid was dissolved in THF (6 mL) and cooled to 0 °C. (Boc)2O (128 
mg, 0.59 mmol) was added in one portion. The reaction was allowed to warm to room 
temperature and stirred for a further 4 h before the solvent was removed in vacuo. The 
Boc
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aqueous phase was extracted with EtOAc (4 x 5 mL) and the combined organic phases were 
washed with brine (5 mL), dried over MgSO4 and concentrated in vacuo to afford the crude 
product, which was purified by flash column chromatography (Rf = 0.38, hexane:EtOAc, 2:1) 
to afford piperidine 143 as colourless oil (17 mg, 16%). 
max: (film)/cm
-1 3447 (OH), 2979 (CH), 2931 (CH), 1743 (C=O), 1670 (C=O), 1424, 1366, 
1287, 1255, 1161, 1066 (C-O) 
H: (400 MHz, CDCl3) 1.43 (9H, s, C(CH3)3), 1.46 (9H, s, C(CH3)3), 1.62 (1H, dt, J 14.1 and 
6.3, CHHCHOH), 1.75 (3H, s, =CCH3), 2.04 (1H, ddd, J 14.1, 6.3 and 3.8, CHHCHOH), 
2.16-2.19 (1H, m, CHOHCH), 3.50 (1H, dd, J 14.1 and 5.0, NCHH), 3.70 (1H, dd, J 14.1 and 
3.8, NCHH), 3.95 (1H, td, J 6.3 and 3.8, CHOH), 4.12 (1H, quin., J 6.3, NCH), 4.30 (2H, d, J 
6.3, OCH2), 4.85 (1H, s, =CHH), 4.88 (1H, s, =CHH) 
C: (75 MHz, CDCl3) 20.0 (=CCH3), 27.8 (C(CH3)3), 28.4 (C(CH3)3), 30.4 (CH2CHOH), 40.7 
(NCH2) 49.2 (NCH2CH), 50.1 (NCH), 67.1 (CH2O), 67.2 (CHOH), 80.0 (C(CH3)3), 82.2 
(C(CH3)3), 112.9 (=CH2), 143.9 (C=CH2), 153.6 (C=O), 154.8 (C=O) 
m/z: (ES)+ 394.2 (100%, [M+Na]+).  
HRMS: [Found: (M+Na)+ 394.2215. C19H33NNaO6 requires M 394.2206] 
 
Further elution, Rf = 0.29, afforded piperidine 144 as a white crystalline solid (13 mg, 15%).   
mp: 171-173 °C (from hexane:EtOAc) 
max: (film)/cm
-1 2954 (CH), 2923 (CH), 2853 (CH), 1743 (C=O) 
H: (400 MHz, CDCl3) 1.45 (9H, s, C(CH3)3),  1.53 (1H, q, J 11.8, NCHCHH), 1.74 (3H, s, 
=CCH3), 2.25 (1H, dt, J 11.8 and 3.8, NCHCHH), 2.35 (1H, dt, J 11.8 and 5.1, NCH2CH), 
2.83 (1H, dd, J 13.6 and 11.8, NCHH), 3.80-3.87 (1H, m, NCH), 3.92 (1H, dd, J 13.6 and 5.1, 
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NCHH), 3.96 (1H, dd, J 8.7 and 4.9, CHHO), 4.40 (1H, t, J 8.7, CHHHO), 4.77 (1H, dt, J 
11.8 and 3.8, CHO), 4.88 (1H, s, =CHH), 4.94 (1H, s, =CHH) 
C: (75 MHz, CDCl3) 20.5 (=CCH3), 27.7 (C(CH3)3, 35.7 (NCHCH2),  43.9  (NCH2), 58.3 
(NCH2CH), 52.8 (NCH), 66.8 (CH2O), 63.6 (CHO), 82.6 (C(CH3)3, 114.6 (=CH2), 141.0 
(C=CH2), 152.8 (C=O), 156.6 (C=O) 
m/z: (ES)+ 320 (100%, [M+Na]+), 264.1 (40, [M+Na-C4H8]) 
HRMS: [Found: (M+Na)+ 320.1479. C15H23NNaO5 requires M 320.1474] 
 
(2S, 4R, 5S)-2-(hydroxymethyl)-5-isopropenylpiperidin-4-ol (145) 
 
NaOH (4.79 g, 0.120 mol) in water (15 mL) was added dropwise over 30 
s to a solution of piperidine 96 (2.36 g, 11.98 mmol) in MeOH (45 mL) 
cooled to 0 °C. The solution was allowed to warm to room temperature 
and then heated to 95 °C for 5 h. After cooling to room temperature the solvent was removed 
in vacuo and the resulting white solid was extracted with CH2Cl2 (20 mL), filtered and 
washed with further portions of CH2Cl2 (3 x 10 mL) before the solvent was removed in vacuo 
to afford the product 145 as hygroscopic white crystalline solid (2.05 g) which was used in 
the next step without any further purification.  
Rf : 0.20 (8:2, CHCl3:MeOH + 1% NH3(aq)) 
[α]D20:  -20.0 (c 1 in CHCl3) 
mp: 106-107 °C (from EtOAc) 
max: (film)/cm
-1 3386 (OH), 3309 (NH), 2925 (CH), 1645 (C=C), 1446, 1216, 754 
H: (300 MHz, CDCl3) 1.44-1.54 (1H, m, NCHCHHCH), 1.78 (3H, s, CH3) 1.85 (1H, dt, J 
14.0 and 2.9, NCHCHHCH), 2.23 (1H, br d, J 11.8, NCH2CH), 2.90 (1H, dd, J 12.1 and 4.0, 
H
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NCHH), 3.07 (1H, dd, J 12.1 and 11.8, NCHH), 3.12-3.18 (1H, m, NCH), 3.31 (3H, br s, 2 x 
OH and NH), 3.43 (1H, dd, J 11.0 and 7.4, CHHOH), 3.65 (1H, dd, J 11.0 and 3.3, CHHOH) 
4.10 (1H, br s, CHOH), 4.68 (1H, s, =CHH), 4.97 (1H, s, =CHH) 
C: (75 MHz, CDCl3) 22.9 (=CCH3), 34.2 (NCHCH2CH), 43.2 (NCH2), 47.8 (NCH2CH), 51.8 
(NCH), 64.3 (CHOH), 65.6 (CH2O), 112.6 (C=CH2), 144.8 (C=CH2) 
m/z: (ES)+  194.4 (20%, [M+Na]+), 172.4 (90, [M+H]+), 154.4 (100) 
X-ray: See Appendix 
 
(2S, 4R, 5S)-4-hydroxy-2-(hydroxymethyl)-5-isopropenylpiperidine-1-carboxylic acid 
tertbutyl ester (146) 
 
Boc Protection  
(Boc)2O (2.62 g, 11.98 mmol) was added in one portion to a stirred 
solution of piperidine 145 (2.05 g) in THF (60 mL) cooled to 0 °C. The 
solution was allowed to warm to room temperature and stirred for a further 5 h before the 
solvent was removed in vacuo. The resulting residue was diluted with water and the aqueous 
phase was extracted with EtOAc (4 x 40 mL) and the combined organic phases were washed 
with brine (50 mL), dried over MgSO4 and concentrated in vacuo to afford the crude product, 
which was purified by flash column chromatography (Rf = 0.25, hexane:EtOAc, 1:3) to afford 
piperidine 146 as colourless oil (2.77 g, 86% over 2 synthetic steps). 
NaOH ring opening and BOC protection in situ 
NaOH (12.5 g, 312 mmol) in water (60 mL) was added over 2 min to a solution of piperidine 
96 (10.1 g, 52.0 mmol) in MeOH (120 mL) cooled to 0 °C. The solution was allowed to warm 
Boc
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to room temperature and then heated to 95 °C for 5 h. The solution was allowed to cool to 
room temperature before being cooled to 0 °C. The solution was neutralised to pH 7 with 
concentrated HCl. NaHCO3 (8.74 g, 104 mmol) was added to the stirred solution followed by 
(Boc)2O (13.6 g, 62.4 mmol) and the reaction allowed to warm to room temperature before 
being stirred overnight. The solvent was removed in vacuo and the aqueous phase was 
extracted with EtOAc (4 x  80 mL). The combined organic phases were washed with brine 
(100 mL), dried over MgSO4 and concentrated in vacuo to afford the crude product, which 
was purified by flash column chromatography (Rf = 0.25, hexane:EtOAc, 1:3) to afford 
piperidine 146 as colourless oil (12.7 g, 90%). 
[α]D20:  -78.8 (c 1 in CHCl3) 
max: (film)/cm
-1 3420 (OH), 2974 (CH), 2930 (CH), 1668 (C=O), 1424, 1366, 1170 
H: (300 MHz, CDCl3) 1.40 (9 H, s, C(CH3)3), 1.73-1.82 (5 H, stack, =CCH3 and 
NCHCH2CH), 2.06-2.26 (2H, stack, NCH2CH and OH), 3.32 (1H, dd, J 13.4 and 9.7, 
NCHH), 3.60-3.74 (3H, stack, CH2OH and NCHH), 3.75-3.87 (1H, m, CHOH), 4.04-4.13 
(1H, m, CHN), 4.24 (1H, br s, OH), 4.69 (1H, s, =CHH), 4.96 (1H, s, =CHH) 
C: (75 MHz, CDCl3) 23.2 (=CCH3), 28.4 (C(CH3)3), 33.3 (NCHCH2CH), 44.8 (NCH2), 46.8 
(NCH2CH), 54.9 (NCH), 63.5 (CH2O), 64.8 (CHOH), 80.4 (C(CH3)3) 112.9 (C=CH2), 144.0 
(C=CH2) 155.4 (C=O) 
m/z: (ES)+  294.0 (100%, [M+Na]+), 238.0 (8, [M+Na-tBu]+) 
HRMS: [Found: (M+Na)+ 294.1677. C14H25NNaO4 requires M 294.1681] 
General Procedure 1: TBDPS/TBS Protection of 1° Hydroxyl  
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Et3N (l.2-2.5 eq) followed by DMAP (0.2 eq) were added to a stirred solution of the alcohol 
(1 eq) in CH2Cl2 (0.3-0.5 M). TBDPSCl/TBSCl (1-1.5 eq) was added dropwise over 1 min to 
the solution and stirred for a further 2 h before the reaction was quenched by the addition of 
water (10 mL). The organic layer was separated and the aqueous layer was further extracted 
with 3 x CH2Cl2. The combined organic layers were washed with brine and dried over MgSO4 
before the solvent was removed in vacuo to give the crude silyl ether product.   
 
(2S, 4R, 5S)-tert-Butyl 2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-hydroxy-5(prop-1-en-2-
yl)piperidine-1-carboxylate (147a) 
 
Silyl ether 147a was prepared from: alcohol 146 (140 mg, 0.52 
mmol), Et3N (86 µL, 0.62 mmol), DMAP (13 mg, 0.10 mmol), 
TBDPSCl (161 µL, 0.62 mmol); in CH2Cl2 (2 mL) according to 
general procedure 1. Purification by flash column chromatography (Rf  = 0.34, hexane:EtOAc, 
5:1) gave the product as a colourless oil (202 mg, 77%). 
[α]D19:  -45.6 (c 1 in CHCl3) 
max: (film)/cm
-1 3454 (OH), 3072 (=CH), 2961 (CH), 2932 (CH), 2858 (CH), 2363 (ArCH), 
1676 (C=O), 1590 (Ar C=C), 1428 (CH2-C=C), 1113 (C-O) 
H: (500 MHz, CDCl3) 1.06 (9H, s, SiC(CH3)3), 1.40 (9H, s, OC(CH3)3), 1.75 (1H,  br s, OH), 
1.83 (3H, s, =CCH3), 1.86-2.08 (2H, m, CHCH2CH), 2.46 (1H, q, J 4.4, NCH2CH), 3.23 (1H, 
dd, J 14.0 and 4.4, NCHH), 3.66-3.82 (2H, m, CH2O), 4.00 (1H, dd, J 14.0 and 4.4, NCHH), 
4.04-4.10 (1H, m, CHOH), 4.27-4.38 (1H, m, NCH), 4.93 (1H, s, =CHH), 5.04 (1H, s, 
=CHH), 7.31-7.47 (6H, m, ArCH), 7.67 (4H, dd, J 1.7 and 7.4, ArCH) 
Boc
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C: (125 MHz, CDCl3) 19.3 (SiC(CH3)3), 24.1 (=CCH3), 27.0 (SiC(CH3)3), 28.5 (OC(CH3)3), 
30.8 (NCHCH2CH), 42.7 (NCH2), 46.0 (NCH2CH), 52.1 (NCH), 64.1 (CH2O), 65.5 (CHOH), 
79.8 (OC(CH3)3) 114.7 (C=CH2), 127.8 (ArCH), 129.82 (ArCH), 133.4 (ArCq), 133.5 (ArCq), 
143.8 (C=CH2) 155.0 (C=O) 
m/z: (ES)+ 532.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 532.2867. C30H43NNaO4 Si requires M 532.2859] 
 
(2S, 4R, 5S)-tert-Butyl 2-(((tert-butyldimethylsilyl)oxy)methyl)-4-hydroxy-5-(prop-1-en-
2-yl)piperidine-1-carboxylate (147b) 
 
Silyl ether 147b was prepared from: alcohol 146 (130 mg, 0.48 mmol), 
Et3N (80 µL, 0.58 mmol), DMAP (12 mg, 0.10 mmol) and TBSCl (87 
mg, 0.58 mmol); in CH2Cl2 (2 mL) according to general procedure 1. 
Purification by flash column chromatography (Rf  = 0.36, hexane:EtOAc, 5:1) gave the 
product as a colourless oil (150 mg, 81%). 
max: (film)/cm
-1 2955 (CH), 2930 (CH), 2858 (CH), 1678 (C=O), 1419 (CH2-C=C), 1366, 
1253, 1120, 838 
H: (300 MHz, CDCl3) 0.03 (6H, s, Si(CH3)2), 0.87 (9H, s, SiC(CH3)3), 1.41 (9H H, s, 
OC(CH3)3), 1.65 (1H,  br s, OH), 1.83 (3H, s, =CCH3), 1.86-2.01 (2H, m, CH2CHOH), 2.49 
(1H, q, J 4.4, NCH2CH), 3.28 (1H, dd, J 14.0 and 4.4, NCHH), 3.62-3.80 (2 H, m, CH2O), 
3.95 (1H, dd, J 14.0 and 4.4, NCHH), 4.07-4.22 (2H, stack, CHOH and NCH), 4.90 (1H, s, 
=CHH), 5.02 (1H, s, =CHH) 
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C: (125 MHz, CDCl3) -5.4 (Si(CH3)2), 18.2 (SiC(CH3)3), 24.0 (=CCH3), 25.9 (SiC(CH3)3), 
28.4 (OC(CH3)3), 30.8 (CH2CHOH), 42.9 (NCH2), 45.8 (NCH2CH), 52.1 (NCH), 63.5 
(CH2O), 65.4 (CHOH), 79.6 (OC(CH3)3) 114.5 (C=CH2), 143.8 (C=CH2) 154.9 (C=O) 
m/z: (ES)+ 408.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 408.2549. C20H39NNaO4 Si requires M 408.2546] 
 
General procedure 2: Acylation of 2° hydroxyl 
 
An acyl chloride (1 eq) was added dropwise over 10 s to a solution of an alcohol (1 eq) in 
pyridine (0.2 M) cooled to 0 °C. The solution was allowed to warm to room temperature and 
stirred for a further 2 h before being quenched with a saturated aqueous solution of NaHCO3. 
The solution was extracted with 4 x CH2Cl2 before the combined organic fractions were 
washed with a solution of 0.1 M HCl, water, brine and dried over MgSO4. 
 
(2S, 4R, 5S)-tert-Butyl 4-acetoxy-2-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(prop-1-en-2-
yl)piperidine-1-carboxylate (150a) 
 
Acetyl ester 150a was prepared from: alcohol 147a (90 mg, 0.18 
mmol), and acetyl chloride (13 µL, 0.18 mmol); in pyridine (1 mL) 
according to general procedure 2. Purification by flash column 
chromatography (Rf  = 0.34, hexane:EtOAc, 6:1) gave the product as a white crystalline solid 
(98 mg, quant). 
[α]D20: -4.4 (c 1 in CHCl3) 
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mp: 73-75 °C (from hexane:EtOAc)  
µ: (Found: C, 69.66; H, 8.32; N, 2.83 C32H45NO5Si requires C, 69.65; H, 8.22; N, 2.54%) 
max: (film)/cm
-1 3075 (=CH), 2972 (CH), 2932 (CH), 2862 (CH), 1737 (C=O), 1695, (C=O), 
1423 (CH2-C=C), 1113 (C-O), 1040, 700 
H: (300 MHz, CDCl3) 1.01 (9H, s, SiC(CH3)3), 1.38 (9H, s, OC(CH3)3), 1.75 (3H, s, =CCH3), 
1.83-1.91 (1H, dt, J 14.0 and 2.9, CHHCHO), 2.01 (3H, s, OC(O)CH3) 2.02-2.13 (1H, m, 
CHHCHO), 2.56 (1H, q, J 4.0, NCH2CH), 3.37 (1H, dd, J 14.0 and 4.0, NCHH), 3.61-3.75 
(2H, m, CH2O), 4.02 (1H, dd, J 14.0 and 4.0, NCHH), 4.36-4.45 (1H, m, NCH), 4.82 (1H, s, 
=CHH), 4.90 (1H, s, =CHH), 5.15-5.24 (1H, m, CHO), 7.30-7.46 (6H, m, ArCH), 7.48-7.52 
(4H, m, ArCH) 
C: (75 MHz, CDCl3) 19.8 (SiC(CH3)3), 21.5 (=CCH3), 24.5 (OC(O)CH3) 27.3 (SiC(CH3)3), 
27.9 (NCHCH2CH), 39.8 (OC(CH3)3), 43.4 (NCH2CH), 43.7 (NCH2), 52.0 (NCH), 64.7 
(CH2O), 70.4 (CHO), 80.1 (OC(CH3)3) 112.3 (C=CH2), 128.4 (ArCH), 129.5 (ArCH), 133.0 
(ArCq), 135.1 (ArCH), 142.2 (C=CH2), 155.0 (NC=O), 169.9 (CH3C=O) 
m/z: (ES)+ 574.2 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 574.2971. C32H45NNaO5 Si requires M 547.2965] 
 
(2S, 4R, 5S)-tert-Butyl 4-(benzoyloxy)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(prop-1-
en-2-yl)piperidine-1-carboxylate (150b) 
 
Benzoyl ester 150b was prepared from: alcohol 147a (84 mg, 0.17 
mmol), and benzoyl chloride (19 µL, 0.17 mmol); in pyridine (1 
mL) according to general procedure 2. Purification by flash column 
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chromatography (Rf  = 0.33, hexane:EtOAc, 9:1) gave the product as a colourless oil (101 mg, 
quant). 
max: (film)/cm
-1 3072 (=CH), 2961 (CH), 2932 (CH), 2858 (CH), 2363 (ArCH), 1678 (C=O), 
1590 (Ar C=C), 1428 (CH2-C=C), 1113 (C-O) 
H: (300 MHz, CDCl3) 1.08 (9H, s, SiC(CH3)3), 1.41 (9H H, s, OC(CH3)3), 1.80 (3H, s, 
=CCH3), 2.02-2.10 (1H, m, CHCHHCH), 2.20-2.33 (1H, m, CHCHHCH), 2.72 (1H, q, J 4.0, 
NCH2CH), 3.35 (1H, dd, J 14.0 and 4.0, NCHH), 3.60-3.88 (2H, m, CH2O), 4.13 (1H, dd, J 
14.0 and 4.0, NCHH), 4.31-4.42 (1H, m, NCH), 4.93 (1H, s, =CHH), 4.97 (1H, s, =CHH), 
5.48-5.59 (1H, m, CHO), 7.31-7.47 (8H, m, ArCH), 7.49-7.53 (3H, m, ArCH), 7.62-7.70 (4H, 
m, ArCH) 
C: (75 MHz, CDCl3) 21.8 (SiC(CH3)3), 26.7 (=CCH3), 29.5 (SiC(CH3)3), 30.3 
(NCHCH2CH), 31.0 (OC(CH3)3), 45.7 (NCH2), 46.1 (NCH2CH), 54.6 (NCH), 66.7 (CH2O), 
72.5 (CHO), 82.4 (OC(CH3)3) 116.5 (C=CH2), 130.4 (ArCH), 131.0 (ArCH), 131.6 (ArCH), 
132.3 (ArCH), 133.0 (ArCq), 133.3 (ArCH), 135.9 (ArCq), 138.2 (ArCH), 145.7 (C=CH2), 
155.0 (C=O), 167.0 (C=O) 
m/z: (ES)+ 636.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 636.3138. C37H47NNaO5 Si requires M 636.3121] 
 
(2S, 4R, 5S)-tert-Butyl 4-acetoxy-2-(((tert-butyldimethylsilyl)oxy)methyl)-5-(prop-1-en-2-
yl)piperidine-1-carboxylate (150c) 
 
Acetyl ester 150c was prepared from: alcohol 147b (115 mg, 0.30 
mmol), and acetyl chloride (17 µL, 0.30 mmol); in pyridine (1.5 mL) 
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according to general procedure 2. Purification by flash column chromatography (Rf  = 0.49, 
hexane:EtOAc, 6:1) gave the product as a colourless oil (106 mg, 83%). 
[α]D20: -18.8 (c 1 in CHCl3) 
max: (neat)/cm
-1 2955 (CH), 2930 (CH), 2897 (CH), 2857 (CH), 1741 (C=), 1697, (C=O), 
1417, 1367, 1242, 1045, 837, 777 
H: (300 MHz, CDCl3) 0.03 (6H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.45 (9H, s, OC(CH3)3), 
1.73 (3H, s, =CCH3), 1.85 (1H, dt, J 13.5 and 4.5, CHHCHO), 2.00-2.12 (4H, stack, 
CHHCHO and C(O)CH3) 2.54-2.63 (1H, m, NCH2CH), 3.26 (1H, dd, J 14.0 and 4.2, NCHH), 
3.62 (1H, dd, J 10.5 and 4.8, CHHO), 3.80 (1H, dd, J 10.5 and 6.8, CHHO),  4.03 (1H, dd, J 
14.0 and 4.2, NCHH), 4.13-4.24 (1H, m, NCH), 4.81 (1H, s, =CHH), 4.90 (1H, s, =CHH), 
5.25-5.34 (1H, m, CHO) 
C: (75 MHz, CDCl3) -5.4 (Si(CH3)2), 18.1 (SiC(CH3)3), 21.2 (=CCH3), 24.0 (C(O)CH3), 26.1 
(SiC(CH3)3), 28.5 (CH2CHO), 29.3 (OC(CH3)3), 43.2 (NCH2CH), 43.8 (NCH2), 51.4 (NCH), 
63.2 (CH2O), 69.1 (CHO), 79.0 (OC(CH3)3) 113.7 (C=CH2), 142.5 (C=CH2), 153.3 (NC=O), 
169.7 (C=O) 
m/z: (ES)+ 450.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 450.2657. C22H41NNaO5 Si requires M 450.2652] 
 
(2S, 4R, 5S)-tert-Butyl 4-(benzoyloxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-5-(prop-1-
en-2-yl)piperidine-1-carboxylate (150d) 
 
Benzoyl ester 150d was prepared from: alcohol 147b (439 mg, 1.14 
mmol), and benzoyl chloride (103 µL, 1.14 mmol); in pyridine (7 mL) 
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according to general procedure 2. Purification by flash column chromatography (Rf  = 0.54, 
hexane:EtOAc, 6:1) gave the product as a white crystalline solid (482 mg, 86%). 
[α]D20: -25.2 (c 1 in CHCl3) 
mp: 70-71 °C (from hexane:EtOAc) 
max: (neat)/cm
-1 2955 (CH), 2930 (CH), 2857 (CH), 1720 (C=O), 1694 (C=O), 1273, 1112, 
838 
H: (400 MHz, CDCl3) 0.03 (3H, s, SiCH3) 0.04 (3H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.44 
(9H, s, OC(CH3)3), 1.76 (3H, s, =CCH3), 2.01 (1H, dt, J 13.5 and 4.2, CHHCHO), 2.19 (1H, 
ddd, J 13.5, 9.8 and 6.6, CHHCHO) 2.71 (1H, q, J 4.2, NCH2CH), 3.38 (1H, dd, J 14.0 and 
4.2, NCHH), 3.68 (1H, dd, J 10.1 and 4.8, CHHO), 3.80 (1H, dd, J 10.1 and 6.7, CHHO),  
4.12 (1H, dd, J 14.0 and 4.2, NCHH), 4.19-4.27 (1H, m, NCH), 4.90 (1H, s, =CHH), 4.94 
(1H, s, =CHH), 5.58 (1H, dt, J 9.8 and 4.2 , CHO), 7.36 (2H, t, J 7.4, ArCH), 7.48 (1H, t, J 
7.4, ArCH), 8.01 (2H, d, J 7.4, ArCH) 
C: (75 MHz, CDCl3) -5.6 (Si(CH3)2), 18.0 (SiC(CH3)3), 24.0 (SiC(CH3)3), 25.7 (=CCH3), 
27.3 (CH2CHO), 28.2 (OC(CH3)3), 43.1 (NCH2), 43.2 (NCH2CH), 51.8 (NCH), 63.4 (CH2O), 
69.7 (CHOH), 79.5 (OC(CH3)3) 113.6 (C=CH2), 128.1 (ArCH), 129.4 (ArCH), 130.3 (ArCq), 
132.7 (ArCH), 143.0 (C=CH2), 154.6 (NC=O), 166.4 (C=O) 
m/z: (ES)+ 512.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 512.2828. C27H43NNaO5 Si requires M 512.2808] 
General Procedure 3: Ozonolysis of an alkene 
 
Ozone was bubbled through a solution of an alkene (1 eq) in CH2Cl2:MeOH (2:1,  0.1 M) at -
78 °C and out into an aqueous KI scrubber. After the solution changed in colour from 
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colourless to clear blue, usually 10 min, O2 was bubbled through the solution followed by 
argon each for 5 min, to remove excess ozone, changing the colour of from clear blue to 
colourless. DMS (1.2 eq) was added and the solution was allowed to warm to room 
temperature before the solvent was removed in vacuo to obtain the crude product. 
 
(2S, 4R, 5S)-tert-Butyl 4-acetoxy-5-acetyl-2-(((tert-butyldiphenylsilyl)oxy)methyl) 
piperidine-1-carboxylate (151a) 
 
Ozone was bubbled through a solution of alkene 150a (50 mg, 0.09 
mmol) in CH2Cl2:MeOH (1:1, 1 mL) and quenched with DMS (7 
µL, 0.10 mmol) according to general procedure3. Purification by 
flash column chromatography (Rf = 0.30, hexane:EtOAc, 2:1) gave ketone 151a as a 
colourless oil (21 mg, 42%). 
[α]D20: +7.2 (c 1 in CHCl3) 
max: (neat)/cm
-1 3186 (ArCH), 3135 (ArCH), 2995 (CH), 2961 (CH), 2931 (CH), 2858 (CH), 
1736 (C=O), 1719 (C=O), 1690 (C=O), 1426, 1366, 1237, 1046, 823, 702 
H: (300 MHz, CDCl3) 1.02 (9H, s, SiC(CH3)3), 1.43 (9H, s, OC(CH3)3), 1.82-1.91 (1H, m, 
CHHCHO), 2.01 (3H, s, OC(O)CH3), 2.15 (3H, s, CC(O)CH3) 2.26-2.39 (1H, m, CHHCHO), 
3.03 (1H, q, J 4.2, NCH2CH), 3.36 (1H, dd, J 4.2 and 14.0, NCHH), 3.63-3.72 (2H, m, 
CH2O), 4.24-4.35 (1H, m, NCHH), 4.39-4.48 (1H, m, NCH), 5.12-5.23 (1H, m, CHO), 7.32-
7.44 (6H, m, ArCH), 7.59-7.61 (4H, m, ArCH) 
C: (75 MHz, CDCl3) 18.1 (SiC(CH3)3), 20.6 (OC(O)CH3), 26.2 (SiC(CH3)3), 26.4 
(CH2CHO), 27.7 (OC(CH3)3), 30.2 (CC(O)CH3), 39.2 (NCH2), 48.0 (NCH2CH), 51.3 (NCH), 
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63.3 (CH2O), 68.3 (CHO), 80.0 (OC(CH3)3), 127.2 (ArCH), 129.4 (ArCH), 132.2 (ArCq), 
135.0 (ArCH), 153.2 (NC=OO), 169.5 (OC=OCH3), 205.4 (CC=OCH3) 
m/z: (ES)+ 576.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 576.2764. C31H43NNaO6Si requires M 576.2757] 
 
(S)-tert-Butyl-3-acetyl-6-(((tert-butyldiphenylsilyl)oxy)methyl)-5,6-dihydropyridine-
1(2H) –carboxylate (152b) and (2S, 4R, 5S)-tert-Butyl 5-acetyl-4-(benzoyloxy)-2-(((tert-
butyldiphenyl silyl)oxy)methyl)piperidine-1-carboxylate (152a) 
 
Ozone was bubbled through a 
solution of alkene 150b (101 mg, 
0.17 mmol) in CH2Cl2:MeOH (2:1, 
3 mL) and quenched with DMS 
(15 µL, 0.20 mmol) according to general procedure 3. Purification by flash column 
chromatography (Rf = 0.47, hexane:EtOAc, 3:1) gave enone 152b as a colourless oil (50 mg, 
61%). 
max: (film)/cm
-1 2961 (CH), 2929 (CH), 2857 (CH), 1697 (C=O), 1680 (C=O), 1106, 701 
H: (300 MHz, CDCl3) 1.07 (9H, s, SiC(CH3)3), 1.44 (9H, s, OC(CH3)3), 2.23 (3H, s, 
(C(O)CH3), 2.26-2.34 (1H, m, CHCHHCH), 2.42-2.58 (1H, m, CHCHHCH), 3.41-3.62 (4H, 
stack, NCH2 and CH2O), 4.32-4.52 (1H, m, NCH), 6.72-6.79 (1H, m, =CH), 7.31-7.47 (6H, 
m, ArCH), 7.56-7.64 (4H, m, ArCH) 
m/z: (ES)+ 516.3(100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 516.2550. C29H39NNaO4 Si requires M 516.2546] 
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Further elution (Rf = 0.32) gave ketone 151b as a colourless oil (10 mg, 10%). 
max: (film)/cm
-1 3072 (ArCH), 3012 (ArCH), 2960 (CH), 2932 (CH), 2858 (CH), 1720 
(C=O), 1694 (C=O), 1603, 1584, 1427, 1272, 1112, 756, 709 
H: (300 MHz, CDCl3) 1.07 (9H, s, SiC(CH3)3), 1.44 (9H, s, OC(CH3)3), 1.94-2.02 (1H, m, 
CHCHHCH), 2.19 (3H, s, C(O)CH3), 2.42-2.55 (1H, m, CHCHHCH), 3.11-3.24 (2H, stack, 
NCHH and NCH2CH), 3.64-3.82 (2H, m, CH2O), 4.31-4.50 (2H, stack, NCH and NCHH), 
5.48-5.52 (1H, m, CHO), 7.31-7.47 (8H, m, ArCH), 7.49-7.53 (3H, m, ArCH), 7.62-7.70 (4H, 
m, ArCH) 
m/z: (ES)+ 638.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 638.2904. C36H45NNaO6 Si requires M 638.2914] 
 
(2S, 4R, 5S)-tert-Butyl 4-acetoxy-5-acetyl-2-(((tert-butyldimethylsilyl)oxy)methyl) 
piperidine-1-carboxylate (151ci) and (2S, 4R, 5S)-tert-Butyl 4-acetoxy-5-acetyl-2-
(hydroxymethyl)piperidine-1-carboxylate (151cii) 
 
Ozone was bubbled through a solution of 
alkene 150c (106 mg, 0.25 mmol) in 
CH2Cl2:MeOH (2:1, 3 mL) and quenched 
with DMS (23 µL, 0.30 mmol) according to general procedure 3. Purification by flash column 
chromatography (Rf = 0.30, hexane:EtOAc, 3:1) gave ketone 151ci as a colourless oil (6 mg, 
5%). 
[α]D21: -21.6 (c 0.5 in CHCl3) 
max: (neat)/cm
-1 2955 (CH), 2930 (CH), 2857 (CH), 1739, (C=O), 1720 (C=O), 1694 (C=O), 
1472, 1419, 1248, 1047, 838, 777 
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H: (300 MHz, CDCl3) 0.04 (6H, s, SiCH3), 0.85 (9H, s, SiC(CH3)3), 1.43 (9H, s, OC(CH3)3), 
1.82-1.91 (1H, m, CHHCHO), 2.02 (3H, s, OC(O)CH3), 2.16 (3H, s, CC(O)CH3), 2.25-2.69 
(1H, m, CHHCHO), 3.06 (1H, q, J 4.2, NCH2CH), 3.26 (1H, dd, J 14.0 and 4.2, NCHH), 3.63 
(1H, dd, J 10.5 and  4.5, CHHO), 3.69 (1H, dd, J 10.5 and 6.3, CHHO), 4.23-4.36  (2H, stack, 
NCHH and NCH), 5.27-5.33 (1H, m, CHO) 
C: (75 MHz, CDCl3) -4.6 (Si(CH3)2), 19.1 (SiC(CH3)3), 22.1 (OC(O)CH3), 26.8 (SiC(CH3)3), 
28.0 (CH2CHO), 29.3 (OC(CH3)3), 31.5 (CC(O)CH3), 41.5 (NCH2), 49.7 (NCH2CH), 52.7 
(NCH), 65.0 (CH2O), 69.9 (CHO), 81.0 (OC(CH3)3) 155.6 (NC=O), 171.4 (OC=OCH3), 
206.5 (CC=OCH3) 
m/z: (ES)+ 452.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 452.2436. C21H39NNaO6Si requires M 452.2444] 
 
Further elution (Rf = 0.36, hexane:EtOAc, 1:3) gave ketone 151cii as a colourless oil (57 mg, 
73%). 
max: (neat)/cm
-1 3384 (OH), 2954 (CH), 2932 (CH), 2858 (CH), 1722 (C=O), 1693 (C=O), 
1472, 1248, 1046 
H: (300 MHz, CDCl3) 1.44 (9H, s, OC(CH3)3), 1.81-1.90 (1H, m, CHHCHO), 2.01 (3H, s, 
OC(O)CH3), 2.10-2.18 (4H, stack, CC(O)CH3 and CHHCHO), 2.75-2.82 (1H, m, NCH2CH), 
3.34-3.45 (1H, m, NCHH), 3.63-3.70 (2H, m, CH2O), 3.82-3.89 (1H, m, NCHH), 3.94-4.02 
(1H, m, NCH), 5.28-5.31 (1H, m, CHO) 
m/z: (ES)+ 338.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 338.1585. C15H25NNaO6 requires M 338.1580] 
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(S)-tert-Butyl 3-acetyl-6-(hydroxymethyl)-5,6-dihydropyridine-1(2H)-carboxylate (152d) 
 
Ozonolysis  
Ozone was bubbled through a solution of alkene 150d (96 mg, 0.20 
mmol) in CH2Cl2:MeOH (1:1, 2 mL) and quenched with DMS (17 µL, 
0.23 mmol) according to general procedure 3. Purification by flash column chromatography 
(Rf = 0.45, hexane:EtOAc, 1:3) gave enone 152d as a colourless oil (15 mg, 29%). 
 
Haloform Reaction  
Bromine (27 µL, 0.53 mmol) was added to a solution of NaOH (63 mg, 1.58 mmol) in water 
(1 mL) cooled to 0 °C, after 5 min the dark brown colour of the solution dissipated and the 
solution was transferred to a solution of ketone 149 (48 mg, 0.18 mmol) in dioxane (0.5 mL) 
cooled to 0 °C. The solution was allowed to warm to rt and stirred overnight. The solution 
was acidified to a pH of 4 with an aqueous solution 1 M HCl. The reaction was concentrated 
in vacuo before the crude residue was taken up in acetone, filtered and concentrated in vacuo 
to give the crude product that was purified by semi-preparative HPLC (water/MeOH gradient 
+ 0.01% TFA) to give the product 152d as a colourless oil (22 mg, 53%). 
max: (film)/cm
-1 3389 (OH), 2978 (CH), 2930 (CH), 2857 (CH), 1671 (C=O), 1366, 1161 
H: (300 MHz, CDCl3) 1.45 (9H, s, OC(CH3)3), 2.22-2.29 (4H, stack, C(O)CH3 and 
NCHCHHCH), 2.45-2.51 (1H, m, NCHCHHCH), 2.65 (1H, br s, OH), 3.41-3.50 (2H, m, 
CH2O), 3.68 (1H, d, J 13.9, NCHH), 4.33-4.52 (2H, stack, NCHH and NCH), 6.83-6.89 (1H, 
m, CH=) 
m/z: (ES)+ 278.1(100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 278.1359. C13H21NNaO4  requires M 278.1368] 
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(2S, 4R, 5S)-tert-Butyl 4-acetoxy-5-acetyl-2-(((tert-butyldiphenylsilyl)oxy)methyl) 
piperidine-1-carboxylate (151a) and (2S, 4R, 5R)-tert-Butyl 4-acetoxy-2-(((tert-butyl 
diphenylsilyl)oxy)methyl)-5-((R)-1,2-dihydroxyethyl)piperidine-1-carboxylate (153) 
 
NaIO4 (135 mg, 0.63 mmol) 
was added to a stirred solution 
of alkene 150a (166 mg, 0.30 
mmol) and 2,6-lutidine (66 µL, 0.60 mmol) in dioxane:water (2:1, 3 mL) cooled to 0 °C. A 
small crystal of OsO4 was added to the solution and the resulting mixture was stirred at 0 °C 
for 2h before the reaction was quenched by the addition of a saturated aqueous solution of 
Na2SO3 (3 mL). The reaction mixture was diluted with EtOAc (5 mL) and the organic phase 
was separated. The aqueous phase was extracted with EtOAc (3 x 5 mL) and the combined 
organic fractions were washed with brine (10 mL) and dried over MgSO4 before the solvent 
was removed in vacuo to give the crude product which was purified by flash column 
chromatography (Rf = 0.33, hexane:EtOAc, 3:1) to give ketone 151a as a colourless oil (107 
mg, 65%). Data vide supra. 
Further elution (Rf  = 0.10) gave diol 153 as a white crystalline solid  (34 mg, 19%). 
mp: 87-88 °C (from hexane:EtOAc) 
max: (neat)/cm
-1 3470 (OH), 2930 (CH), 2858 (CH), 1734 (C=O), 1677 (C=O), 1427, 1244, 
1113, 756 
H: (300 MHz, CDCl3) 1.03 (9H, s, SiC(CH3)3), 1.15 (1H, br s, OH), 1.21 (1H, br s, OH), 1.37 
(9H, s, OC(CH3)3), 1.39 (3H, s, CCH3), 1.72-1.87 (1H, m, CHHCHO), 2.03-2.12 (4H, stack, 
CCH3 and CHHCHO), 2.14-2.27 (1H, m, NCH2CH), 3.35-3.41 (2H, m, NCH2), 3.62-3.83 
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(2H, m, CH2O), 3.89-4.07 (1H, m, NCH), 5.31-4.41 (1H, m, CHO), 7.32-7.43 (6H, m, ArCH), 
7.51-7.62 (4H, m, ArCH) 
C: (75 MHz, CDCl3) 18.0 (SiC(CH3)3), 19.7 (COHCH3), 21.5 (NCH2CH), 22.0 (OC(O)CH3), 
25.2 (SiC(CH3)3), 27.6 (OC(CH3)3), 28.3 (CH2CHO), 30.2 (CC(O)CH3), 37.7 (NCH2), 49.9 
(NCH2CH), 51.3 (NCH), 63.2 (CH2OH), 66.1 (CH2OSi), 67.8 (CHO), 71.2 (CqOH) 78.6 
(OC(CH3)3), 126.1 (ArCH), 128.1 (ArCH), 131.2 (ArCq), 133.8 (ArCH), 153.0 (NC=OO), 
166.7 (OC=OCH3) 
m/z: (ES)+ 608.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 608.3018. C32H47NNaO7Si requires M 608.3020] 
X-ray: See Appendix  
 
(2S, 4R, 5S)-5-Acetyl-4-hydroxy-2-(hydroxymethyl)piperidine-1-carboxylic acid tert-
butyl ester (149) 
 
2,6-Lutidine (10.2 mL, 93.4 mmol) was added to a solution of alkene 
146 (11.5 g, 42.4 mmol) in dioxane:water (2:1, 210 mL) cooled to 0 °C. 
NaIO4 (22.7 g, 106 mmol) followed by OsO4 (10 mg, 0.1 mol%) were 
added to the stirred solution. After 5 min a white precipitate began to fall out of solution. The 
reaction was stirred at 0 °C for 30 min before being allowed to warm to room temperature and 
stirred for a further 5 h. The reaction was cooled to 0 °C and quenched with a saturated 
aqueous solution of Na2SO3 (100 mL). The aqueous phase was extracted with EtOAc (5 x 200 
mL) before the combined organic phases were washed with brine (200 mL), dried over 
MgSO4 and concentrated in vacuo to afford the product 149 as a colourless oil (11.2 g, 97%). 
Rf :  0.24 (EtOAc) 
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[α]D20:  -104.2 (c 1 in CHCl3) 
max: (film)/cm
-1 3391 (OH), 2976 (CH), 2932 (CH), 1693 (C=O), 1662 (C=O), 1159, (C-O), 
1051 (C-O) 
H: (400 MHz, CDCl3) 1.40 (9H, s, C(CH3)3), 1.76 (1H, dt, J 13.5 and 4.3, NCHCHHCH), 
1.80-1.90 (1H, m, NCHCHHCH), 2.13 (3H, s, CHC(O)CH3), 2.66 (1H, q, J 3.4, NCH2CH), 
3.24 (1H, dd, J 14.2 and 3.4, NCHH), 3.55 (2H, d, J 6.4, CH2OH) 3.64-3.82 (2H, m, 2 x OH), 
3.92-4.21 (3H, stack, NCHH, CHOH and CHN) 
C: (100 MHz, CDCl3) 28.2 (C(CH3)3), 29.5 (C(O)CH3), 31.3 (NCHCH2CH), 41.2 (NCH2), 
51.8 (NCH2CH), 53.2 (NCH), 61.8 (CH2O), 66.3 (CHOH), 80.5 (C(CH3)3), 155.1 (OC=O), 
210.9 (CH3C=O) 
m/z: (ES)+  296.2 (100%, [M+Na]+), 240.1 (11, [M+Na-tBu]+) 
HRMS: [Found: (M+Na)+ 296.1469. C13H23NNaO5 requires M 296.1474] 
 
(2S, 4R, 5R)-tert-Butyl 4-hydroxy-5-((E)-1-(hydroxyimino)ethyl)-2-(hydroxy methyl) 
piperidine-1-carboxylate (158) 
 
Et3N (23 µL, 0.17 mmol) was added to a stirred solution of ketone 149 
(15 mg, 0.06 mmol) in EtOH (0.5 mL) followed by the addition of 
hydroxylamine hydrochloride (6 mg, 0.08 mmol). The reaction was 
heated to reflux for 2 h before being allowed to cool to room temperature and quenched by the 
addition of water (5 mL). The solvent was removed in vacuo and the aqueous phase was 
extracted with EtOAc (4 x 5 mL). The combined organic fractions were washed with brine (5 
mL) and dried over MgSO4 before being concentrated in vacuo to give the oxime product 158 
as a colourless oil (16 mg, quant.) 
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Rf : 0.53 (CHCl3:MeOH, 9:1) 
max: (film)/cm
-1 3506 (OH), 3295 (OH), 2976 (CH), 2932 (CH), 1668 (C=O, C=N), 1159, 
1051, 950 (N-O)  
H: (300 MHz, CDCl3) 1.42 (9H, s, C(CH3)3), 1.62-1.70 (1H, m, NCHCHHCH) 1.90-2.04 
(4H, stack, NCHCHHCH and CCH3), 2.39-2.44 (1H, m, NCH2CH), 3.51-3.68 (2H, m, 
NCHH), 3.60-3.71 (2H, m, CH2OH) 3.92-4.01 (1H, m, CHOH), 4.14-4.25 (1H, m, CHN) 
C: (75 MHz, CDCl3) 17.4 (CCH3), 28.5 (C(CH3)3), 31.8 (NCHCH2CH), 40.5 (NCH2CH), 
45.2 (NCH2), 53.9 (NCH), 61.8 (CH2O), 68.3 (CHOH), 80.2 (C(CH3)3), 155.0 (C=O), 159.4 
(C=N-OH) 
m/z: (ES)+  311.2 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 311.1590. C13H24N2NaO5 requires M 311.1583] 
 
O-(Mesitylsulfonyl)hydroxylamine (162) 
 
NaHCO3 (2.2 g, 25.9 mmol) was added in small portions over 5 min to 
a stirred solution of hydroxylamine hydrochloride (1.0 g, 14.3 mmol) in 
CH2Cl2:water (1:1 20 mL) cooled to 0 °C. After 10 min (Boc)2O (2.5 g, 11.5 mmol) was 
added in one portion. The reaction mixture was allowed to warm to room temperature and 
stirred overnight. The reaction was diluted with a saturated aqueous solution of NaHCO3 (25 
mL) and the organic phase separated. The aqueous phases was further extracted with CH2Cl2 
(3 x 25 mL) and dried over MgSO4 before the solvent was removed in vacuo to give N-Boc 
hydroxylamine as a colourless oil that solidified on standing (1.4 g).113 Et3N (1.8 mL, 12.7 
mmol) was added to a solution of N-Boc hydroxylamine (1.4 g, 10.6 mmol) in MeCN (10 
mL) cooled to 0 °C. MesCl (2.3 g, 10.6 mmol) in MeCN (5 mL) was added dropwise over 10 
SO
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min to the solution resulting in a white precipitate. The solution was allowed to warm to room 
temperature and stirred for a further 4 h. The reaction mixture was filtered and washed with 
Et2O (3 x 5 mL). The combined filtrates were concentrated in vacuo to give the crude N-Boc 
mesitylhydroxylamine as a yellow oil (3.6 g). TFA (20 mL) was added to N-Boc 
mesitylhydroxylamine (3.6 g) cooled to 0 °C. The solution was allowed to warm to room 
temperature and stirred for a further 30 min before being poured into ice cold water (20 mL). 
The solution was extracted with Et2O (4 x 20 mL) and the combined organic phases were 
washed with a saturated aqueous solution of NaHCO3 (20 mL) and dried over MgSO4 before 
the solvent was removed in vacuo to give the product 162 as a pale yellow solid. (2.0 g, 64% 
over 3 steps). 
mp: 90-92 °C (from Et2O) (Lit.
114 90-91 °C) 
max: (neat)/cm
-1 3371 (NH), 3262 (NH), 2975 (CH), 2988 (CH), 1603, 1330, 1149 
H: (300 MHz, CDCl3) 2.23 (3H, s, CH3), 2.64 (6H, s, CH3), 4.70 (2H, br s, NH2), 6.93 (2H, 
CH) 
C: (101 MHz, CDCl3) 20.9 (CH3), 23.1 (CH3), 131.7 (ArCH), 138.2 (ArCq), 139.5 (ArCq), 
143.0 (ArCq) 
 
(S)-tert-Butyl 3-acetyl-6-(((tert-butyldiphenylsilyl)oxy)methyl)5,6-dihydropyridine  -
1(2H)-carboxylate (152b) 
 
Haloform Reaction  
Bromine (6 µL, 0.13 mmol) was added to a solution of NaOH (10 
mg, 0.25 mmol) in water (0.5 mL) cooled to 0 °C, after 2 min the 
dark brown colour of the solution dissipated and the solution was then transferred to a 
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solution of ketone 151a (23 mg, 0.04 mmol) in dioxane (0.5 mL) cooled to 0 °C. The solution 
was stirred at 0 °C for 4 h before being quenched with a saturated aqueous solution of NH4Cl 
(5 mL). The mixture was extracted was with EtOAc (4 x 5 mL) and the combined organic 
fractions were washed with a saturated aqueous solution of Na2SO3 (10 mL), water (10 mL) 
and brine (10 mL) before being concentrated in vacuo to give the crude product that was 
purified by flash column chromatography (Rf = 0.46, hexane:EtOAc, 3:1) to give the product 
152b as a colourless oil (10 mg, 52%). 
Silyl Enol Ether Formation 
KHMDS (0.5 M solution in toluene, 108 µL, 0.05 mmol) was added dropwise over 10 s to a 
stirred solution of ketone 151a (30 mg, 0.05 mmol) in CH2Cl2 (0.5 mL) containing 4 Å MS 
cooled to -78 °C. TMSOTf (10 μL, 0.05 mmol) was added immediately afterwards and the 
resulting solution was stirred at -78 °C for a further 1 h before being quenched by the addition 
of water (2 mL). The solvent was removed in vacuo and the aqueous phase was extracted with 
EtOAc (4 x 4 mL). The combined organic fractions were washed with brine (4 mL) before 
being dried over MgSO4 and concentrated in vacuo to give the crude product, which was 
purified by flash column chromatography (Rf  = 0.46, hexane:EtOAc, 3:1) to give the product 
152b  as a colourless oil (20 mg, 83%).   
Oxidative Cleavage of Silyl Enol Ether  
NaIO4 (33 mg, 0.15 mmol) was added to a stirred solution of 2,6-lutidine (13 µL, 0.12 mmol) 
in dioxane:water (1:1, 1 mL) cooled to 0 °C. A small crystal of OsO4 was added to the 
mixture before a solution of silyl enol ether 164 (30 mg, 0.06 mmol) in dioxane (0.5 mL) was 
added dropwise over 2 min. The solution was allowed to warm to rt before being stirred for a 
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further 20 min. The reaction was quenched by the addition of a saturated aqueous solution of 
NaSO3 (5 mL) and diluted with EtOAc (5 mL). The organic phase was separated and the 
aqueous phase further extracted with EtOAc (3 x 5 mL). The combined organic fractions were 
washed with water (5 mL), brine (5 mL) and dried over MgSO4 before being concentrated in 
vacuo to give the crude product. The crude product was purified by flash column 
chromatography  (Rf = 0.45, hexane:EtOAc, 1:3) to give the enone 152b as a colourless oil 
(13 mg, 82%). 
max: (film)/cm
-1 3389 (OH), 2978 (CH), 2930 (CH), 1670 (C=O), 1366, 1161, 1064 
H: (400 MHz, CDCl3) 1.43 (9 H, s, C(CH3)3), 2.25 (3H, s, C(O)CH3), 2.30-2.35 (1H, m, 
NCHCHHCN) 2.51-2.59 (1H, m, NCHCHHCH) 2.67 (1H, br, s, OH), 3.42-3.51 (2H, m, 
CH2OH), 3.62-3.71 (1H, m, NCHH), 4.35-3.53 (2H, stack, NCHH and NCH), 6.84-6.89 (1H, 
m, =CH) 
C: (75 MHz, CDCl3) 25.1 (C(O)CH3), 26.1 (NCHCH2CH), 28.4 (C(CH3)3),  39.2 (NCH2), 
49.8 (NCH), 63.2 (CH2O), 80.5 (C(CH3)3), 136.1 (=Cq), 136.3 (=CH), 155.1 (OC=O), 196.9 
(CH3C=O) 
m/z: (ES)+  278.1 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 278.1479. C13H21NNaO4 requires M 278.1471] 
 
(2S*, 4R*, 5S*)-tert-butyl 5-acetyl-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
hydroxypiperidine-1-carboxylate (148a) 
 
 
Silyl ether 148a was prepared from: piperidine 149 (0.98 g, 3.60 
mmol), Et3N (1.00 mL, 7.19 mmol), DMAP (88 mg, 0.72 mmol) 
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and TBDPSCl (0.94 mL, 3.60 mmol); in a solution of CH2Cl2 (7 mL) according to general 
procedure 1. The crude material was purified by flash column chromatography (Rf  = 0.32, 
hexane:EtOAc, 2:1) to give the product 148a as a colourless oil (1.68 g, 91%). 
max: (film)/cm
-1 3427 (OH), 3078 (ArCH), 3056 (ArCH), 2970 (CH), 2932 (CH), 2859 (CH), 
1690 (C=O), 1671  (C=O), 1426, 1106, 1079, 701 
H: (300 MHz, CDCl3) 1.05 (9H, s, SiC(CH3)3), 1.40 (9H, s, OC(CH3)3), 1.51-1.70 (1H, m, 
NCHCHH), 1.88-2.09 (1H, m, NCHCHH), 2.26 (3H, s, C(O)CH3), 2.68-2.82 (1H, m, 
NCH2CH), 3.08 (1H, dd, J 14.6 and 3.7, NCHH), 3.67 (2H, dd, J 6.4 and 3.0, CH2O), 3.84-
4.01 (1H, m, CHOH), 4.26-4.48 (1H, m, NCH), 4.51-4.71 (1H, m, NCHH), 7.32-7.49 (6H, m, 
ArCH), 7.65 (4H, dd, J 7.4 and 1.7, ArCH) 
C: (101 MHz, CDCl3) 19.1 (SiC(CH3)3), 26.9 (SiC(CH3)3), 28.3 (OC(CH3)3), 29.6 
(C(O)CH3), 31.1 (NCHCH2), 41.1 (NCH2), 51.7 (NCH2CH), 52.3 (NCH), 63.3 (CH2O), 67.3 
(CHOH),80.2 (OC(CH3)3), 127.8 (ArCH), 129.8 (ArCH), 133.1 (ArCq), 135.5 (ArCH), 135.6 
(ArCH), 154.8 OC=O), 212.2 (CH3C=O) 
m/z: (ES)+  534.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 534.2662. C29H41NNaO5Si requires M 534.2652] 
 
General Procedure 4: TMS Ether Formation 
A solution containing the ketone (1 eq) in CH2Cl2 (0.1-0.2 M) was transferred via cannula to a 
r.b. flask containing 4 Å MS and stirred for 5 min at room temperature. Et3N (2-6 eq) was 
added to the mixture and the resulting solution was stirred for a further 5 min before being 
cooled to -78 °C. TMSOTf (2-3 eq) was added dropwise over 5 min and the resulting solution 
was stirred at -78 °C for a further 5 h. The solution was diluted with CH2Cl2 (0.1 M) and then 
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poured into a saturated aqueous solution of NaHCO3. The organic phase was separated and 
the aqueous phase was further extracted with CH2Cl2 x 3. The combined organic fractions 
were washed with brine and dried over MgSO4 before the solvent was removed in vacuo to 
give the crude product. 
 
(2S*, 4R*, 5S*)-tert-butyl 5-acetyl-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-hydroxy 
piperidine-1-carboxylate (163) 
 
Silyl ether 163 was prepared from: alcohol 148a (80 mg, 0.16 
mmol), Et3N (66 µL, 0.46 mmol) and TMSOTf (60 µL, 0.32 mmol); 
in CH2Cl2 (1.6 mL) according to general procedure 4. The crude 
product as a light brown oil which was purified by flash column chromatography 
(hexane:EtOAc, 6:1, Rf = 0.49) to give the pure product 163 as a colourless oil (76mg, 82%).  
max: (film)/cm
-1 3076 (ArCH), 3052 (ArCH), 2959 (CH), 2935 (CH), 2858 (CH), 1713 
(C=O), 1693 (C=O), 1427, 1251, 1161, 1099, 840, 701 
H: (300 MHz, CDCl3) 0.11 (9H, s, Si(CH3)3), 1.05 (9H, s, SiC(CH3)3), 1.41 (9H, s, 
OC(CH3)3), 1.85-1.95 (1H, m, NCHCHH), 2.02-2.15 (1H, m, NCHCHH), 2.17 (3H, s, 
C(O)CH3), 2.76 (1H, q, J 3.7, NCH2CH), 3.08 (1H, dd, J 14.2 and 3.7, NCHH), 3.65 (1H, dd, 
J 10.1 and 5.4, CHHO), 3.73 (1H, dd, J 10.1 and 6.8, CHHO), 4.20 (1H, dd, J 14.2 and 3.7, 
NCHH), 4.26-4.42 (2H, stack, NCH and CHO), 7.32-7.55 (6H, m, ArCH), 7.65 (4H, dd, J 7.5 
and 1.6, ArCH) 
C: (101 MHz, CDCl3) 0.29 (Si(CH3)3), 19.3 (SiC(CH3)3), 27.0 (SiC(CH3)3), 28.5 
(OC(CH3)3), 31.3 (C(O)CH3), 32.0 (NCHCH2), 40.4 (NCH2), 52.0 (CH), 52.1 (CH), 64.5 
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(CH2O), 67.1 (CHO), 79.8 (OC(CH3)3), 127.9 (ArCH), 129.9 (ArCH), 133.3 (ArCq), 133.4 
(ArCq), 135.6 (ArCH), 135.7 (ArCH), 155.0 OC=O), 208.1 (CH3C=O) 
m/z: (ES)+  606.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 606.3054. C32H49NNaO5Si2 requires M 606.3047] 
 
General Procedure 5: Silyl Enol Ether Formation 
A solution containing the  ketone (l eq) in CH2Cl2 (0.1 M) was transferred via cannula to a 
r.b. flask containing 4 Å MS. The solution was stirred for 5 min at room temperature before 
Et3N (5 eq) was added and the resulting mixture was cooled to -40 °C. TMSOTf (2 eq) was 
added dropwise and the resulting solution was stirred at -40 °C for a further 3 h. The solution 
was diluted with CH2Cl2 and then poured into a saturated aqueous solution of NaHCO3. The 
organic phase was separated and the aqueous phase was further extracted with 3 x CH2Cl2. 
The combined organic layers were washed with brine and dried over Na2SO4 before the 
solvent was removed in vacuo to afford the crude silyl enol ether product. The crude product 
was diluted with Et2O and the colourless Et2O layer was removed while the denser light 
brown layer, containing triethylammonium triflate, was further extracted with 3 x Et2O. The 
Et2O layers were combined and the solvent removed in vacuo to give the silyl enol ether 
product.  
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(2S*, 4R*, 5S*)-tert-butyl 2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-((trimethylsilyl) oxy)-
5-(1-((trimethylsilyl)oxy)vinyl)piperidine-1-carboxylate (164) 
 
Silyl enol ether 164 was prepared from: ketone 163 (1.43 g, 2.80 
mmol), Et3N (1.95 mL, 14.0 mmol) and TMSOTf (1.01 mL, 5.60 
mmol); in CH2Cl2 (30 mL) according to general procedure 5 gave 
the product 164 as a colourless oil (1.60 g, 97%). 
Rf : 0.34 (hexane:EtOAc, 10:1 + 1% Et3N) 
max: (film)/cm
-1 3076 (ArCH), 3052 (ArCH), 2959 (CH), 2933 (CH), 2858 (CH), 1693 
(C=O), 1249, 1104, 838, 701 
H: (300 MHz, C6D6) 0.17 (9H, s, Si(CH3)3), 0.26 (9H, s, Si(CH3)3), 1.18 (9H, s, SiC(CH3)3), 
1.42 (9H, s, OC(CH3)3), 1.93 (1H, dt, J 13.1 and 4.0, NCHCHH), 2.29 (1H, dd, J 8.7 and 4.0, 
NCH2CH), 2.34-2.46 (1H, m, NCHCHH), 3.21 (1H, dd, J 14.2 and 4.0, NCHH), 3.82-3.97 
(2H, m, CH2O), 4.22-4.32 (4H, stack NCHH, CHO and =CH2), 4.44-4.72 (1H, m, NCH), 
7.21-7.27 (6H, m, ArCH), 7.76-7.83 (4H, m, ArCH) 
C: (101 MHz, C6D6) 0.34 (Si(CH3)3), 0.44 (Si(CH3)3), 19.5 (SiC(CH3)3), 27.2 (SiC(CH3)3), 
28.6 (OC(CH3)3), 32.0 (NCHCH2), 44.0 (NCH2), 46.9 (NCH2CH), 53.1 (NCH), 65.0 (CH2O), 
67.3 (CHO), 79.0 (OC(CH3)3), 91.8 (C=CH2), 128.2 (ArCH), 130.1 (ArCH), 133.9 (ArCq), 
134.0 (ArCq), 136.0 (ArCH), 155.0 (OC=O), 158.9 (C=CH2) 
m/z: (ES)+  678.4 (97%, [M+Na]+), 466.3 (100) 
HRMS: [Found: (M+Na)+ 678.3445. C35H57NNaO5Si3 requires M 678.3442] 
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General procedure 6: Ozonolysis of Silyl Enol Ether 
 NaHCO3 (10 eq) was added to a stirred solution of silyl enol ether X (1 eq) in CH2Cl2 (0.2 
M). The resulting solution was cooled to -78 °C before MeOH (0.2 M) was added dropwise 
over 5 min. A stream of gas containing O3/O2 was passed through a glass pipette and bubbled 
into the solution before passing out through a gas scrubber containing an aqueous solution of 
10% KI to remove any excess O3. The stream of O3/O2 was continued until the solution turned 
in colour from colourless to blue, usually 5 min. O2 Was then bubbled through the solution for 
2 min before Ar was bubbled through the solution for a further 2 min resulting in a colour 
change of blue to colourless. DMS (10 eq) was added to the solution and stirred at -78 °C for 
5 min before being allowed to warm to room temperature and stirred at room temperature 
until a negative test for peroxides was detected using starch/I2 paper (positive test equates to a 
dark purple spot after exposure to water whereas as negative test equates to a colourless spot 
under the same conditions), usually 2 h. The reaction mixture was cooled to 0 °C and 
acidified to pH 4 with 1 M HCl before the solvent was removed in vacuo and the residue 
taken up in acetone, filtered and the residue washed with 3 x further portions of acetone. The 
solvent was removed in vacuo to give the carboxylic acid. 
 
(3S*, 4R*, 6S*)-1-(tert-butoxycarbonyl)-6-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
hydroxy piperidine-3-carboxylic acid (166) 
 
TBDPS Ozonolysis 
Carboxylic acid 166 was prepared from: Silyl enol ether 164 
(0.53 g, 0.81 mmol), NaHCO3 (0.68g, 8.10 mmol), DMS (0.59 
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mL, 8.10 mmol): in CH2Cl2:MeOH (1:1,  8 mL) according to general procedure 6 to give the 
product 166 as a white foam (430 mg, quant.).   
Rf : 0.54 (hexane:EtOAc, 1:3 + 1% AcOH) 
max: (film)/cm
-1 3396 (OH) 3072 (ArCH), 3051 (ArCH), 2959 (CH), 2929 (CH), 2856 (CH), 
1693 (C=O), 1669 (C=O), 1427, 1110, 701 
H: (400 MHz, CD3OD) 0.97 (9H, s, SiC(CH3)3), 1.36 (9H, s, OC(CH3)3), 1.80 (1H, dd, J 12.9 
and 4.3, NCHCHH), 2.09 (1H, dt, J 12.9 and 6.7, NCHCHH), 2.59-2.67 (1H, m, NCH2CH), 
2.87 (1H, dd, J 14.2 and 3.5, NCHH), 3.60-3.71 (2H, m, CH2O), 3.83-3.98 (1H, m, CHOH), 
4.27 (1H, d, J 14.2, NCHH),  4.46 (1H, dd, J 12.6 and 6.2, NCH), 7.26-7.41 (6H, m, ArCH), 
7.56-7.66 (4H, m, ArCH) 
C: (101 MHz, CD3OD) 20.0 (SiC(CH3)3), 27.4 (SiC(CH3)3), 28.7 (OC(CH3)3), 30.7 
(NCHCH2), 41.6 (NCH2), 46.3 (NCH2CH), 53.5 (NCH), 64.2 (CH2O), 66.3 (CHOH), 81.1 
(OC(CH3)3), 128.9 (ArCH), 131.0 (ArCH), 134.3 (ArCq), 134.4(ArCq), 136.6 (ArCH), 136.7 
(ArCH), 156.7 (NC=O), 175.2 (HOC=O) 
m/z: (ES)- 512.3 (100%, [M-H]-) 
HRMS: [Found: (M-H)- 512.2474. C28H38NNaO6Si requires M 512.2468] 
General Procedure 7: Curtis Rearrangement 
Et3N (2.4 eq) was added to a stirred solution of the carboxylic acid  (1 eq) in toluene (0.1 M) 
at room temperature. The resulting mixture was heated to 80 °C for 2 h before being allowed 
to cool to room temperature. After cooling the reaction was quenched by the addition of a 
saturated solution of NaHCO3. The solution was diluted with EtOAc and the organic phase 
was separated. The aqueous phase was further extracted with 3 x EtOAc and the combined 
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organic phases were washed water and brine before being dried over MgSO4 and concentrated 
in vacuo to give the crude oxazolidinone product. 
 
(3aS*, 6S*, 7aR*)-tert-butyl 6-(((tert-butyldiphenylsilyl)oxy)methyl)-2-oxohexahydro 
oxazolo[4,5-c]pyridine-5(6H)-carboxylate (167) 
 
 
Oxazolidinone 167 was prepared from: carboxylic acid 166 (381 mg, 
0.74 mmol), Et3N (0.25 mL, 1.78 mmol) and DPPA (0.17 mL, 0.74 
mmol); in toluene (7 mL) according to general procedure 7 to give 
the crude product as an orange oil, which was purified by flash 
column chromatography (Rf  = 0.53, hexane:EtOAc, 1:3) to give the product 167 as a white 
crystalline product (256 mg, 83%). 
mp: 174-175 °C (from hexane:EtOAc) 
max: (film)/cm
-1 3293 (NH) 3081 (ArCH), 3063 (ArCH), 2966 (CH), 2931 (CH), 2858 (CH), 
1749 (C=O), 1683 (C=O), 1410, 1108, 700 
H: (400 MHz, CDCl3) 1.05 (9H, s, SiC(CH3)3), 1.35 (9H, s, OC(CH3)3), 2.10-2.28 (2H, m, 
CH2CHO), 3.14 (1H, br d, J 14.2, NCHH), 3.60 (1H, dd, J 10.2 and 1.7 , CHNH), 3.87 (1H, 
dd, J 10.2 and 4.3, CHHO), 4.00 (1H, br d, J 9.2, CHNH), 4.03-4.25 (2H, stack, NCHH and 
CHNCH2), 5.02 (1H,  br d, J 9.1, CHO), 5.36 (1H, br s, NH), 7.32-7.50 (6H, m, ArCH), 7.62 
(4H, t,  J 7.7, ArCH) 
C: (101 MHz, CDCl3) 19.3 (SiC(CH3)3), 26.5 (CH2CHNCH2 ), 27.0 (SiC(CH3)3), 28.7 
(OC(CH3)3), 41.9 (NCH2), 49.6 (CHNCH2), 51.4 (NCH2CH), 65.5 (CH2O), 73.2 (CHO), 80.8 
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(OC(CH3)3), 128.0 (ArCH), 129.9( ArCH),  130.0 (ArCH), 133.1 (ArCq), 133.2 ArCq), 135.5 
(ArCH) 135.6 (ArCH), 156.0 (C=O), 158.6 (C=O) 
m/z: (ES)+ 533.2 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 533.2450. C28H38N2NaO5Si requires M 533.2448] 
X-ray: See Appendix 
 
(2S, 4R, 5S)-5-Acetyl-4-(trimethylsilyloxy)-2-((trimethylsilyloxy)methyl) piperidine-1-
tertbutyl carboxylic acid (168) 
 
Silyl ether 168 was prepared from: alcohol 149 (45 mg, 0.17 mmol), 
Et3N (80 µL, 0.59 mmol) and TMSOTf (108 µL, 0.51 mmol); in 
CH2Cl2 (2 mL) according to general procedure 4. The crude product 
was purified by flash column chromatography (Rf = 0.45, hexane:EtOAc, 6:1 + 1% Et3N) to 
give the product 168 as a colourless oil (52 mg, 75%). 
max: (film)/cm
-1 2958 (CH), 2936 (CH), 1693 (C=O), 1662 (C=O), 1250, (C-O), 1095 (C-O) 
H: (300 MHz, CDCl3) 0.05 (9H, s, Si(CH3)3), 0.08 (9H, s, Si(CH3)3), 1.50 (9H, s, C(CH3)3), 
1.76-1.84 (1H, m, NCHCHHCH), 1.93 (3H, s, CHC(O)CH3), 2.13-2.27 (1H, m, 
NCHCHHCH) 2.41 (1H, q, J 3.4, NCH2CH), 3.09 (1H, dd, J 14.2 and 3.4, NCHH), 3.58 (1H, 
dd, J 10.1 and 4.9, CHHOH), 3.68 (1H, dd, J 10.1 and 4.9, CHHOH), 4.21 (1H, q, J, 4.9, 
CHN), 4.32 (1H, dd, J 14.2 and 3.4, NCHH) 4.39-4.59 (1H, m, CHOH) 
C: (75 MHz, CDCl3) -0.6 (Si(CH3)3), 0.2 (Si(CH3)3), 28.5 (C(CH3)3), 31.4 (NCHCH2CH), 
31.6 (C(O)CH3), 41.2 (NCH2), 52.1 (NCH2CH), 52.3 (NCH), 63.7 (CH2O), 67.6 (CHOH), 
79.4 (C(CH3)3), 155.0 (OC=O), 206.2 (CH3C=O) 
m/z: (ES)+ 440.2 (95%, [M+Na]+), 368.2 (100, [M+Na+H-Si(CH3)3]
+) 
Boc
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HRMS: [Found: (M+Na)+ 440.2267. C19H39NNaO5Si2 requires M 440.2265] 
 
(2S, 4R, 5S)-4-((tert-Butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy) methyl)-5-
(1-((tert-butyldimethylsilyl)oxy)vinyl)piperidine (170) and 1-((3S, 4R, 6S)-4-((tert-butyldi 
methylsilyl)oxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)piperidin-3-yl)ethanone (171) 
 
A solution containing ketone 149 
(117 mg, 0.43 mmol) in CH2Cl2 (4 
mL) was transferred via cannula to 
a r.b. flask containing 4 Å MS and stirred for 5 min at room temperature. 2,6-Lutidine (187 
µL, 1.71 mmol) was added to the mixture and the resulting solution was stirred for a further 5 
min before being cooled to 0 °C. TBSOTf (344 µL, 1.50 mmol) was added dropwise over 3 
min and the resulting solution was stirred at 0 °C for a further 2 h. The solution was diluted 
with CH2Cl2 (4 mL) and then poured into a saturated aqueous solution of NaHCO3 (10 mL). 
The organic phase was separated and the aqueous phase was further extracted with CH2Cl2  (3 
x 10 mL). The combined organic fractions were washed with brine (15 mL) and dried over 
Na2SO4 before the solvent was removed in vacuo to give the crude product as a colourless oil. 
The crude product was purified by flash column chromatography (Rf = 0.46, hexane:EtOAc, 
6:1 + 1% Et3N) to give 170 as a colourless oil (115 mg, 61%).  
max: (film)/cm
-1 3125 (NH), 2985 (CH), 2857 (CH), 1253, 1086, 832, 778 
H: (300 MHz, CDCl3) 0.04 (12H, s, SiCH3), 0.17 (6H, s, SiCH3), 0.87 (18H, s, C(CH3)3), 
0.93 (9H, s, C(CH3)3), 1.31-1.44 (1H, m, NCHCHHCH), 1.54-1.77 (1H, m, NCHCHHCH), 
1.83 (1H br s, NH), 2.06 (1H, q, J 3.8, NCH2CH), 2.91-3.23 (3H, stack, NCH2 and CHNH), 
2.66-3.33 (2H, m, CH2O), 3.99-4.29 (3H, stack, =CH2 and CHO) 
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m/z: (ES)+ 538.4 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 538.3640. C26H57NNaO3Si3 requires M 538.3646] 
Further elution gave 171 (Rf = 0.11) as a colourless oil (33 mg, 23%). 
max: (film)/cm
-1 3124 (NH), 2952 (CH), 2929 (CH) 2857 (CH),  1712 (C=O), 1252, 1085, 
830, 774 
H: (300 MHz, CDCl3) 0.01-0.09 (12H, s, SiCH3), 0.88 (18H, s, C(CH3)3), 1.27 (1H, br s, 
NH), 1.42 (1H, dt, J 13.4 and 4.1, NCHCHH), 1.59-1.47 (1H, m, NCHCHH), 2.21 (3H, s, 
C(O)CH3), 2.35-2.48 (1H, m, NCH2CH), 3.03 (1H, m, CHNH), 3.21 (2H, d, J 3.5, CH2O), 
3.40  (1H, dd, J 9.8 and 7.0, NCHH), 3.50 (1H, dd,  J 9.8 and 4.1, NCHH), 4.37 (1H, dd, J 7.0 
and 4.1, CHO),  
C: (101 MHz, CDCl3) -5.2 (SiCH3), 18.4 (C(CH3)3), 25.8 (C(CH3)3), 26.0 (C(CH3)3), 28.3 
(C(O)CH3), 36.4 (NCHCH2), 42.5 (CH2N), 51.6 (NCH2CH), 55.3(CHN), 66.3 (CH2O), 67.5 
(CHO), 208.3 (C=O), 
m/z: (ES)+  402.2 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 402.2852. C20H44NNaO3Si2 requires M 402.2860 
 
(2S, 4R, 5S)-4-(Trimethylsilyloxy)-2-((trimethylsilyloxy)methyl)-5-(1-(trimethyl 
silyloxy)vinyl) piperidine-1-carboxylic acid tertbutyl ester (172) 
 
A solution containing ketone 149 (8.98 g, 32.9 mmol) in CH2Cl2 
(150 mL) was transferred via cannula to a r.b. flask containing 4 Å 
MS with further portions of CH2Cl2 (3 x 5 mL) to complete the 
transfer. The solution was stirred for 5 min at room temperature before Et3N (36.5 mL, 263 
mmol) was added and the resulting mixture was cooled to -40 °C. TMSOTf (19.0 mL, 105 
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mmol) was added dropwise over 20 min to the stirred solution at -40 °C and the resulting 
solution was stirred for a further 3 h. The solution was diluted with CH2Cl2  (100 mL) and 
then poured into a saturated aqueous solution of NaHCO3 (200 mL). The organic phase was 
separated and the aqueous phase was further extracted with CH2Cl2 (3 x 100 mL). The 
combined organic layers were washed with brine (100 mL) and dried over Na2SO4 before the 
solvent was removed in vacuo to afford the crude product as a light brown oil. The crude 
product was diluted with Et2O (100 mL) and the colourless Et2O layer was removed while the 
denser light brown layer containing triethylammonium triflate was further extracted with Et2O 
(4 x 20 mL). The Et2O layers were combined and the solvent removed in vacuo to give the 
product 173 as a colourless oil (15.6 g, 92%).  
Rf : 0.65 (6:1, hexane:EtOAc + 1% Et3N) 
[α]D20: -13.2 (c 1 in CH2Cl2) 
max: (film)/cm
-1 2958 (CH), 2932 (CH), 2905 (CH), 1693 (C=O), 1249, 1084, 835, 747 
H: (400 MHz, CD2Cl2) 0.10 (9H, s, Si(CH3)3), 0.11 (9H, s, Si(CH3)3),  0.21 (9H, s, Si(CH3)3), 
1.43 (9H, s, OC(CH3)3), 1.70 (1H, dt, J 13.2 and 3.7, NCHCHHC), 2.08 (1H, ddd, J 13.2, 
10.4 and 6.3, NCHCHHC), 2.26 (1H, q, J 4.2, NCH2CH), 3.18 (1H, dd, J 13.7 and 4.2, 
NCHH), 3.60-3.71 (2H, m, CH2O), 4.01 (1H, dd, J 13.7 and 4.2,  NCHH), 4.11 (2H, s, =CH2), 
4.13-4.22 (2H, stack, NCH and CHO) 
C: (101 MHz, CD2Cl2) -0.22 (Si(CH3)3), 0.53 (Si(CH3)3), 28.9 (OC(CH3)3), 31.5 (NCHCH2), 
44.1 (NCH2), 46.9 (NCH2CH), 53.2 (NCH), 63.4 (CH2O), 67.3 (CHO), 79.6 (OC(CH3)3), 
92.0 (C=CH2, 155.5 (OC=O), 158.9 (C=CH2) 
m/z: (ES)+  512.2 (20%, [M+Na]+), 440.2 (100, [M+Na-C3H9Si]
+), 368.2 (60 [M+Na-
C6H18Si2]
+) 
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HRMS: [Found: (M+Na)+ 512.2657. C22H47NNaO5Si3 requires M 512.2660] 
 
(3S, 4R, 6S)-1-(tert-Butoxycarbonyl)-4-hydroxy-6-(hydroxymethyl)piperidine-3-
carboxylic acid (173) 
 
 
NaHCO3 (25.2 g, 299 mmol) was added to a stirred solution of silyl 
enol ether 172 (14.7 g, 30.0 mmol) in CH2Cl2 (75 mL). The resulting 
suspension was cooled to -78 °C before MeOH (75 mL) was added 
dropwise over 20 min. A stream of gas containing O3/O2 was passed through a gas dispersion 
tube and bubbled into the solution before passing out through a gas scrubber containing an 
aqueous solution of 10% KI to remove any excess O3. The stream of O3/O2 was continued for 
10 min, resulting in the solution turning in colour from colourless to blue. O2 was then 
bubbled through the solution for 5 min before Ar was bubbled through the solution for a 
further 5 min resulting in the solution turning in colour from blue to colourless. DMS (22.0 
mL, 300 mmol) was added over 5 min to the stirred solution at -78 °C. The resulting solution 
was stirred at -78 °C for 15 min before being allowed to warm to room temperature and 
stirred at room temperature until a negative test for peroxides was detected using starch/I2 
paper, usually 2 h. The reaction mixture was cooled to 0 °C and acidified to pH 4 with 
concentrated HCl. The solution was concentrated in vacuo to give a white solid that was taken 
up in acetone (50 mL), filtered and washed with further portions of acetone (4 x 20 mL). The 
solvent was removed in vacuo to give the product 173 as white amorphous solid (8.26 g, 
quant.). 
Rf : 0.21 (9:1, CHCl3:MeOH + 1% AcOH) 
[α]D21:  -80.2 (c 1 in MeOH) 
Boc
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mp: 141-143 °C (from CHCl3:MeOH) 
max: (film)/cm
-1 3384 (OH), 2920 (CH), 2851 (CH), 1695 (C=O), 1664 (C=O), 1417, 1161, 
1049 
H: (400 MHz, CD3OD) 1.29 (9H, s, OC(CH3)3), 1.71 (1H, ddd, J 13.2, 4.6 and 1.4, 
NCHCHH), 1.88-2.03 (1H, m, NCHCHH), 2.58-2.62 (1H, m, NCH2CH), 3.01 (1H, dd, J 14.4 
and 3.7, NCHH), 3.44 (1H, dd, J 11.3 and 7.0, CH2O), 3.49 (1H, dd, J 11.3 and 7.4, CH2O), 
3.93 (1H, dt,  J 10.5 and 4.6, CHOH), 4.15-4.26 (2H, stack, NCH and NCHH) 
C: (101 MHz, CD3OD) 28.8 (OC(CH3)3), 30.8 (NCHCH2), 41.8 (NCH2), 46.6 (NCH2CH), 
54.0 (NCH), 62.0 (CH2O), 66.3 (CHOH), 81.4 (OC(CH3)3), 157.2 (NC=O), 175.7 (HOC=O) 
m/z: (ES)– 274.1 (100%, [M-H]–) 
HRMS: [Found: (M-H)- 274.1294. C12H20NNaO6 requires M 274.1291] 
 
 
(3aS, 6S, 7aR)-tert-Butyl 6-(hydroxymethyl)-2-oxohexahydrooxazolo[4,5-c]pyridine-
5(6H)-carboxylate (27) 
 
TBAF Deprotection 
TBAF (1 M soln. in THF, 0.59 mL, 0.59 mmol) was added dropwise over 
30 s to a solution of silyl ether 167 (209 mg, 0.39 mmol) in THF (2 mL). 
The solution was stirred at room temperature for 5 h before the solvent was removed in vacuo. 
The crude material was purified by flash column chromatography (Rf = 0.20, EtOAc) to give 
the product 27 as a white crystalline (111 mg, quant.). 
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Curtius Rearrangement  
Et3N (11.5 mL, 83.1 mmol) was added to a solution of acid 173 (9.15 g, 33.2 mmol) in 
toluene (330 mL) and the resulting mixture was heated to 80 °C. DPPA (7.46 mL, 33.2 mmol) 
was added dropwise over 5 min to the solution and heating was continued for a further 2 h, 
with gas evolution noticed for 30 min. The solution was allowed to cool to room temperature 
and the reaction quenched by the addition of saturated aqueous solution of NaHCO3 (150 
mL). The solution was diluted with EtOAc (300 mL) and the organic phase was separated. 
The aqueous phase was further extracted with EtOAc (3 x 300 mL) and the combined organic 
layers were washed with brine (300 mL) and dried over MgSO4 before the solvent was 
removed in vacuo to afford the crude product as a light brown solid. The crude product was 
purified by flash column chromatography (Rf = 0.20, EtOAc) to give the product 27 as a white 
crystalline solid (6.79 g, 75%).  
[]D
19: -107 (c 1.0 in MeOH) (Lit.24 [α]21D: -111.4 (c 0.92 in MeOH)) 
mp: 147-148 °C (from hexane:EtOAc) 
µ: (Found: C, 52.99; H, 7.47; N, 7.47 C12H20N2O5 requires C, 52.93; H, 7.40; N, 7.40%) 
max: (neat)/cm
-1 3295 (OH, NH), 2978 (CH), 2934 (CH), 2881 (CH), 1733 (C=O), 1666 
(C=O), 1412, 1365, 1246, 1135, 1054 (C-O) 
H: (300 MHz, CDCl3) 1.45 (9H, s, OC(CH3)3), 1.69-2.05 (1H, m, CH2CHO), 2.06-2.35 (1H, 
m, CH2CHO), 2.42 (1H, br s, OH), 2.95-3.08 (1H, m, NCHH), 3.43-3.67 (1H, m, CHHO), 
3.68-3.90 (1H, m, CHHO), 3.96 (1H, br d, J 8.6, CHNH), 4.01-4.29 (2H, stack, NCHH and 
CHNCH2), 4.97 (1H, br d, J 8.5, CHO), 5.73-5.98 (1H, m, NH) 
H: (400 MHz, CD3OD) 1.51 (9H, s, OC(CH3)3), 1.98-2.14 (1H, m, CH2CHO), 2.16-2.33 (1H, 
m, CH2CHO), 3.05-3.30 (1H, m, NCHH), 3.50-3.67 (1H, m, CHHO), 3.71-3.86 (1H, dd, J 
 192 
10.2 and 4.3, CHHO), 3.92 (1H, br d, J 14.9, CHNH), 3.97-4.11 (2H, stack, NCHH and 
CHNCH2), 5.06 (1H,  br dd, J 2.4 and 6.3, CHO) 
C: (101 MHz, CD3OD) 26.9 (CH2CHNCH2 ), 28.7 (C(CH3)3), 42.6 (NCH2), 51.0 (CHNCH2), 
52.7 (NCH2CH), 64.5 (CH2O), 75.1 (CHO), 81.6 (C(CH3)3), 157.5 (C=O), 161.4 (C=O) 
m/z: (ES)+ 295.1 (100%, [M+Na]) 
HRMS: [Found: (M+Na)+ 295.1277. C12H20N2NaO5 requires M 295.1270] 
X-ray: See Appendix 
 
(2S, 4R, 5R)-tert-Butyl 5-acetyl-4-hydroxy-2-(hydroxymethyl)piperidine-1-carboxylate 
(175) 
 
 
NaIO4/Na2SO3 Epimerisation 
NaIO4 (4.27 g, 20.0 mmol) was added in one portion to a stirred solution 
of ketone 149 (2.18 g, 7.99 mmol) in dioxane (40 mL). A saturated 
aqueous solution of Na2SO3 (40 mL) was added and the resulting mixture was heated to 40 °C 
for 1 h. The solvent was removed in vacuo and the reaction mixture was diluted with water 
(100 mL) and EtOAc (100 mL). The organic phase was separated and the aqueous phase was 
further extracted with EtOAc (4 x 100 mL). The combined organic fractions were washed 
with brine and dried over MgSO4 before the solvent was removed in vacuo to give the product 
175 as a colourless oil (2.16 g, 99%). 
DBU Epimerisation 
DBU (54 µL, 0.36 mmol) was added to solution of ketone 149 (49 mg, 0.18 mmol) in CH2Cl2 
(1.8 mL). The resulting solution was stirred at room temperature for 4 h before being 
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quenched by the addition of water (5 mL). The solution was diluted with CH2Cl2 (5 mL) and 
the organic phase was separated. The aqueous phase was further extracted with CH2Cl2 (3 x 5 
mL) and the combined organic phases were washed with water (10 mL), brine (10 mL) and 
dried over MgSO4 before the solvent was removed in vacuo to give the product 175 as a 
colourless oil (48 mg, 98%). 
Rf : 0.34 (EtOAc) 
[]D
20: +10.4 (c 1.0 in CHCl3)  
max: (film)/cm
-1 3394 (OH), 2975 (CH), 2932 (CH), 1692 (C=O), 1662 (C=O), 1159, (C-O), 
1052 (C-O) 
H: (400 MHz, CDCl3) 1.44 (9 H, s, C(CH3)3), 1.49-1.63 (1H, m, CHHCHOH) 2.01 (1H, dd, J 
13.1 and 4.1, CHHCHOH), 2.24 (3H, s, CHC(O)CH3), 2.54 (1H, ddd, J 12.2, 10.1 and 4.1, 
NCH2CH), 2.65-2.93 (2H, stack, OH and NCHH), 3.16 (1H, br s, OH), 3.51-3.74 (2H, m, 
CH2OH), 3.95-4.16 (1H, m, CHOH), 4.20-4.52 (2H, stack, CHN and NCHH) 
C: (101 MHz, CDCl3) 28.5 (C(CH3)3), 31.0 (C(O)CH3), 33.1 (NCHCH2CH), 39.6 (NCH2), 
53.0 (NCH), 57.0 (NCH2CH), 61.7 (CH2O), 66.4 (CHOH), 80.9 (C(CH3)3), 155.4 (OC=O), 
210.6 (CH3C=O) 
m/z: (ES)+  296.2 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 296.1470. C13H23NNaO5 requires M 296.1474] 
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(2S, 4R, 5R)-tert-Butyl 5-acetyl-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-    
hydroxypiperidine-1-carboxylate (176) 
 
Silyl ether 176 was prepared from: Alcohol 175 (1.38 g, 5.05 
mmol), Et3N (0.85 mL, 6.06 mmol), DMAP (124 mg, 1.02 mmol) 
and TBDPSCl (1.3 mL, 5.05 mmol) in CH2Cl2 (17 mL) according to 
general procedure 1. The crude product was purified by flash column chromatography (Rf = 
0.30, hexane:EtOAc, 2:1) to give the product 176 as a colourless oil (2.47 g, 96%). 
[]D
21: +4.8 (c 1.0 in MeOH)  
max: (film)/cm
-1 3428 (OH), 3079 (ArCH), 3056 (ArCH), 2970 (CH), 2932 (CH), 2859 (CH), 
1690 (C=O), 1671  (C=O), 1425, 1105, 1077, 700 
H: (300 MHz, CDCl3) 1.07 (9H, s, SiC(CH3)3), 1.42 (9H, s, OC(CH3)3), 1.51-1.70 (1H, m, 
NCHCHH), 1.86-2.08 (1H, m, NCHCHH), 2.24 (3H, s, C(O)CH3), 2.40-2.61 (1H, m, 
NCH2CH), 2.65-2.79 (1H, m, NCHH), 3.05 (1H, br s, OH), 3.65 (2H, m,  CH2O), 4.02-4.15 
(1H, m, CHOH), 4.35-4.60 (2H, stack, NCH and NCHH), 7.35-7.49 (6H, m, ArCH), 7.64 
(4H, dd, J 1.7 and 7.5, ArCH) 
C: (101 MHz, CDCl3) 19.1 (SiC(CH3)3), 26.8 (SiC(CH3)3), 28.3 (OC(CH3)3), 30.3 
(C(O)CH3), 29.9 (NCHCH2), 39.7 (NCH2), 52.6 (NCH), 56.9 (NCH2CH), 62.9 (CH2O), 66.1 
(CHOH), 80.2 (OC(CH3)3), 127.7 (ArCH), 129.7 (ArCH), 133.0 (ArCq), 135.4 (ArCH), 154.5 
(OC=O), 209.1 (CH3C=O) 
m/z: (ES)+  534.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 534.2660. C29H41NNaO5Si requires M 534.2652] 
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(2S, 4R, 5R)-tert-Butyl 5-acetyl-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
((trimethylsilyl)oxy)piperidine-1-carboxylate (177) 
 
Silyl ether 177 was prepared from: alcohol 176 (221 mg, 0.43 
mmol), TMSOTf (0.19 mL, 0.86 mmol), Et3N (0.12 mL, 0.86 
mmol); in CH2Cl2 (4 mL) according to general procedure 4. 
Purification by flash column chromatography (Rf = 0.20, hexane:EtOAc, 6:1) gave the 
product 177 as a colourless oil (276 mg, 78%). 
max: (film)/cm
-1 3077 (ArCH), 3056 (ArCH), 2958 (CH), 2935 (CH), 2859 (CH), 1714 
(C=O), 1693 (C=O), 1411, 1161, 1097, 840, 701 
H: (400 MHz, CDCl3) 0.08 (9H, s, Si(CH3)3), 1.05 (9H, s, SiC(CH3)3), 1.35 (9H, s, 
OC(CH3)3), 1.45-1.58 (1H, m, NCHCHH), 1.97-2.09 (1H, m, NCHCHH), 2.16 (3H, s, 
C(O)CH3), 2.51-2.62 (1H, m, NCH2CH) 2.63-2.74 (1H, m, NCHH), 3.48-3.69 (2H, m, 
CH2O), 3.95-4.06 (2H, stack, NCHH and CHO), 4.20-4.34 (1H, m, NCH), 7.29-7.50 (6H, m, 
ArCH), 7.66 (4H, dd, J 7.4 and 1.6 , ArCH) 
C: (101 MHz, CDCl3) 0.04 (Si(CH3)3), 19.0 (SiC(CH3)3), 26.6 (SiC(CH3)3), 28.1 
(OC(CH3)3), 32.6 (C(O)CH3), 34.1 (NCHCH2), 40.1 (NCH2), 52.4 (NCH), 56.6 (NCH2CH), 
62.3.5 (CH2O), 68.5 (CHO), 79.8 (OC(CH3)3), 127.6 (ArCH), 129.6 (ArCH), 133.9 (ArCq), 
135.3  (ArCH), 154.5 (OC=O), 209.8 (CH3C=O) 
m/z: (ES)+  606.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 606.3050. C32H49NNaO5Si2 requires M 606.3047] 
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N
TBDPSO
TMSO O
 196 
(2S, 4R, 5R)-tert-Butyl 2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-((trimethylsilyl) oxy)-5- 
(1-((trimethylsilyl)oxy)vinyl)piperidine-1-carboxylate (178) 
 
Silyl enol ether 178 was prepared from: ketone 176 (2.09 g, 4.08 
mmol), Et3N (2.74 mL, 16.3 mmol) and TMSOTf (1.84 mL, 10.2 
mmol); in CH2Cl2 (40 mL) according to general procedure 5 to 
give the product 178as a colourless oil (2.14 g, 80%).  
Rf : 0.20 (hexane:EtOAc, 10:1 + 1% Et3N) 
[]D
20: +7.6 (c 1.0 in CH2Cl2)  
max: (film)/cm
-1 2958 (CH), 2934 (CH), 2859 (CH), 2903 (CH), 1695 (C=O), 1250, 1099, 
839, 740, 701 
H: (300 MHz, C6D6) 0.11 (9H, s, Si(CH3)3), 0.22 (9H, s, Si(CH3)3), 1.21 (9H, s, SiC(CH3)3), 
1.45 (9H, s, OC(CH3)3), 1.63-1.74 (1H, m, NCHCHH), 2.25-2.41 (1H, m, NCHCHH), 2.43-
2.59 (1H, m, NCH2CH)), 3.01-3.19 (1H, m, NCHH), 3.82-3.96 (2H, m, CH2O), 4.10-4.48 
(4H, stack NCHH, CHO and =CH2), 4.47-4.59 (1H, m, NCH), 7.21-7.27 (6H, m, ArCH), 7.80 
(4H, d, J 7.1, ArCH) 
C: (101 MHz, C6D6) 0.1 (Si(CH3)3), 0.6 (Si(CH3)3), 19.4 (SiC(CH3)3), 27.1 (SiC(CH3)3), 28.4 
(OC(CH3)3), 34.6878 (NCH2), 51.1 (NCHCH2), 46.9 (NCH2CH), 53.0 (NCH), 62.7 (CH2O), 
66.6 (CHO), 79.1 (OC(CH3)3), 91.6 (C=CH2), 128.1 (ArCH), 130.0 (ArCH), 133.6 (ArCq), 
135.8 (ArCH), 154.5 (OC=O), 157.4 (C=CH2) 
m/z: (ES)+  678.4 (100%, [M+Na]+), 556.4 (22) 
HRMS: [Found: (M+Na)+ 678.3452. C35H57NNaO5Si3 requires M 678.3442] 
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(3R, 4R, 6S)-1-(tert-Butoxycarbonyl)-6-(((tert-butyldiphenylsilyl)oxy)methyl)-4-hydroxy 
piperidine-3-carboxylic acid (179) 
 
Carboxylic acid 179 was prepared from: Silyl enol ether  178 
(0.69 g, 1.05 mmol), NaHCO3 (0.89 g, 10.5 mmol) and DMS 
(0.77 mL, 10.5 mmol); in CH2Cl2:MeOH (1:1, 10 mL) according 
to general procedure 6 to give the product 179 as a white foam (533 mg, 92%). 
Rf : 0.45 (hexane:EtOAc, 1:3 + 1% AcOH) 
[]D
20: +5.6 (c 1.0 in MeOH)  
max: (film)/cm
-1 3426 (OH), 3074 (ArCH), 3051 (ArCH), 2960 (CH), 2932 (CH), 2859 (CH), 
1694 (C=O), 1667 (C=O), 1427, 1164, 1106, 823, 700 
H: (400 MHz, CD3OD) 0.97 (9H, s, SiC(CH3)3), 1.27-1.55 (10H, stack, OC(CH3)3 and 
NCHCHH), 1.88-2.08 (1H, m, NCHCHH), 2.12-2.33 (1H, m, NCH2CH), 2.80 (1H, t, J 12.4, 
NCHH), 3.65 (2H, d, J 6.2, CH2O), 3.77-4.23 (2H, stack, CHOH and NCHH),  4.30-4.57 (1H, 
m, NCH), 7.24-7.47 (6H, m, ArCH), 7.53-7.66 (4H, m, ArCH) 
C: (101 MHz, CD3OD) 19.7 (SiC(CH3)3), 27.4 (SiC(CH3)3), 28.7 (OC(CH3)3), 34.7 
(NCHCH2), 40.4 (NCH2), 52.0 (NCH2CH), 54.2 (NCH), 64.4 (CH2O), 67.3 (CHOH), 81.6 
(OC(CH3)3), 128.9 (ArCH), 131.0 (ArCH), 134.0 (ArCq), 136.6 (ArCH), 156.2 (NC=O), 
175.6 (HOC=O) 
m/z: (ES)– 512.3 (100%, [M-H]–) 
HRMS: [Found: (M-H)– 512.2471. C28H38NNaO6Si  requires M 512.2468] 
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(3aR, 6S, 7aR)-tert-Butyl 6-(((tert-butyldiphenylsilyl)oxy)methyl)-2-oxohexa 
hydrooxazolo[4,5-c]pyridine-5(6H)-carboxylate (180) 
 
Oxazolidinone 180 was prepared from: carboxylic acid 179 (313 mg, 
0.61 mmol), Et3N (187 µL, 1.34 mmol) and DPPA (137 µL, 0.61 
mmol); in toluene (6 mL) according to general procedure 7. 
Purification by flash column chromatography (Rf = 0.31, 
hexane:EtOAc, 2:1) gave the product 180 as a white foam (230 mg, 74%). 
[]D
20: +3.5 (c 1.0 in CHCl3)  
max: (film)/cm
-1 3305 (NH) 3077 (ArCH), 3062 (ArCH), 2934 (CH), 2931 (CH), 2890 (CH), 
1762 (C=O), 1691 (C=O), 1390, 1231, 1106, 701 
H: (400 MHz, CDCl3) 1.06 (9H, s, SiC(CH3)3), 1.39 (9H, s, OC(CH3)3), 1.85-2.07 (1H, m, 
CHHCHO), 2.52 (1H, dd, J 3.2 and 11.9, CHHCHO), 2.80 (1H, t, J 12.1, NCHH), 3.20-3.38 
(1H, m, CHNH), 3.54-3.79 (2H, m, CHHO), 4.19-4.33 (1H, m, CHO), 4.55 (1H, dd, J 4.3 and 
12.1, NCHH),  4.70-4.78 (1H, m, CHNCH2), 5.89 (1H, br s, NH), 7.32-7.52 (6H, m, ArCH), 
7.56-7.75 (4H,  m, ArCH) 
C: (101 MHz, CDCl3) 19.1 (SiC(CH3)3), 26.9 (SiC(CH3)3, 28.4 (OC(CH3)3), 28.5 
(CH2CHNCH2), 43.9 (NCH2), 52.7 (CHNCH2), 58.4 (CHNH), 63.5 (CH2O), 79.0 (CHO), 
80.9 (OC(CH3)3), 127.9 (ArCH), 129.9( ArCH),  130.0 (ArCH), 132.6 (ArCq), 132.7 (ArCq), 
135.5 (ArCH), 154.7 (C=O), 160.7 (C=O) 
m/z: (ES)+ 533.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 533.2456. C28H38N2NaO5Si requires M 533.2448] 
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(2S, 4R, 5R)-tert-Butyl 5-amino-4-hydroxy-2-(hydroxymethyl)piperidine-1-carboxylate 
(181) 
 
TBAF (1 M soln. in THF, 0.10 mL, 0.10 mmol) was added to a solution 
of silyl ether 180 (53 mg, 0.10 mmol) in THF (1 mL). The reaction 
mixture was stirred at room temperature overnight before the solvent was 
removed in vacuo and the residue purified by flash column chromatography (Rf = 0.17, 
CHCl3:MeOH, 8:2 + 1% NH3(aq)) to give the product 181 as a colourless oil (21 mg, 74%). 
[]D
21: +15.3 (c 1.5 in MeOH)  
max: (film)/cm
-1 3353 (NH, OH), 2966 (CH), 2924 (CH), 2931 (CH), 2855 (CH), 1668 
(C=O), 1416, 1365, 1248, 1164, 1053 
H: (400 MHz, CD3OD) 1.35 (9H, s, OC(CH3)3), 1.36-1.45 (1H, m, CHHCHO), 2.91-2.10 
(1H, m, CHHCHO), 2.34-2.42 (1H, m, CHNH2), 2.47-2.65 (1H, m, NCHH), 3.34-3.41 (1H, 
m, CHOH), 3.43-3.58 (2H, m, CHHO), 3.96-4.07 (1H, m, NCHH), 4.15-4.26 (1H, m, 
CHNCH2) 
C: (101 MHz, CD3OD) 28.7 (OC(CH3)3), 33.9 (CH2CHNCH2), 43.8 (NCH2), 52.9 
(CHNCH2), 55.9 (CHNH2), 61.5 (CH2O), 71.2 (CHOH), 81.4 (OC(CH3)3), 156.7 (C=O) 
m/z: (ES)+ 269.2 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 269.1479. C11H22N2NaO4 requires M 269.1477] 
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(3aR, 6S, 7aR)-tert-Butyl 6-(hydroxymethyl)-2-oxohexahydrooxazolo[4,5-c]pyridine-
5(6H)-carboxylate (182) 
 
A solution of HF.pyridine  (70% HF in pyridine, 62 µL, 2.78 mmol) was 
added to a solution of silyl ether 180 (71 mg, 0.14 mmol) in THF:pyridine 
(1:1, 1 mL). The resulting mixture was stirred at rt for 3 h before being 
cooled to 0 °C and quenched with a saturated aqueous solution of NaHCO3 (2 mL). The 
mixture was extracted with EtOAc (4 x 5 mL) and the combined organic fractions washed 
with brine and dried over MgSO4 before the solvent was removed in vacuo. The crude 
product was purified by flash column chromatography (Rf = 0.22, hexane:EtOAc, 1:3) to give 
the product 182 as a white amorphous solid (31 mg, 81%). 
[]D
20: +19.2 (c 1.0 in MeOH)  
mp: 135-136 °C (from hexane:EtOAc) 
max: (film)/cm
-1 3328 (NH, OH), 2934 (CH), 2922 (CH), 2853 (CH), 1746 (C=O), 1670 
(C=O), 1237, 1161, 1085, 1030 
H: (400 MHz, CDCl3) 1.39 (9H, s, OC(CH3)3), 1.49-1.60 (1H, br s, OH), 1.77-2.01 (1H, m, 
CHHCHO), 2.22-2.31 (1H, m, CHHCHO), 2.78-3.01 (1H, m, NCHH), 3.21-3.34 (1H, m, 
CHNH), 3.62-3.74 (2H, m, CHHO), 4.15-4.27 (1H, m, CHO), 4.42-4.73 (2H, stack, NCHH 
and CHNCH2), 4.46 (1H, br s, NH) 
m/z: (ES)+ 295.2 (100%, [M+Na]+), 327.2 (29, [M+MeOH+Na]+) 
HRMS: [Found: (M+Na)+ 295.1274. C12H20N2NaO5 requires M 295.1270] 
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(6S, 7R, 8aS)-6-Acetyl-7-hydroxytetrahydro-1H-oxazolo[3,4-a]pyridin-3(5H)-one (185) 
 
Dihydroxylation/oxidative cleavage 
2,6-Lutidine (700 µL, 0.60 mmol) was added to a solution of piperidine 96 
(60 mg, 0.30 mmol) in dioxane:water (3:1, 4 mL). OsO4 (one small crystal) 
followed by NaIO4 (0.26 g, 1.20 mmol) was added to the solution. After 15 
min a white precipitate began to fall out of solution. The reaction was stirred for a further 2 h 
before being quenched with saturated aqueous solution of Na2SO3 (5 mL). The solvent was 
removed in vacuo and the aqueous phase was extracted with EtOAc (4 x 10 mL). The 
combined organic phases were washed with brine (10 mL), dried over MgSO4 and 
concentrated in vacuo to afford the crude product as a yellow solid, which was purified by 
flash column chromatography (Rf = 0.21, EtOAc) to give the product 185 as a white 
crystalline solid  (54 mg, 90%). 
Ozonolysis 
Ozone was bubbled through a solution of piperidine 96 (105 mg, 0.53 mmol) in 
CH2Cl2:MeOH (3:1, 4 mL) at -78 °C and out into an aqueous KI scrubber. After 15 min the 
solution turned in colour from colourless to clear blue. O2 was bubbled through the solution 
followed by Ar, each for 10 min, resulting in a colour change from blue to colourless. DMS 
(470 µL, 0.64 mmol) was added and after warming to room temperature the solvent was 
removed in vacuo   obtain the crude product as an off white crystalline solid, which was 
purified by flash column chromatography (Rf = 0.21, EtOAc) to give the product 185 as a 
white crystalline solid (106 mg, quant.). 
[α]D20 : -173 (c 1.0 in CHCl3) 
N
OH O
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mp: 160-162 °C (from hexane:EtOAc)  
max: (film)/cm
-1 3514 (OH), 2925 (CH), 1747 (C=O), 1704 (C=O) 
H: (300 MHz, CDCl3): 1.41-1.50 (1H, m, CHHCHOH), 1.99 (1H, dt, J 13.3 and 3.7, 
CHHCHOH), 2.20 (3H, s, CH3), 2.65-2.69 (1H, m, CHCOCH3), 3.29 (1H, t, J 12.5, NCHH), 
3.85-3.96 (2H, stack, NCHH and CHHO), 4.04-4.13 (1H, m, NCH), 4.38 (1H, t, J 8.2 
CHHO), 4.44 (1H, br s, CHOH)  
C: (75 MHz, CDCl3) 29.2 (CH3), 35.7 (CH2CHO), 37.4 (NCH2), 48.7 (NCH2CH), 51.5 
(NCH), 64.0 (CHOH), 67.5 (CH2OCO), 157.1 (OCO), 209.8 (COCH3)  
m/z: (ES)+ 222.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 222.0748. C9H13NNaO4 requires M 222.0742] 
 
 
(6R, 7R, 8aS)-7-Hydroxy-6-((E)-1-(hydroxyimino)ethyl)tetrahydro-1H-oxazolo [3,4-
a]pyridin-3(5H)-one (186) 
 
Et3N (0.23 mL, 1.67 mmol) was added to a stirred solution of ketone 185 
(111 mg, 0.56 mmol) dissolved in EtOH (6 mL) followed by the addition 
of hydroxylamine hydrochloride (58 mg, 0.84 mmol). The reaction was 
heated to reflux for 5 h before being allowed to cool to room temperature 
and quenched by the addition of water (10 mL). The solvent was removed in vacuo and the 
aqueous phase was extracted with EtOAc (4 x 10 mL). The combined organic fractions were 
washed with brine (10 mL) and dried over MgSO4 before being concentrated in vacuo to give 
the oxime product 186 as a white crystalline solid (92 mg, 78%). 
Rf : 0.24 (EtOAc) 
N
OH N
OH
O
O
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mp: 153-155 °C (from EtOAc) 
max: (neat)/cm
-1 3404 (OH), 3243 (OH), 2923 (CH), 2877 (CH), 1710 (C=O), 1433, 1244, 
1006, 960 
H: (300 MHz, CD3OD): 1.61-1.74 (1H, m, CHHCHOH), 1.94 (3H, s, CH3), 2.05 (1H, dt, J 
12.5 and 3.5, CHHCHOH), 2.40-2.49 (1H, m, CHCOCH3), 3.41 (1H, t, J 12.5, NCHH), 3.66 
(1H, dd, J 12.5 and 4.5, NCHH) 3.95-4.04 (1H, m, CHHO), 4.12-4.20 (1H, m, NCH), 4.38 
(1H, br s, CHOH) 4.49 (1H, t, J 8.2 CHHO), 
C: (75 MHz, CD3OD) 11.6 (CH3), 36.5 (CH2CHO), 38.2 (NCH2), 55.7 (NCH2CH), 49.4 
(NCH), 64.6 (CHOH), 68.1 (CH2OCO), 155.4 (C=O), 158.1 (C=N-OH)  
m/z: (ES)+ 237.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 237.0839. C9H14N2NaO4 requires M 237.0851] 
X-ray: See Appendix 
 
(S)-6-Acetyl-8,8a-dihydro-1H-oxazolo[3,4-a]pyridin-3(5H)-one (188) 
 
O-(mesitylsulfonyl)hydroxylamine 162 (37 mg, 0.17 mmol) was added to a 
stirred solution of ketone 185 (32mg, 0.16 mmol) dissolved in EtOH (1.5 
mL). The resulting mixture was heated to 120 °C in a sealed tube for 3 h 
before being allowed to cool to room temperature and concentrated in vacuo 
to give the crude product that was purified by flash column chromatography (Rf = 0.22, 
hexane:EtOAc, 1:3) to give the enone 188 as a white crystalline solid (27 mg, 93%). 
mp: 112-114 °C (from hexane:EtOAc) 
max: (neat)/cm
-1 2964 (CH), 2908 (CH), 1749 (C=O), 1658 (C=O), 1641, 1417, 1248, 1069, 
750 
N
O
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H: (300 MHz, CDCl3) 2.24 (3H, s, CH3), 2.30-2.39 (1H, m, CHHCH=), 2.42-2.55 (1H, m, 
CHHCH=), 3.67-3.81 (2H, stack, and NCHH and NCH), 4.01 (1H, dd, J 8.2 and 4.0, CHHO,) 
4.35 (1H, d, J 14.0 NCHH), 4.46 (1H, t, J 8.2 CHHO), 6.82-6.91 (1H, m, CH=) 
C: (75 MHz, CDCl3) 25.2 (CH3), 29.9 (CH2CH=), 39.9 (NCH2), 49.4 (NCH), 68.2 (CH2O), 
135.6 (CH=), 137.7 (Cq=) 155.6 (NC=O), 196.2 (C=O)  
m/z: (ES)+ 204.0 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 204.0629. C9H11NNaO3 requires M 204.0637] 
 
(6S, 7R, 8aS)-6-Acetyl-7-((di-tert-butyl(hydroxy)silyl)oxy)tetrahydro-1H-oxazolo [3,4-
a]pyridin-3(5H)-one (190) and (S)-6-Acetyl-8,8a-dihydro-1H-oxazolo[3,4-a]pyridin-
3(5H)-one (188) 
 
Et3N (105 μL, 0.75 mmol) was added to a solution 
of ketone 185 (50 mg, 0.25 mmol) in CH2Cl2 (2.5 
mL) cooled to -78 °C. di(tert-
butyl)silylbis(trifluoromethanesulfonate) (92 µL, 
0.25 mmol) was added dropwise over 1 min and the resulting solution stirred at -78 °C for 1 h 
before being allowed to warm to 0 °C and stirred for a further 3 h. The reaction was 
concentrated in vacuo and the crude product was purified by flash column chromatography 
(Rf  = 0.50, hexane:EtOAc, 1:3) to give the silyl ether 190 as a colourless oil (34 mg, 38%). 
max: (film)/cm
-1 3514 (OH), 2925 (CH), 2809 (CH), 1747 (C=O), 1704 (C=O), 1050 
H: (300 MHz, CDCl3): 0.97 (9H, s, C(CH3)3), 1.03 (9H, s, C(CH3)3), 1.57 (1H, ddd, J 13.4, 
11.7 and 1.9, CHHCHO), 2.18 (1H, dt, J 13.4 and 3.7, CHHCHO), 2.23 (3H, s, CH3), 2.50 
(1H, ddd, J 11.9, 4.7 and 1.7, NCH2CH),  2.65 (1H, br s, OH), 3.52 (1H, dd, J 13.2 and 11.9, 
N
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NCHH), 3.89-4.04 (2H, stack, NCHH and CHHO), 4.08-4.20 (1H, m, NCH), 4.46 (1H, t, J 
8.2 CHHO), 4.89-5.02 (1H, br s, CHO)  
C: (75 MHz, CDCl3) 20.9 (C(CH3)3), 27.2 (C(CH3)3),  28.7 (C(O)CH3), 37.3 (CH2), 37.4 
(CH2), 49.0 (NCH2CH), 53.7(NCH), 65.8 (CHO), 67.4 (CH2O), 15731 (OCO), 206.2 
(COCH3)  
m/z: (ES)+ 380.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 380.1872. C17H31NNaO5Si requires M 380.1869] 
Further elution (Rf = 0.22) gave the enone 188 as a white crystalline solid (19 mg, 41%). Data 
vide supra. 
 
(6S, 7R, 8aS)-6-acetyl-7-(trimethylsilyloxy)tetrahydro-1H-oxazolo[3,4-a]pyridin-3(5H)-
one (191) 
 
A solution of ketone 185 (100 mg, 0.50 mmol) in CH2Cl2 (5 mL) was 
transferred via cannula to a r.b. flask containing 4 Å MS and stirred for 5 min 
at room temperature. Et3N (140 µL, 1.00 mmol) was added to the solution and 
the resulting mixture was stirred for a further 5 min before being cooled to -78 °C. TMSOTf 
(182 µL, 0.50 mmol) was added dropwise over 5 min and the resulting solution was stirred at 
-78 °C for a further 5h. The solution was diluted with CH2Cl2 (5 mL) and then poured into a 
saturated aqueous solution of NaHCO3 (10 mL). The organic phase was separated and the 
aqueous phase was further extracted with CH2Cl2 (3 x 10 mL). The combined organic layers 
were dried over Na2SO4 and the solvent removed in vacuo to afford the crude product as a 
light brown oil. The crude product was purified by flash column chromatography (Rf = 0.57, 
N
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hexane:EtOAc, 3:1 + 1% Et3N) to give the product 191 as a white crystalline solid (102 mg, 
75%). 
mp: 64-65 °C (from hexane:EtOAc)  
max: (neat)/cm
-1 2957 (CH), 1736 (C=O), 1709 (C=O), 1433, 1250, 1026, 849, 756 
H: (300 MHz, CDCl3): 0.04 (9H, s, Si(CH3)3), 1.56 (1H, ddd, J 13.4, 11.6 and 1.9, 
CHHCHO), 1.85 (1H, dt, J 13.4 and 3.8, CHHCHO), 2.10 (3H, s, CH3), 2.43 (1H, ddd, J 
11.9, 4.9 and 2.1, NCH2CH), 3.45 (1H, dd, J 13.4 and 11.9, NCHH), 3.79 (1H, dd, J 13.4 and 
4.9, NCHH), 3.86 (1H, dd, J 8.2 and 5.1, CHHO), 3.91-4.04 (1H, m, NCH), 4.37 (1H, t, J 8.2 
CHHO), 4.53-4.68 (1H, m, CHO)  
C: (75 MHz, CDCl3) 0.02 (Si(CH3)3), 28.1 (C(O)CH3), 36.9 (CH2CHO), 37.5 (NCH2), 48.7 
(NCH2CH), 52.8 (NCH),  66.3 (CHO), 67.2 (CH2O), 157.2 (OC=O), 205.9 (C=OCH3)  
m/z: (ES)+ 294.1 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 294.1134. C12H21NNaO4Si requires M 294.1138] 
 
 
(6S, 7R, 8aS)-7-(Trimethylsilyloxy)-6-(1-(trimethylsilyloxy)vinyl)tetrahydro-1H-oxazolo 
[3,4-a]pyridin-3(5H)-one (192) 
 
A solution containing ketone 185 (516 mg, 2.59 mmol) in CH2Cl2 (26 
mL) was transferred via cannula to a r.b. flask containing 4 Å MS and 
stirred for 5 min at room temperature. Et3N (1.44 mL, 10.36 mmol) was 
added to the mixture and the resulting solution was stirred for a further 5 
min before being cooled to 0 °C. TMSOTf (1.17 mL, 6.48 mmol) was added dropwise over 5 
min and the resulting solution was stirred at 0 °C for a further 1 h. The solution was diluted 
with CH2Cl2 (20 mL) and then poured into a saturated aqueous solution of NaHCO3 (25 mL). 
N
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The organic phase was separated and the aqueous phase was further extracted with CH2Cl2 
(50 x 3 mL). The combined organic layers were dried over Na2SO4 and the solvent removed 
in vacuo to afford the crude product as a light brown oil, which was purified by flash column 
chromatography (Rf = 0.84, hexane:EtOAc, 1:3 + 1% Et3N) to give the product 192 as a white 
crystalline (757 mg, 84%). 
mp: 77-79 °C (from benzene) 
[α]D20 : -32.1 (c 1 in CH2Cl2) 
max: (neat)/cm
-1 2959 (CH), 2909 (CH), 1760 (C=O), 1633, 1427, 1250, 1230, 1042, 829, 756 
H: (400 MHz, C6D6): 0.07 (9H, s, Si(CH3)3), 0.14 (9H, s, Si(CH3)3), 0.83 (1H, ddd, J 13.2, 
11.7 and 1.9, CHHCHO), 1.18 (1H, dt, J 13.2 and 3.8, CHHCHO), 1.94 (1H, dd, J 12.2 and 
4.5, NCH2CH), 3.12 (1H, t, J 12.2, NCHH), 3.18 (1H, dd, J 8.1 and 5.0, CHHO), 3.39-3.52 
(1H, m, NCH), 3.65 (1H, t, J 8.1, CHHO), 3.86 (1H, s, =CHH), 3.91 (1H, dd, J 12.2 and 4.5, 
NCHH), 4.10 (1H, s, =CHH), 4.13-4.17 (1H, m, CHO) 
C: (101 MHz, CDCl3) 0.14 (Si(CH3)3), 0.22 (Si(CH3)3), 37.7 (CH2CHO), 38.7 (NCH2), 46.3 
(NCH2CH), 48.9 (NCH),  66.2 (CHO), 66.9 (CH2O), 90.7 (=CH2), 156.8 (Cq=CH2) 156.9 
(C=O) 
m/z: (ES)+ 366.3 (100%, [M+Na]+)  
HRMS: [Found: (M+Na)+ 366.1519. C15H29NNaO4Si2 requires M 366.1533] 
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(6S, 7R, 8aS)-7-Hydroxy-3-oxohexahydro-1H-oxazolo[3,4-a]pyridine-6-carboxylic acid 
(193) 
 
Carboxylic acid 193 prepared from: silyl enol ether 192 (543 mg, 1.58 
mmol), NaHCO3 (1.34 g, 15.8 mmol) and DMS (1.18 mL, 15.8 mmol); in 
CH2Cl2:MeOH (1:1, 16 mL) according to general procedure 6. The crude 
product was purified by flash column chromatography (Rf = 0.21, 
CHCl3:MeOH, 8:2 + 1% AcOH) to give the product 193 as a white amorphous solid (299 mg, 
95%).  
mp: decomposition at 130 °C (from MeOH) 
[α]D20 : -62.5 (c 1 in MeOH) 
max: (neat)/cm
-1 3476 (OH), 2919 (CH), 1718 (C=O), 1682 (C=O), 1464, 1276, 1190, 1030, 
1042, 754 
H: (400 MHz, d
6-DMSO): 1.39-1.55 (1H, m, CHHCHO), 1.79 (1H, dt, J 13.2 and 3.7, 
CHHCHO), 2.36-2.48 (1H, m, NCH2CH), 3.13-3.20 (1H, m, NCHH), 3.52 (1H, dd, J 13.1 
and 5.2, NCHH), 3.81 (1H, dd, J 8.4 and 5.7, CHHO), 3.86-3.98 (1H, m, NCH), 4.27-4.39 
(2H, stack, CHHO and CHO) 
C: (101 MHz, d
6-DMSO) 36.3 (CH2CHO), 36.5 (NCH2), 44.2 (NCH2CH), 48.0 (NCH),  63.8 
(CHO), 67.0 (CH2O), 156.2 (NC=O), 172.4 (C=OOH) 
m/z: (ES)– 200.0 (100%, [M+Na]–)  
HRMS: [Found: (M+Na)– 200.0562. C8H10NO5 requires M 200.0559] 
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(3aS, 8aS, 9aR)-Hexahydro-2H-dioxazolo[3,4-a:5',4'-d]pyridine-2,6(3H)-dione (184) 
 
Et3N (333 µL, 2.39 mmol) was added to a solution of acid 193 (192 mg, 0.96 
mmol) in toluene (10 mL) at room temperature. The resulting mixture was 
heated to 80 °C and DPPA (236 µL, 1.05 mmol) was added dropwise over 1 
min to the solution and heating was continued for a further 4 h. The solution 
was allowed to cool to room temperature and the reaction was quenched by the addition of a 
saturated aqueous solution of NaHCO3 (10 mL). The solution was diluted with EtOAc (10 
mL) and the organic phase was separated. The aqueous phase was further extracted with 
EtOAc (3 x 20 mL) and the combined organic layers were washed with brine and dried over 
MgSO4. The solvent was removed in vacuo to afford the crude product as a light brown solid. 
The crude product was purified by flash column chromatography (Rf = 0.24, CHCl3:MeOH, 
9:1) to give the product 184 as a white amorphous solid (142 mg, 75%). 
mp: 134-135 °C (from MeOH) 
[α]D20 : -80.4 (c 1 in CHCl3) 
max: (neat)/cm
-1 3245 (NH), 2994 (CH), 2992 (CH), 1780 (C=O), 1719 (C=O), 1430, 1220, 
759 
H: (300 MHz, d
6-DMSO): 1.73-1.90 (1H, m, CHHCHO), 2.10-2.26 (1H, m, CHHCHO), 2.93 
(1H, dd, J 13.3 and 7.1, NCHH), 3.62 (1H, dd, J 13.3 and 6.0, NCHH), 3.82-3.96 (3H, stack, 
NCH, NCH2CH and CHHO), 4.31-4.51 (1H, m, CHHO), 4.66-4.78 (1H, m, CHO), 7.81 (1H, 
br s, NH) 
C: (101 MHz, d
6-DMSO) 30.5 (CH2CHO), 42.1 (NCH2), 47.4 (NCH2CH), 47.6 (NCH), 67.8 
(CH2O), 791 (CHO), 156.7 (C=O) 158.3 (C=O) 
m/z: (ES)+ 221.1 (100%, [M+Na]+)  
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HRMS: [Found: (M+Na)+ 221.0529. C8H10N2NaO4 requires M 221.0538] 
 
General Procedure 8: Wittig Reaction 
Methyl(triphenylphosphoranylidene)acetate (1.5 eq) was added in one portion to a stirred 
solution of aldehyde (1 eq) dissolved in toluene (0.2 M) at room temperature. The resulting 
solution has heated to reflux until the reaction was judged to be complete by TLC analysis. 
After cooling to room temperature the solvent was removed in vacuo and the resulting residue 
was taken up in Et2O (0.2 M) and cooled to 0 °C for 30 min. The precipitates were filtered off 
and filter cake washed with further portions of ice cold 3 x Et2O. The combined filtrates were 
concentrated in vacuo to afford the crude allylic ester.  
 
Methyl 4-nitrocinnamate (202a) 
 
Ester 202a was prepared from aldehyde 200a (1.28 g, 8.50 mmol) and 
methyl(triphenylphosphoranylidene)acetate (4.26 g, 12.75 mmol) according to 
General Procedure 8. After 2 h and purification by flash column 
chromatography (Rf = 0.35, hexane:EtOAc, 3:1) afforded the product 202a as a 
yellow solid (1.41 g, 80%). Ester 202a was obtained as a 7:1 mixture of E:Z stereoisomers. In 
the case of the NMR spectra, only data for the major E stereoisomer is reported. 
mp: 136-137 °C (from toluene) (lit. E-isomer115 159-160 °C, Z-isomer116 86-88 °C) 
max: (film)/cm
-1 3030 (ArCH), 1718 (C=O), 1642 (C=C), 1598 (ArC=C), 1523 (as NO2), 
1348 (s NO2,), 1216, 759 
CO2Me
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H: (300 MHz, CDCl3) 3.84 (3H, s, CH3), 6.56 (1H, d, J 16.0, =CH), 7.64-7.75 (3H, stack, 
=CH and ArCH), 8.25 (2H, d, J 8.8, ArCH) 
C: (75 MHz, CDCl3) 52.5 (CH3), 122.2 (=CH), 124.3 (ArCH), 128.8 (ArCH), 140.6 (Cq), 
142.0 (=CH), 148.6 (Cq), 166.6 (C=O) 
m/z: (EI)+ 207 (42%, [M]+), 176 (100, [M-OMe]+) 
 
Methyl 4-trifluoromethylcinnamate (202b) 
 
Ester 202b was prepared from aldehyde 200b (1.37 mL, 10.0 mmol) and 
methyl(triphenylphosphoranylidene)acetate (5.02 g, 15.0 mmol) according to 
General Procedure 8. After 5 h and purification by flash column 
chromatography (Rf = 0.68, hexane:EtOAc, 3:1) afforded the 202b product as a 
white powder (2.08 g, 90%). Ester 202b was obtained as a 42:1 mixture of E:Z stereoisomers. 
In the case of the NMR spectra, only data for the major E stereoisomer is reported. 
mp: 75-76 °C (from hexane:EtOAc) (lit.117 E-isomer 77-79 °C) 
max: (film)/cm
-1 3021 (ArCH), 1718 (C=O), 1642 (C=C), 1512 (ArC=C), 1324 (CF3), 1215, 
1068, 755 
H: (300 MHz, CDCl3) 3.67 (3H, s, CH3), 6.35 (1H, d, J 16.2, =CH), 7.35-7.47 (4H, stack, 
ArCH), 7.52 (1H, d, J 16.2, =CH) 
C: (75 MHz, CDCl3) 51.5 (CH3), 120.2 (=CH), 123.8 (q, J 272, CF3), 125.6 (ArCH), 128.0 
(ArCH), 131.5 (q, J 32, CqCF3), 137.7 (Cq), 142.7 (=CH), 166.5 (C=O) 
m/z: (EI)+ 230 (48%, [M]+), 199 (100, [M-OMe]+)  
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Methyl 4-bromocinnamate (202c) 
  
 
Ester 202c was prepared from aldehyde 200c (1.83 mL, 10.0 mmol) and 
methyl(triphenylphosphoranylidene)acetate (5.02 g, 15.0 mmol) according to 
General Procedure 8. After 3 h and purification by flash column 
chromatography (Rf = 0.66, hexane:EtOAc, 3:1) afforded the product 202c as a 
white powder (2.19 g, 90%). Ester 202c was obtained as a 37:1 mixture of E:Z stereoisomers. 
In the case of the NMR spectra, only data for the major E stereoisomer is reported. 
mp: 81-83 °C (from toluene) (lit.118 E-isomer 82-84 °C (from ethanol)) 
max: (film)/cm
-1 3032 (ArCH), 1712 (C=O), 1636 (C=C), 1586 (ArC=C), 1486 (ArC=C), 
1170 (C-O) 
H: (300 MHz, CDCl3) 3.72 (3H, s, CH3), 6.33 (1H, d, J 16.1, =CH), 7.26 (2H, d, J 8.5, 
ArCH), 7.46 (2H, d, J 8.5, ArCH), 7.52 (1H, d, J 16.1, =CH) 
C: (75 MHz, CDCl3) 51.7 (CH3), 118.4 (=CH), 124.4 (Cq), 129.4 (ArCH), 132.0 (ArCH), 
133.2 (Cq), 143.3 (=CH), 166.9 (C=O) 
m/z: (EI)+ 238 (62%, [M(81Br)]+), 240 (64, [M(79Br)]+), 207 (97, [M(81Br)-OMe]+), 209 (100, 
[M(79Br)]-OMe+) 
   
Methyl 4-methylcinnamate (202d) 
 
Ester 202d was prepared from aldehyde 200d (0.98 mL, 8.17 mmol) and 
methyl(triphenylphosphoranylidene)acetate (4.09 g, 12.24 mmol) according to 
General Procedure 8. After 2 h and purification by flash column 
chromatography (Rf = 0.82, hexane:EtOAc, 3:1) afforded the product 202d as a 
CO2Me
Br
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white powder (1.30 g, 90%). Ester 202d was obtained as a 12:1 mixture of E:Z stereoisomers. 
In the case of the NMR spectra, only data for the major E stereoisomer is reported. 
mp: 51-54 °C (from Et2O) (lit.
119 E-isomer 52-54 °C) 
max: (film)/cm
-1 3021 (ArCH), 2951 (CH), 1715 (C=O), 1636 (C=C), 1436, 1315, 1214, 1172, 
755 
H: (300 MHz, CDCl3) 2.35 (3H, s, CCH3), 3.81 (3H, s, OCH3), 6.48 (1H, d, J 16.0, =CH), 
7.16 (2H, d, J 8.7, ArCH), 7.40 (2H, d, J 8.7, ArCH), 7.66 (1H, d, J 16.0, =CH) 
C: (75 MHz, CDCl3) 19.6 (CCH3), 49.7 (OCH3), 114.9 (=CH), 126.3 (ArCH), 127.8 (ArCH), 
129.4 (Cq), 138.8 (Cq), 143.0 (=CH), 165.6 (C=O) 
m/z: (EI)+ 176 (25%, [M]+), 145 (100, [M-OMe]+) 
HRMS: [Found: (M)+ 176.0845. C11H12O2 requires M 176.0837] 
 
(Z)-Methyl 4-methoxycinnamate (202ei ) and (E)-Methyl 4-methoxycinnamate (202eii) 
 
 
Esters  (202ei) and (202eii) were prepared from aldehyde 
(200e) (1.22 g, 10.0 mmol) and 
methyl(triphenylphosphoranylidene)acetate (5.02 g, 15.0 
mmol) according to General Procedure 8. After 2 h and 
purification by flash column chromatography (Rf = 0.43, hexane:EtOAc, 3:1) afforded the Z-
isomer 202ei  as a colourless oil (60 mg, 3%). 
max: (film)/cm
-1 2951 (CH), 2838 (CH), 1721 (C=O), 1624, 1604, 1512, 1444, 1260, 1165, 
1031 
H: (300 MHz, CDCl3) 3.71 (3H, s, CH3), 3.82 (3H, s, CH3), 5.72 (1H, d, J 16.0, =CH), 6.85 
(3H, stack, ArCH and =CH), 7.60 (2H, d, J 8.7, ArCH) 
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C: (75 MHz, CDCl3) 54.2 (CH3), 57.7 (CH3), 115.9 (ArCH), 119.1 (=CH), 127.1 (Cq), 134.6 
(ArCH), 145.9 (=CH), 162.0 (Cq), 167.8 (C=O) 
 
Further elution (Rf = 0.41) gave the E-isomer 202eii as a white powder (1.59 g, 81%)  
mp: 82-83 °C (from EtOAc) (Lit.120 84-86 °C) 
max: (film)/cm
-1 2964 (CH), 2844 (CH), 1719 (C=O), 1639, 1604, 1515, 1289, 1177, 1026 
H: (300 MHz, CDCl3) 3.72 (3H, s, CH3), 3.75 (3H, s, CH3), 6.25 (1H, d, J 16.7, =CH), 6.85 
(2H, d, J 8.5 ArCH), 7.39 (2H, d, J 8.5, ArCH), 7.12 (1H, d, J 16.7, =CH) 
C: (75 MHz, CDCl3) 52.3 (CH3), 55.9 (CH3), 57.7 (CH3), 115.0 (ArCH), 115.9 (=CH), 127.7 
(Cq), 130.3 (ArCH), 145.1 (=CH), 162.0 (Cq), 167.5 (C=O) 
m/z: (EI)+ 192 (77%, [M]+), 161 (100, [M-OMe]+) 
 
General Procedure 9: DIBAL Reduction 
A solution of DIBAL-H 1.0 M in toluene (2.2 eq) was added dropwise over 5 min to a stirred 
solution of cinnamate ester (1 eq) dissolved in THF (0.2 M) cooled to 0 °C. The reaction was 
stirred at 0 °C until the reaction was judged to be complete by TLC analysis. The reaction was 
quenched by the addition of a saturated aqueous solution of Rochelle’s salt. The aqueous 
phase was extracted with Et2O x 4. The combined organic phases were washed with brine and 
dried over MgSO4 before being concentrated in vacuo to afford the crude allylic alcohol.  
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Hydroxymethyl 4-nitrocinnamol (203a) 
 
Alcohol 203a was prepared from ester 202a (309 mg, 1.49 mmol) and DIBAL-H 
(1 M soln. in hexanes, 3.7 mL, 3.73 mmol) according to General Procedure 9. 
After 4 h and purification by flash column chromatography (Rf = 0.27, 
hexane:EtOAc, 1:1) afforded the product 203a as a yellow powder (168 mg, 
63%). Alcohol 203a was obtained as a 7:1 mixture of E:Z stereoisomers. In the case of the 
NMR spectra, only data for the major E stereoisomer is reported. 
mp: 111-114 °C (from hexane:EtOAc) (Lit. E-isomer121 107 °C, Z-isomer122 127-129 °C 
(benzene) 
max: (film)/cm
-1 3445 (OH), 3020 (ArCH), 1598 (ArC=C), 1519 (as NO2), 1345 (s NO2,), 
1216, 756 
H: (300 MHz, CDCl3) 1.94 (1H, br s, OH), 4.39 (2H, d, J 5.2, CH2), 6.53 (1H, dt, J 16.2 and 
5.2, =CHCH2), 6.70 (1H, d, J 16.2, CqCH=), 7.49 (2H, d, J 8.6  ArCH), 8.15 (2H, d, J 8.6, 
ArCH) 
C: (75 MHz, CDCl3) 63.2 (CH2), 124.1 (ArCH), 127.0 (ArCH), 128.3 (=CH), 133.8 (=CH), 
143.4 (Cq), 147.0 (Cq) 
m/z: (EI)+ 179 (81%, [M]+), 137 (100) 
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Hydroxymethyl 4-trifluoromethylcinnamol (203b) 
 
 
Alcohol 203b was prepared from ester 202b  (2.06 g, 9.94 mmol) and DIBAL-
H (1 M soln. in hexanes, 19.7 mL, 19.7 mmol) according to General Procedure 
9. After 4 h and purification by flash column chromatography (Rf = 0.27, 
hexane:EtOAc, 3:1) afforded the product 203b  as a white powder (1.73 g, 
96%).  
mp: 61-60 °C (from hexane:EtOAc) (lit.123 62-64 °C) 
max: (film)/cm
-1 3333 (OH), 3052 (=CH), 2926 (CH), 2870 (CH), 1614 (C-O), 1414,  (CF3), 
1125 
H: (300 MHz, CDCl3) 1.73 (1H, t, J 5.3, OH), 4.37 (2H, t, J 5.3, CH2), 6.45 (1H, dt, J 16.0 
and 5.3,  =CHCH2), 6.66 (1H, dd, J 16.0, CqCH=), 7.46 (2H, d, J 8.3, ArCH), 7.56 (2H, d, J 
8.3, ArCH) 
C: (75 MHz, CDCl3) 62.8 (CH2), 124.2 (q, J 272, CF3), 125.4 (ArCH), 126.2 (ArCH), 128.9 
(=CH), 129.2 (q, J 32, CqCF3), 131.4 (=CH), 140.3 (Cq) 
m/z: (EI)+ 202 (71%, [M]+), 160 (100, [M]+) 
 
Hydroxymethyl 4-bromocinnamol (203c) 
 
 
Alcohol 203c was prepared from ester  202c  (2.19 g, 9.08 mmol) and DIBAL-H 
(1 M soln. in hexanes, 22.7 mL, 22.7 mmol)  according to General Procedure 9. 
After 1 h and purification by flash column chromatography (Rf = 0.33, 
hexane:EtOAc, 2:1) afforded the product  203c  as a white powder (1.88 g, 97%). 
CF3
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Alcohol 203c was obtained as a 47:1 mixture of E:Z stereoisomers. In the case of the NMR 
spectra, only data for the major E stereoisomer is reported. 
mp: 66-68 °C (from hexane:EtOAc) (Lit.124 E-isomer 68-69 °C) 
max: (film)/cm
-1 3400 (OH), 3052 (=CH), 2923 (CH), 2871 (CH), 1651 (C-O), 1487,  1400, 
1215 
H: (300 MHz, CDCl3) 3.34 (1H, s, OH), 4.31 (2H, d, J 5.5, CH2), 6.34 (1H, dt, J 15.8 and 
5.5,  =CHCH2), 6.55 (1H, d, J 15.8, CqCH=), 7.23 (2H, d, J 8.5, ArCH), 7.43 (2H, d, J 8.5, 
ArCH) 
C: (75 MHz, CDCl3) 63.4 (CH2), 121.5 (Cq), 128.0 (ArCH), 129.4 (=CH), 129.7 (=CH), 
131.7 (ArCH), 135.7 (Cq) 
m/z: (EI)+ 214 (35%, [M(81Br)]+), 212 (37, [M(79Br)]+), 171 (46), 160 (48), 133 (100), 115 
(65), 91 (85), 77 (78) 
 
Hydroxymethyl 4-methylcinnamol  (203d) 
 
Alcohol 203d was prepared from ester 202d  (1.28 g, 7.24 mmol) and DIBAL-H  
(1 M soln. in hexanes, 15.9 mL, 15.9 mmol) according to General Procedure 9. 
After 1 h and purification by flash column chromatography (Rf = 0.31, 
hexane:EtOAc, 3:1) afforded the product 203d as a white powder (1.01 g, 94%). 
Alcohol 203d was obtained as a 16:1 mixture of E:Z stereoisomers. In the case of the NMR 
spectra, only data for the major E stereoisomer is reported. 
mp: 43-45 °C (from hexane:EtOAc) (Lit.125 E-isomer 52-3 °C)  
max: (film)/cm
-1 3279 (OH), 3034 (ArCH), 2948 (CH), 2918 (CH), 2853 (CH), 1512, 1010, 
972, 759 
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H: (300 MHz, CDCl3) 1.93 (1H, br s, OH), 2.34 (3H, s, CH3), 4.35 (2H, d, J 5.0, CH2), 6.31 
(1H, dt, J 16.0 and 5.0, =CHCH2), 6.55 (1H, d, J 16.0, CqCH=), 7.19 (2H, d, J 8.5, ArCH), 
7.26 (2H, d, J 8.5, ArCH) 
C: (75 MHz, CDCl3) 20.5 (CH3), 63.0 (CH2), 125.7 (ArCH), 126.7 (=CH), 128.6 (ArCH), 
130.4 (=CH), 133.4 (Cq), 136.5 (Cq) 
m/z: (EI)+ 148 (66%, [M]+), 105 (100), 92 (65) 
 
Hydroxymethyl 4-methoxycinnamol (203e) 
 
Alcohol 203e was prepared from ester 202e (1.06 g, 5.53 mmol) and DIBAL-H 
(1 M soln. in hexanes, 13.8 mL, 13.8 mmol) according to General Procedure 9. 
After 1 h and purification by flash column chromatography (Rf = 0.14, 
hexane:EtOAc, 3:1) afforded the product 203e as a white powder (870 mg, 94%). 
mp: 72-73 °C (from EtOAc) (Lit. 1264 72-74 °C (from hexane:Et2O)  
max: (film)/cm
-1 3410 (OH), 3028 (ArCH), 2933 (CH), 2839 (CH), 1606, 1511, 1335, 1157 
H: (300 MHz, CDCl3) 1.86 (1H, br s, OH), 3.78 (3H, s, CH3), 4.25 (2H, d, J 5.0, CH2), 6.21 
(1H, dt, J 16.3 and 5.0, =CHCH2), 6.51 (1H, d, J 16.3, CqCH=), 6.82 (2H, d, J 8.7, ArCH), 
7.29 (2H, d, J 8.7, ArCH) 
C: (75 MHz, CDCl3) 55.5 (CH3), 63.8 (CH2), 113.1 (ArCH), 126.5 (=CH), 128.4 (ArCH), 
129.5 (Cq), 131.5 (=CH), 158.2 (Cq) 
m/z: (EI)+ 164 (44%, [M]+), 121 (100), 108 (35) 
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General Procedure 10: PBr3 Bromination 
 
A solution of PBr3 (1 M soln. in CH2Cl2, 1.2 eq) was added dropwise over 1 min to a stirred 
solution of allylic alcohol (1eq) dissolved in CH2Cl2 (0.1 M) cooled to 0 °C. The reaction was 
stirred at 0 °C until the reaction was judged to be complete by TLC analysis. The reaction was 
quenched by the addition of water. The organic phase was separated and the aqueous phase 
further extracted with CH2Cl2 x 3. The combined organic phases were washed with brine and 
dried over MgSO4 before being concentrated in vacuo to afford the crude allylic bromide. 
 
Bromomethyl 4-nitrocinnamol (204a) 
 
Bromide 204a was prepared from alcohol 203a (1.88 g, 8.81 mmol) and PBr3 (1 
M soln. in CH2Cl2, 4.40 mL, 4.40 mmol) according to General Procedure 11. 
After 2 h and purification by flash column chromatography (Rf = 0.32, 
hexane:EtOAc, 5:1) afforded the product 204a  as a yellow powder (191 mg, 
84%). Bromide 204a was obtained as a 7:1 mixture of E:Z stereoisomers. In the case of the 
NMR spectra, only data for the major E stereoisomer is reported. 
mp: 66-68 °C (from hexane:EtOAc) (Lit.126 E-isomer 76 °C) 
max: (film)/cm
-1 3057 (ArCH), 1598 (ArC=C), 1519 (as NO2), 1436, 1345 (s NO2,),  
H: (300 MHz, CDCl3) 4.15 (2H, d, J 7.4, CH2), 6.55 (1H, dt, J 15.8 and 7.4, =CHCH2), 6.70 
(1H, d, J 15.8, CqCH=), 7.50 (2H, d, J 8.8, ArCH), 8.16 (2H, d, J 8.8, ArCH) 
C: (75 MHz, CDCl3) 32.0 (CH2), 124.1 (ArCH), 127.4 (ArCH), 130.0 (=CH), 132.2 (=CH), 
142.3 (Cq), 147.4 (Cq) 
m/z: (EI)+ 243 (7%, [M(81Br)]+), 241 (7, [M(79Br)]+), 162 (70), 115 (100 
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Bromomethyl 4-trifluoromethylcinnamol (204b) 
 
 
Bromide 204b was prepared from alcohol 203b (1.48 g, 7.31 mmol) and PBr3 (1 
M soln. in CH2Cl2, 8.8 mL, 8.8 mmol) according to General Procedure 10. After 
1 h and purification by flash column chromatography (Rf = 0.75, hexane:EtOAc, 
6:1) afforded the product 204b as a white crystalline solid (1.91 g, 99%) 
mp: 35-36 °C (from hexane:EtOAc) (Lit.127 35.9-36.8 °C) 
max: (film)/cm
-1 3042 (=CH), 2968 (CH), 2929 (CH), 1614 (C-O), 1413, 1325 (CF3), 1123 
H: (300 MHz, CDCl3) 4.15 (2H, d, J 7.5, CH2), 6.48 (1H, dt, J 15.6 and 7.5,  =CHCH2), 6.65 
(1H, d, J 15.6, CqCH=), 7.45 (2H, d, J 8.1, ArCH), 7.57 (2H, d, J 8.1, ArCH) 
C: (75 MHz, CDCl3) 32.4 (CH2), 124.2 (q, J 272, CF3), 125.6 (ArCH), 126.9 (ArCH), 127.9 
(=CH), 129.9 (q, J 32, CqCF3), 132.8 (=CH), 139.3 (Cq) 
m/z: (EI)+ 266 (55%, [M(81Br)]+), 264 (55, [M(79Br)]+), 185 (100) 
 
Bromomethyl 4-bromocinnamol (204c) 
 
 
Bromide 204c was prepared from alcohol 203c (1.88 g, 8.81 mmol) and PBr3 (1 
M soln. in CH2Cl2, 4.4 mL, 4.4 mmol) according to General Procedure 10. After 2 
h and purification by flash column chromatography (Rf = 0.75, hexane:EtOAc, 
1:1) afforded the product 204c as a white powder (2.38 g, 99%). 
mp: 72-74 °C (from hexane:EtOAc) (Lit.128 72-76 °C) 
max: (film)/cm
-1 3014 (CH), 1643 (C=C), 1584 (ArC=C), 1487 (ArC=C), 1214, 1202, 973, 
756 
CF3
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H: (300 MHz, CDCl3) 4.13 (2H, d, J 7.7, CH2), 6.37 (1H, dt, J 15.5 and 7.7,  =CHCH2), 6.55 
(1H, d, J 15.5, CqCH=), 7.23 (2H, d, J 8.5, ArCH), 7.44 (2H, d, J 8.5, ArCH) 
C: (75 MHz, CDCl3) 33.1 (CH2), 122.1 (Cq), 125.9 (=CH), 128.2 (ArCH), 131.7 (ArCH), 
133.3 (=CH), 134.7 (Cq) 
m/z: (EI)+ 278 (5%, [M(81Br, 81Br]+), 276 (5%, [M(81Br, 79Br]+), 274 (2%, [M(79Br, 79Br]+),  
228 (30), 147 (100), 116 (85), 84 (90) 
 
Bromomethyl 4-methylcinnamol (204d) 
 
Bromide 204d was prepared from alcohol 203d (0.97 g, 6.57 mmol) and PBr3 (1 
M soln. in CH2Cl2, 7.9 mL, 7.9 mmol) according to General Procedure 10. After 
1 h and purification by flash column chromatography (Rf = 0.75, hexane:EtOAc, 
6:1) afforded the product 204d as a white powder (1.15 g, 83%). 
mp: 64-66 °C (from hexane:EtOAc) (Lit.129 64-65 °C) 
max: (film)/cm
-1 3023 (ArCH), 2962 (CH), 2921 (CH), 1641, 1511, 1199, 971, 801 
H: (300 MHz, CDCl3) 2.31 (CH3), 4.15 (2H, d, J 7.4, CH2), 6.33 (1H, dt, J 7.4 and 15.8, 
=CHCH2), 6.61 (1H, d, J 15.8, CqCH=), 7.12 (2H, d, J 8.8, ArCH), 7.26 (2H, d, J 8.8, ArCH) 
C: (75 MHz, CDCl3) 20.0 (CH3), 32.6 (CH2), 123.0 (=CH), 125.5 (ArCH), 128.1 (ArCH), 
131.0 (Cq), 133.3 (=CH), 136.8 (Cq) 
m/z: (EI)+ 212 (5%, [M(81Br)]+), 210 (5, [M(79Br)]+), 131 (100, [M-Br]+) 
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Chloromethyl 4-methoxycinnamol (205) 
 
 
Thionyl chloride (0.27 mL, 3.71 mmol) was added to a stirred solution of alcohol 
203e (580 mg, 3.53 mmol) in Et2O (7 mL) cooled to 0 °C. The reaction was 
stirred for 1 min at 0 °C before the solvent was removed in vacuo to give the 
crude product 203e as a pale yellow oil (603 mg) that was used straight away in 
the next reaction without further purification. 
H: (300 MHz, CDCl3) 3.79 (3H, s, CH3), 4.23 (2H, d, J 5.0, CH2), 6.27 (1H, dt, J 16.3 and 
5.0, =CHCH2), 6.55 (1H, d, J 16.3, CqCH=), 6.83 (2H, d, J 8.7, ArCH), 7.31 (2H, d, J 8.7, 
ArCH) 
 
General Procedure 11: Alkylation of 3-(p-Toluenesulfonyl)aminopropanol) 
 
Cesium carbonate (1.3 eq) was added to a stirred solution of sulfonamide (1 eq) dissolved in 
MeCN (0.1 M). The resulting mixture was cooled to 0 °C and the alkylating agent (1 eq) was 
added in one portion. The reaction was allowed to warm to room temperature and stirred 
overnight. The reaction was quenched by the addition of water and the solvent removed in 
vacuo. The aqueous phase was extracted with CH2Cl2 x 4 and the combined organic phases 
were washed with brine and dried over MgSO4 before being concentrated in vacuo to afford 
the crude alkylated product. 
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(E)-N-(3-Hydroxypropyl)-4-methyl-N-(3-(4-nitrophenyl)allyl)benzenesulfonamide (207a) 
 
Alcohol 207a was prepared from sulfonamide 206 (0.58 g, 2.53 mmol), 
Cs2CO3 (0.91 g, 2.79 mmol) and bromide 204a (0.61 g, 2.53 mmol) according 
to General Procedure 11. Purification by flash column chromatography (Rf = 
0.30, hexane:EtOAc, 1:2) afforded the product 207a as a yellow oil (0.62 g, 
63%). 
max: (film)/cm
-1 3533 (OH), 2926 (CH), 2876 (CH), 2855(CH), 1597 (ArC=C), 1517 (as 
NO2), 1343 (as SO2, s NO2), 1157 (s SO2) 
H: (300 MHz, CDCl3) 1.15 (1H, br s, OH), 1.69-1.78 (2H, m, CH2CH2CH2), 2.40 (3H, s, 
CH3), 3.20 (2H, t, J 6.6, NCH2CH2), 3.70 (2H, t, J 5.7, CH2OH), 3.97 (2H, d, J 6.3, 
CH2CH=), 6.16 (1H, dt, J 16.3 and 6.3, CH2CH=), 6.51 (1H, d, J 16.3, CqCH=), 7.29 (2H, d, J 
8.1, ArCH), 7.35 (2H, d, J 8.8, ArCH), 7.70 (2H, d, J 8.1, ArCH), 8.10 (2H, d, J 8.8, ArCH) 
C: (75 MHz, CDCl3) 21.5 (CH3), 31.0 (CH2CH2CH2), 44.8 (NCH2), 50.3 (NCH2), 58.9 
(OCH2), 123.9 (ArCH), 127.0 (ArCH), 127.1 (ArCH), 129.5 (=CH), 129.8 (ArCH), 131.4 
(=CH), 136.4 (Cq), 142.5 (Cq), 143.7 (Cq), 147.0 (Cq) 
m/z: (ES)+ 413.1 (100%, [M+Na]+) 
HRMS: Found: (M+Na)+ 413.1153. C19H22N2NaO5S requires M, 413.1147 
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(E)-N-(3-Hydroxypropyl)-4-methyl-N-(3-(4-(trifluoromethyl)phenyl)allyl)benzene 
sulfonamide (207b) 
 
Alcohol 207b was prepared from sulfonamide 206 (1.01 g, 4.41 mmol), 
Cs2CO3 (1.87 g, 5.73 mmol) and bromide 204b (1.17 g, 4.41 mmol) according 
to General Procedure 11. Purification by flash column chromatography (Rf = 
0.33, hexane:EtOAc, 1:1) afforded the product 207b as a white crystalline 
powder (1.63 g, 90%). 
mp: 58-60 °C (from hexane:EtOAc)  
µ: Found: C, 58.45; H, 5.47; N, 3.87. C20H22F3NO3S requires C, 58.10; H, 5.36; N, 3.39% 
max: (film)/cm
-1 3520 (OH), 2930 (CH), 1615 (C=C), 1598 (ArC=C), 1494 Ar(C=C), 1326 
(CF3), 1158 (SO2), 1067 (C-O) 
H: (300 MHz, CDCl3) 1.67-1.78 (2H, m, CH2CH2CH2), 2.37 (3H, s, CH3), 2.72 (1H, br s, 
OH), 3.28 (2H, t, J 6.6, NCH2CH2), 3.68 (2H, t, J 5.7, CH2OH), 3.95 (2H, d, J 6.6, CH2CH=), 
6.03 (1H, dt, J 15.8 and 6.6, CH2CH=), 6.45 (1H, d, J 15.8, CqCH=), 7.23-7.32 (4H, stack, 
ArCH), 7.48 (2H, d, J 8.1, ArCH), 7.69 (2H, d, J 8.1, ArCH) 
C: (75 MHz, CDCl3) 21.1 (CH3), 30.8 (CH2CH2CH2), 44.4 (NCH2), 50.2 (NCH2), 58.8 
(OCH2), 124.4 (q, J 272, CF3), 125.8 (ArCH), 126.9 (ArCH), 127.4 (=CH), 127.5 (ArCH), 
129.9 (q, J 32, CqCF3), 130.2 (ArCH), 132. (=CH), 137.0 (Cq), 140.0 (Cq), 144.1 (Cq) 
m/z: (ES)+ 436.2 (100%, [M+Na]+) 
HRMS: Found: (M+Na)+ 436.1173. C20H22F3NNaO3S requires M, 436.1170 
 
 
 
CF3
Ts
N
OH
 225 
(E)-N-(3(4-Bromophenyl)allyl)N(3-hydroxypropyl)-4-methylbenzenesulfonamide (207c) 
 
Alcohol 207c was prepared from sulfonamide 204 (1.92 g, 8.36 mmol), Cs2CO3 
(3.54 g, 11.8 mmol) and bromide 204d  (2.30 g, 8.36 mmol) according to 
General Procedure 11. Purification by flash column chromatography (Rf = 0.36, 
hexane:EtOAc, 1:1) afforded the product 207c as a colourless oil (3.11 g, 88%). 
max: (film)/cm
-1 3526 (OH), 3030 (ArCH), 2928 (CH), 2877 (CH), 1652 
(C=C), 1598 (ArC=C), 1487 (ArC=C), 1334 (as SO2), 1157 (s SO2), 1071 (C-O) 
H: (300 MHz, CDCl3) 1.66-1.67 (2H, m, CH2CH2CH2), 2.39 (3H, s, CH3), 2.60 (1H, br s, 
OH), 3.26 (2H, t, J 6.4, NCH2CH2), 3.68 (2H, t, J 5.9, CH2OH), 3.91 (2H, d, J 6.6, CH2CH=), 
5.91 (1H, dt, J 6.6 and 15.8, CH2CH=), 6.35 (1H, d, J 15.8, CqCH=), 7.06 (2H, d, J 8.5, 
ArCH), 7.27 (2H, d, J 8.1, ArCH), 7.36 (2H, d, J 8.5, ArCH), 7.68 (2H, d, J 8.1, ArCH) 
C: (75 MHz, CDCl3) 21.4 (CH3), 31.0 (CH2CH2CH2), 44.4 (NCH2), 50.3 (NCH2), 58.8 
(OCH2), 121.7 (Cq), 124.9 (=CH), 127.1 (ArCH), 127.9 (ArCH), 129.7 (ArCH), 131.8 
(ArCH), 132.4 (=CH), 135.0 (Cq), 136.6 (Cq), 143.4 (Cq) 
m/z: (ES)+ 448.0 (89%, [M(81Br)+Na]+), 446.0 (100, [M(79Br)+Na]+) 
HRMS: [Found: (M(79Br)+Na)+ 446.0421. C19H22BrNNaO3S requires M, 446.0401] 
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(E)-N-(3-Hydroxypropyl)-4-methyl-N-(3-(p-tolyl)allyl)benzenesulfonamide (207d) 
 
Alcohol 207d was prepared from sulfonamide 206 (1.05 g, 4.56 mmol), 
Cs2CO3 (1.93 g, 5.93 mmol) and bromide 204d (0.97 g, 4.56 mmol) according 
to General Procedure 11. Purification by flash column chromatography (Rf = 
0.33, hexane:EtOAc, 1:1) afforded the product 207d as a colourless oil (1.46 g, 
89%). 
max: (film)/cm
-1 3533 (OH), 3027 (=CH), 2924 (CH), 2876 (CH), 1653, 1598 (ArC=C), 1513 
(C=C), 1494 (ArC=C), 1453, 1335 (as SO2), 1157 (s SO2), 1089 (C-O) 
H: (300 MHz, CDCl3) 1.65-1.76 (2H, m, CH2CH2CH2), 2.30 (3H, s, CH3), 2.35-2.43 (4H, 
stack, CH3 and OH), 3.25 (2H, t, J 6.6, NCH2CH2), 3.71 (2H, q, J 5.7, CH2OH), 3.93 (2H, d, J 
7.0, CH2CH=), 5.84 (1H, dt, J 15.5 and 7.0, CH2CH=), 6.35 (1H, d, J 15.5, CqCH=), 7.05-
7.16 (5H, stack, ArCH), 7.25 (2H, d, J 8.0, ArCH), 7.73 (2H, d, J 8.0, ArCH) 
C: (75 MHz, CDCl3) 20.9 (CH3), 30.6 (CH2CH2CH2), 43.6 (NCH2), 50.3 (NCH2), 58.4 
(CH2OH), 122.4 (=CH), 126.0 (ArCH), 127.0 (ArCH), 128.9 (ArCH), 130.5 (ArCH), 132.9 
(Cq), 133.5 (=CH), 136.0 (Cq), 137.6 (Cq), 143.1 (Cq) 
m/z: (ES)+ 382.2 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 382.1455. C20H25NNaO3S requires M, 382.1453] 
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(E)-N-(3-Hydroxypropyl)-N-(3-(4-methoxyphenyl)allyl)-4-methylbenzene sulfonamide 
(207e) 
 
Alcohol 207e was prepared from sulfonamide 204 (0.58 g, 3.53 mmol), 
Cs2CO3 (1.50 g, 4.59 mmol) and chloride 205 (603 mg) according to General 
Procedure 11. Purification by flash column chromatography (Rf = 0.38, 
hexane:EtOAc, 1:1) afforded the product 207e as a colourless oil (101 mg, 
44% over 2 synthetic steps). 
max: (film)/cm
-1 3525 (OH), 3032 (=CH), 2934 (CH), 2838 (CH), 1651, 1607, 1511 (C=C), 
1455, 1332 (as SO2), 1250, 1156 (s SO2), 1089 (C-O), 1032 
H: (300 MHz, CDCl3) 1.65-1.79 (2H, m, CH2CH2CH2), 2.39 (3H, s, CH3), 2.49 (1H, br s, 
OH), 3.25 (2H, t, J 6.4, NCH2CH2), 3.72 (2H, br s, CH2OH), 3.76 (3H, s, CH3), 3.91 (2H, d, J 
7.2, CH2CH=), 5.85 (1H, dt, J 15.8 and 7.2, CH2CH=), 6.35 (1H, d, J 15.8, CqCH=), 6.78 
(2H, d, J 8.0, ArCH), 7.13 (2H, d, J 8.0, ArCH), 7.28 (2H, d, J 8.8, ArCH), 7.71 (2H, d, J 8.8, 
ArCH) 
C: (75 MHz, CDCl3) 21.4 (CqCH3), 30.7 (CH2CH2CH2), 43.6 (NCH2), 50.6 (NCH2), 55.2 
(OCH3), 58.6 (CH2OH), 113.9 (ArCH), 121.4 (=CH), 127.1 (ArCH), 127.6 (ArCH), 128.7 
(Cq), 129.7 (ArCH), 133.4 (=CH), 136.6 (Cq), 143.4 (Cq), 159.4 (Cq) 
m/z: (ES)+ 398.3 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 398.1392. C20H25NNaO4S requires M, 398.1402] 
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N-Cinnamyl-N-(3-hydroxypropyl)-4-methylbenzenesulfonamide (207f) 
 
Alcohol 207f was prepared from sulfonamide 206 (1.02 g, 4.44 mmol), Cs2CO3 
(1.59 g, 4.88 mmol) and cinnamyl bromide (0.87 g, 4.43 mmol) according to 
General Procedure 11. Purification by flash column chromatography (Rf = 0.30, 
hexane:EtOAc, 1:1) afforded the product  207f as a white amorphous powder 
(1.24 g, 81%). 
mp: 69-70 °C (from hexane:EtOAc) 
µ: Found: C, 66.10; H, 6.87; N, 4.18. C19H23NO3S requires C, 66.06; H, 6.71; N, 4.05% 
max: (film)/cm
-1 3535 (OH), 3027 (=CH), 2927 (CH), 1598 (ArC=C), 1495 (ArC=C), 1335 
(as SO2), 1157 (s SO2), 1089 (C-O) 
H: (300 MHz, CDCl3) 1.66-1.77 (2H, m, CH2CH2CH2), 2.36 (3H, s, CH3), 2.51 (1H, t J 5.7, 
OH), 3.27 (2H, t, J 6.6, NCH2CH2), 3.67 (2H, t, J 5.7, CH2OH), 3.93 (2H, d, J 7.0, CH2CH=), 
5.91 (1H, dt, J 15.8 and 7.0, CH2CH=), 6.42 (1H, d, J 15.8, CqCH=), 7.19-7.27 (7H, stack, 
ArCH), 7.70 (2H, d, J 8.1, ArCH) 
C: (75 MHz, CDCl3) 21.3 (CH3), 30.9 (CH2CH2CH2), 44.1 (NCH2), 50.3 (NCH2), 58.8 
(CH2OH), 123.9 (=CH), 126.3 (ArCH), 127.0 (ArCH), 128.4 (ArCH), 129.7 (ArCH), 133.7 
(=CH), 136.0 (Cq), 136.6 (Cq), 143.3 (Cq) 
m/z: (ES)+ 368.0 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 368.1301. C19H23NNaO3S requires M, 368.1296] 
General Procedure 12: Swern oxidation 
Anhydrous DMSO (3 eq) was added at a rapid rate to a solution of oxalyl chloride (1.5 eq) 
dissovled in CH2Cl2 (0.2 M) at -78 °C. The resulting mixture was stirred for 5 min before a 
Ts
N
OH
 229 
solution of the alcohol (1 eq) dissolved in CH2Cl2 (0.2 M) was added dropwise over 10 min. 
After 30 min Et3N (5 eq) was added dropwise over 1 min and the resulting solution was 
stirred for a further 3 h at -78 °C before being allowed to warm to room temperature. Water 
was added and the organic phase was separated before the aqueous phase was further 
extracted with 3 x CH2Cl2. The combined organic phases were washed with water and brine 
before being dried over MgSO4 and evaporated in vacuo to give the crude aldehyde. 
 
(E)-4-Methyl-N-(3-(4-nitrophenyl)allyl)-N-(3-oxopropyl)benzenesulfonamide (194a) 
 
Aldehyde 194a was prepared from alcohol 207a (0.60 g, 1.55 mmol), oxalyl 
chloride (170 µL, 1.90 mmol), DMSO (260 µL, 3.66 mmol) and Et3N (1.10 mL, 
7.86 mmol) according to general procedure 12. Work-up afforded 194a as a 
yellow oil (0.60 g, quant.).  
Rf : 0.43 (hexane:EtOAc, 1:1)  
max: (film)/cm
-1 2924 (CH), 2857 (CH), 1721 (C=O), 1597, 1607, 1516 (as NO2), 1338 (s 
NO2, as SO2), 1155 (s SO2) 
H: (300 MHz, CDCl3) 2.42 (3H, s, CH3), 2.83 (2H, t, J 6.8, CH2CHO), 3.46 (2H, t, J 6.8, 
NCH2CH2), 3.98 (2H, d, J 6.3, CH2CH=), 6.18 (1H, dt, J 15.8 and 6.3, CH2CH=), 6.53 (1H, d, 
J 15.8, CqCH=), 7.32 (2H, d, J 8.1, ArCH), 7.39 (2H, d, J 8.6, ArCH), 7.70 (2H, d, J 8.1, 
ArCH), 8.13 (2H, d, J 8.6, ArCH), 9.73 (1H, s, CHO) 
C: (75 MHz, CDCl3) 21.5 (CH3), 41.6 (CH2), 43.7 (CH2), 50.9 (CH2CH=), 123.9 (ArCH), 
127.0 (ArCH), 127.2 (ArCH), 129.3 (=CH), 129.9 (ArCH) 131.5 (=CH), 136.1 (Cq), 142.5 
(Cq), 143.9 (Cq), 147.1 (Cq), 200.2 (C=O), 
m/z: (ES)+ 411.3 (100%, [M+Na]+) 
NO2
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HRMS: [Found: (M+Na)+ 411.0982. C19H20N2NaO5S requires M, 411.0991] 
 
(E)-4-Methyl-N-(3-oxopropyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide  (194b) 
 
Aldehyde 194b was prepared from alcohol 207b (1.07 g, 2.59 mmol), oxalyl 
chloride (280 µL, 3.14 mmol), DMSO (440 µL, 6.20 mmol) and Et3N (1.82 
mL, 13.00 mmol) according to general procedure 12. Work-up afforded 194b 
as a white crystalline powder (1.02 g, 96%). 
Rf : 0.54 (hexane:EtOAc, 1:1) 
mp: 60-62 °C (from CH2Cl2:EtOAc) 
max: (film)/cm
-1 2956 (CH), 2934 (CH), 1722 (C=O), 1613 (C=C), 1324 (CF3), 1154 (SO2), 
1107 
H: (300 MHz, CDCl3) 2.41 (3H, s, CH3), 2.81 (2H, t, J 7.0, CH2CHO), 3.45 (2H, t, J 7.0, 
NCH2CH2), 3.95 (2H, d, J 6.3, CH2CH=), 6.06 (1H, dt, J 6.3 and 15.8, CH2CH=), 6.47 (1H, d, 
J 15.8, CqCH=), 7.29 (2H, d, J 8.1, ArCH), 7.33 (2H, d, J 8.5, ArCH), 7.51 (2H, d, J 8.1, 
ArCH), 7.69 (2H, d, J 8.15 ArCH), 9.71 (1H, s, CHO) 
C: (75 MHz, CDCl3) 21.5 (CH3), 41.5 (CH2), 43.9 (CH2), 51.1 (CH2), 124.1 (q, J 272, CF3), 
125.7 (ArCH), 126.7 (ArCH), 126.9 (=CH), 127.3 (ArCH), 129.8 (q, J 32, CqCF3), 129.9 
(ArCH), 132.5 (=CH), 136.3 (Cq), 139.5 (Cq), 143.9 (Cq), 200.2 (C=O) 
m/z: (ES)+ 466.1 (100%, [M+Na+MeOH]+), 434.1 (50, [M+Na]+ 
HRMS: Found: (M+Na)+ 434.1029. C20H20F3NNaO3S requires M, 436.1170 
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(E)-N-(3-(4-Bromophenyl)allyl)-4-methyl-N-(3-oxopropyl)benzenesulfonamide (194c) 
 
Aldehyde 194c was prepared from alcohol 207c (1.14 g, 2.69 mmol), oxalyl 
chloride (290 µL, 3.25 mmol), DMSO (460 µL, 6.48 mmol) and Et3N (1.90 
mL, 13.58 mmol) according to general procedure 12. Work-up afforded 207c 
as a white crystalline powder (1.02 g, 96%). 
Rf : 0.29 (hexane:EtOAc, 2:1) 
mp: 61-63 °C (from hexane:EtOAc) 
max: (film)/cm
-1 2956 (CH), 2917 (CH), 1720 (C=O), 1333 (as SO2), 1154 (s SO2) 
H: (300 MHz, CDCl3) 2.43 (3H, s, CH3), 2.82 (2H, t, J 7.0, CH2CHO), 3.44 (2H, t, J 7.0, 
NCH2CH2), 3.92 (2H, d, J 6.6, CH2CH=), 5.96 (1H, dt, J 15.8 and 6.6, CH2CH=), 6.39 (1H, d, 
J 15.8, CqCH=), 7.12 (2H, d, J 8.5, ArCH), 7.31 (2H, d, J 8.1, ArCH), 7.41 (2H, d, J 8.5, 
ArCH), 7.70 (2H, d, J 8.1, ArCH), 9.72 (1H, s, CHO) 
C: (75 MHz, CDCl3) 21.5 (CH3), 41.3 (NCH2CH2), 43.8 (CH2CHO), 51.1 (NCH2CH=), 121.9 
(CqBr), 124.8 (CH2CH=), 127.1 (ArCH), 127.3 (ArCH), 128.0 (ArCH), 129.9 (ArCH), 131.7 
(ArCH) 132.8 (=CHCq), 135.0 (=CHCq), 136.2 (CqCH3), 143.7 (CqSO2), 200.1 (C=O) 
m/z: (ES)+ 477.9 (98%, [M(81Br)+MeOH+Na]+), 477.9 (100, [M(79Br)+MeOH+Na]+), 445.9 
(95, [M(81Br)+ Na]+), 443.8 (100, [M(79Br+Na]+),   
HRMS: [Found: (M(79Br)+Na)+ 444.0244. C19H20BrNNaO3S requires M, 444.0245] 
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(E)-4-Methyl-N-(3-oxopropyl)-N-(3-(p-tolyl)allyl)benzenesulfonamide (194d) 
 
Aldehyde 194d was prepared from alcohol 207d (690 mg, 1.92 mmol), oxalyl 
chloride (252 µL 2.88 mmol), DMSO (409 µL, 5.76 mmol) and Et3N (1.39 mL, 
9.60 mmol) according to general procedure 12. Work-up afforded 194d as a 
colourless oil (685 mg, 94%). 
Rf : 0.60 (hexane:EtOAc, 1:1) 
max: (film)/cm
-1 2922 (CH), 1722 (C=O), 1598 (ArC=C), 1494 (ArC=C), 1335 (as SO2), 1155 
(s SO2) 
H: (400 MHz, CDCl3) 2.31 (3H, s, CH3), 2.44 (3H, s, CH3), 2.82 (2H, t, J 7.0, CH2CHO), 
3.47 (2H, t, J 7.0, NCH2CH2), 3.93 (2H, d, J 8.7, CH2CH=), 5.85 (1H, dt, J 16.0 and 8.7, 
CH2CH=), 6.40 (1H, d, J 16.0, CqCH=), 7.09 (2H, d, J 8.0, ArCH), 7.17 (2H, d, J 8.0, ArCH), 
7.31 (2H, d, J 9.0, ArCH), 7.73 (2H, d, J 9.0, ArCH), 9.72 (1H, s, CHO) 
C: (101 MHz, CDCl3) 21.8 (CH3), 22.1 (CH3), 41.8 (CH2CHO), 44.5 (NCH2CH2), 51.9 
(NCH2CH=), 123.4 (=CH), 127.0 (ArCH), 128.0 (ArCH), 128.0 (ArCH), 130.0 (ArCH), 
130.5 (ArCH), 133.9 (Cq), 134.8 (=CH), 137.2 (Cq), 138.7 (Cq), 144.2 (Cq), 200.8 (CHO) 
m/z: (ES)+ 412 (45%, [M+MeOH+Na]+), 380.0 (100, [M+Na]+) 
HRMS: [Found: (M+Na)+ 380.1292. C20H23NNaO3S requires M, 380.1296] 
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(E)-N-(3-(4-Methoxyphenyl)allyl)-4-methyl-N-(3-oxopropyl)benzenesulfonamide (194e) 
 
Aldehyde 194e was prepared from alcohol 207e (350 mg, 0.93 mmol), oxalyl 
chloride (122 µL, 1.40 mmol), DMSO (199 µL, 2.80 mmol) and Et3N (0.65 
mL, 4.67 mmol) according to general procedure 12. Work-up afforded the 
product 194e as a colourless oil (319 mg, 92%). 
Rf : 0.48 (hexane:EtOAc, 1:1) 
max: (film)/cm
-1 2960 (CH), 2933 (CH), 1720 (C=O), 1606 (ArC=C), 1510 (ArC=C), 1334 
(as SO2), 1155 (s SO2) 
H: (300 MHz, C6D6) 2.04 (3H, s, CqCH3), 2.48 (2H, t, J 7.0, CH2CHO), 3.34-3.49 (4H, stack, 
OCH3 and NCH2CH2), 3.75 (2H, d, J 7.7, CH2CH=), 5.84 (1H, dt, J 16.0 and 7.7, CH2CH=), 
6.30 (1H, d, J 16.0, CqCH=), 6.78 (2H, d, J 7.8, ArCH), 6.93 (2H, d, J 7.0, ArCH), 7.34 (2H, 
d, J 7.0, ArCH), 7.65 (2H, d, J 7.8, ArCH), 9.45 (1H, s, CHO) 
C: (101 MHz, C6D6) 21.0 (CqCH3), 41.3 (CH2CHO), 43.9 (NCH2CH2), 51.4 (NCH2CH=), 
54.8 (OCH3), 114.3 (ArCH), 122.0 (=CH), 127.5 (ArCH), 128.0 (ArCH), 129.2 (Cq), 129.7 
(ArCH), 133.7 (=CH), 137.4 (Cq), 143.1 (Cq), 160.0 (Cq), 199.5 (CHO) 
m/z: (ES)+ 428.2 (30%, [M+MeOH+Na]+), 396.2 (100, [M+Na]+) 
HRMS: [Found: (M+Na)+ 396.1240. C20H23NNaO4S requires M, 396.1245] 
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N-Cinnamyl-4-methyl-N-(3-oxopropyl)benzenesulfonamide (194f) 
 
NMO (611 mg, 5.22 mmol) was added to a stirred solution of alcohol 207f (1.00 
g, 2.90 mmol) in CH2Cl2 (15 mL) containing 4 Å MS cooled to 0 °C. The 
reaction was stirred for 15 min before TPAP (91 mg, 0.29 mmol) was added in 
one portion and the reaction stirred for a further 10 min before being allowed to 
warm to room temperature. After 0.5 h the reaction was filtered through a plug of silica and 
washed with further portions of CH2Cl2 (3 x 10 mL). The combined filtrates were 
concentrated in vacuo and the crude product purified by flash column chromatography (Rf = 
0.55, hexane:EtOAc, 1:1) to give the product 194f as a colourless oil (848 mg, 85 % yield). 
max: (film)/cm
-1 3027 (=CH), 2924 (CH), 1721 (C=O), 1597 (ArC=C), 1494 (ArC=C), 1449, 
1334 (as SO2), 1153 (s SO2) 
H: (300 MHz, CDCl3) 2.43 (3H, s, CH3), 2.83 (2H, t, J 7.0, CH2CHO), 3.45 (2H, t, J 7.0, 
NCH2CH2), 3.94 (2H, d, J 6.6, CH2CH=), 5.95 (1H, dt, J 15.8 and 6.6, CH2CH=), 6.45 (1H, d, 
J 15.8, CqCH=), 7.20-7.33 (7H, stack, ArCH), 7.72 (2H, d, J 8.5, ArCH), 9.73 (1H, s, CHO) 
C: (75 MHz, CDCl3) 21.5 (CH3), 41.2 (CH2CHO), 43.8 (NCH2CH2), 51.1 (NCH2CH=), 123.8 
(=CH), 126.4 (ArCH), 127.2 (ArCH), 128.0 (ArCH), 128.6 (ArCH), 129.8 (ArCH), 134.1 
(=CH), 135.9 (Cq), 136.3 (Cq), 142.5 (Cq), 143.6 (Cq), 200.3 (CHO) 
m/z: (ES)+ 398.2 (20%, [M+MeOH+Na]+), 366.1 (100%, [M+Na]+) 
HRMS: [Found: (M+Na)+ 366.1146. C19H21NNaO3S requires M, 366.1140] 
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General Procedure 13: Prins Cyclisation 
MeAlCl2 (2 eq) was added dropwise over 1 min to a solution of the aldehyde (1 eq) dissolved 
in CH2Cl2 (0.1 M) at -78 °C. The resulting solution was stirred at -78 °C for 8 h before being 
allowed to warm to room temperature overnight. The solution was quenched by the addition 
of water. The organic phase was separated and the aqueous phase was further extracted with 3 
x CH2Cl2. The combined organic phases were washed with water and brine before being dried 
over MgSO4 and evaporated in vacuo to give the crude cyclisation product. 
 
(3S*,4S*)-3-((R*)-chloro(4-nitrophenyl)methyl)-1-tosylpiperidin-4-ol (197a) 
 
 
Piperidine 207a was prepared from aldehyde 194a (99 mg, 0.26 
mmol) and MeAlCl2 (1 M soln. in hexanes, 0.52 mL, 0.52 mmol) in 
CH2Cl2 (2.6 mL) according to General Procedure 13. Purification by 
flash column chromatography (Rf = 0.30, hexane:EtOAc, 1:1) afforded the products 197(R)a 
and 198(S)a in a 5:1 mixture as a colourless oil (49 mg, 77%). In he case of the NMR spectra, 
only data for the major piperidine 197(R)a are reported. 
max: (film)/cm
-1 3539 (OH), 2925 (CH), 2857 (CH), 1518 (as NO2), 1341 (as SO2, s NO2), 
1156 (s SO2) 
H: (300 MHz, CDCl3) 1.48-1.55 (1H, m, CHHCHOH), 1.74-1.86 (2H, stack, CHHCHOH 
and OH), 1.94-1.98 (1H, m, CHCHOH), 2.34 (3H, s, CH3), 2.56-2.63 (1H, m, NCHHCH2), 
2.83 (1H, dd, J 11.9 and 8.9, NCHHCH), 3.31-3.45 (2H, stack, NCHHCH2 and NCHHCH), 
3.98-3.63 (1H, m, CHOH), 5.35 (1H, d, J 5.27, CHCl), 7.17-7.33 (6H, stack, ArCH ), 7.48 
(2H, d, J 8.2, ArCH) 
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C: (101 MHz, CDCl3) 21.6 (CH3), 31.2 (NCH2CH2), 43.9 (CH2), 44.0 (CH2), 49.8 
(CHCHOH),  62.1 (CHCl), 67.7 (CHOH), 123.9 (ArCH), 127.1 (ArCH), 129.1 (ArCH), 129.8 
(ArCH), 133.4 (Cq), 139.0 (Cq), 143.7 (Cq), 147.0 (Cq) 
m/z: (ES)+ 447.0 (100%, [M+Na]+) 
HRMS: Found: (M+Na)+ 447.0798. C19H22ClN2NaO5S requires M, 447.0757 
 
(3S*,4S*)-3-((R*)-(4-bromophenyl)chloromethyl)-1-tosylpiperidin-4-ol (197c) 
 
Piperidine 207c was prepared from aldehyde 194c (105 mg, 0.25 
mmol) and MeAlCl2 (1 M soln. in hexanes, 0.50 mL, 0.50 mmol) in 
CH2Cl2 (2.5 mL) according to General Procedure 13. Purification by 
flash column chromatography (Rf = 0.38, hexane:EtOAc, 1:1) afforded the products 197(R)c 
and 198(S)c in a 6:1 mixture as a white foam (88 mg, 77%). In the case of the NMR spectra, 
only data for the major piperidine 197(R)c are reported. 
max: (film)/cm
-1 3535 (OH), 2924 (CH), 2857 (CH), 1333 (as SO2), 1154 (s SO2) 
H: (400 MHz, CDCl3) 1.53 (1H, dt, J 9.1 and 3.6, CHHCHOH), 1.73-1.83 (1H, m, 
CHHCHOH), 1.93-1.98 (2H, stack, CHCHOH and OH), 2.36 (3H, s, CH3), 2.59-2.65 (1H, m, 
NCHHCH2), 2.79 (1H, dd, J 11.4 and 8.9, NCHHCH), 3.28 (1H, dd, J 11.4 and 2.3, 
NCHHCH). 3.39-3.42 (1H, m, NCHHCH), 3.50-3.55 (1H, m, CHOH), 5.34 (1H, d, J 5.0, 
CHCl), 7.16 (2H, d, J 8.4, ArH), 7.24 (2H, d, J 8.2, ArH), 7.42 (2H, d, J 8.2, ArH), 7.50 (2H, 
d, J 8.4, ArH) 
C: (101 MHz, CDCl3) 21.6 (CH3), 32.2 (NCH2CH2), 43.8 (CH2), 43.9 (CH2), 49.7 
(CHCHOH),  60.5 (CHCl), 67.5 (CHOH), 123.3 (ArCH), 127.6 (ArCH), 129.1 (ArCH), 131.9 
(ArCH), 133.4 (Cq), 133.2 (Cq), 138.1 (Cq), 143.9 (Cq) 
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m/z: (ES)+ 481.9 (100%, [M(81Br)+Na]+), 479.9 (72, [M(79Br)+Na]+), 445.9 (90, 
[M(81Br)+Na-Cl]+), 443.8 (86, [M(79Br+Na-Cl]+) 
HRMS: Found: (M+Na)+ 480.0010. C19H21BrClNNaO3S requires M, 447.0012 
 
(3S*,4S*)-3-((R*)-chloro(p-tolyl)methyl)-1-tosylpiperidin-4-ol (197d) 
 
Piperidine 197d was prepared from aldehyde 194d (74 mg, 0.21 
mmol) and MeAlCl2 (1 M soln. in hexanes, 0.42 mL, 0.42 mmol) in 
CH2Cl2 (2.0 mL) according to General Procedure 13. Purification by 
flash column chromatography (Rf = 0.47, hexane:EtOAc, 1:1) afforded the products 197(R)d 
and 198(S)d in a 3:1 mixture as a colourless oil (26 mg, 32%). In the case of the NMR 
spectra, only data for the major piperidine 197(R)d are reported. 
max: (film)/cm
-1 3537 (OH), 2924 (CH), 2855 (CH), 1333 (as SO2), 1153 (s SO2) 
H: (400 MHz, CDCl3) 1.53-1.56 (2H, stack CHHCHOH and OH), 1.75-1.84 (1H, m, 
CHHCHOH), 1.98-1.09 (1H, m, CHCHOH), 2.25 (3H, s, CH3), 2.36 (3H, s, CH3), 2.60-2.68 
(1H, m, NCHHCH2), 2.83 (1H, dd, J 11.6 and 9.2, NCHHCH), 3.33-3.40 (2H, stack, 
NCHHCH2 and NCHHCH), 3.50-3.56 (1H, m, CHOH), 5.32 (1H, d, J 5.1, CHCl), 7.16-7.22 
(4H, stack, ArH), 7.42 (2H, d, J 8.3, ArH), 7.50 (2H, d, J 8.3 ArH) 
m/z: (ES)+ 416.1 (100%, [M+Na] 
HRMS: Found: (M+Na)+ 416.1032. C20H24ClNNaO3S requires M, 416.1063 
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(3S*,4S*)-3-((R*)-chloro(phenyl)methyl)-1-tosylpiperidin-4-ol (197f) 
 
Piperidine 197f was prepared from aldehyde 194f (100 mg, 0.29 mmol) and 
MeAlCl2 (1 M soln. in hexanes, 0.58 mL, 0.58 mmol) in CH2Cl2 (3.0 mL) 
according to General Procedure 13. Purification by flash column 
chromatography (Rf = 0.47, hexane:EtOAc, 1:1) afforded the products 197(R)f and 198(S)f in 
a 5:1 mixture as a colourless oil (78 mg, 71%). In the case of the NMR spectra, only data for 
the major piperidine 197(R)f are reported. 
max: (film)/cm
-1 3535 (OH), 2925 (CH), 2856 (CH), 1334 (as SO2), 1154 (s SO2) 
H: (400 MHz, CDCl3) 1.48-1.504 (1H, stack CHHCHO), 1.74-1.90 (2H, stack, CHHCHOH 
and OH), 1.99-1.08 (1H, m, CHCHOH), 2.37 (3H, s, CH3), 2.58-2.67 (1H, m, NCHHCH2), 
2.87 (1H, dd, J 11.4 and 8.9, NCHHCH), 3.36-3.41 (2H, stack, NCHHCH2 and NCHHCH), 
3.46-3.55 (1H, m, CHOH), 5.35 (1H, d, J 5.0, CHCl), 7.12-7.22 (6H, stack, ArH), 7.48 (2H, 
d, J 8.3, ArH) 
C: (101 MHz, CDCl3) 21.6 (CH3), 29.7 (NCH2CH2), 43.8 (CH2), 43.9 (CH2), 49.8 
(CHCHOH),  61.4 (CHCl), 67.5 (CHOH), 127.1 (ArCH), 127.6 (ArCH), 128.4 (ArCH), 128.8 
(ArCH), 129.8 (ArCH), 133.4 (Cq), 133.3 (Cq), 139.0 (Cq), 143.7 (Cq) 
m/z: (ES)+ 404.1 [22%, M37Cl], 402.1 (100, [M35Cl+Na] 
HRMS: Found: (M+Na)+ 402.08084. C19H22ClNNaO3S requires M, 402.0907 
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6. Appendix 
HPLC trace of the crude reaction mixture from the Prins cyclisation 
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HPLC trace of trans piperidine 98 
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HPLC trace of cis piperidine 96 
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HPLC trace of trans chloride 99 
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